株探米国株
日本語 英語
エドガーで原本を確認する
000032033512/312025Q1FALSEhttp://fasb.org/us-gaap/2024#RealizedInvestmentGainsLosseshttp://fasb.org/us-gaap/2024#OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParenthttp://fasb.org/us-gaap/2024#RealizedInvestmentGainsLosseshttp://fasb.org/us-gaap/2024#OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentxbrli:sharesiso4217:USDiso4217:USDxbrli:sharesgl:segmentxbrli:puregl:Issuegl:issuergl:securitygl:loangl:guaranteegl:complainantgl:claimgl:extension_option00003203352025-01-012025-03-310000320335us-gaap:CommonStockMember2025-01-012025-03-310000320335gl:JuniorSubordinatedDebenturesMember2025-01-012025-03-3100003203352025-04-3000003203352025-03-3100003203352024-12-310000320335gl:PartnershipInterestFairValueOptionMember2025-03-310000320335gl:PartnershipInterestFairValueOptionMember2024-12-310000320335us-gaap:LifeInsuranceSegmentMember2025-01-012025-03-310000320335us-gaap:LifeInsuranceSegmentMember2024-01-012024-03-310000320335us-gaap:HealthInsuranceProductLineMember2025-01-012025-03-310000320335us-gaap:HealthInsuranceProductLineMember2024-01-012024-03-3100003203352024-01-012024-03-310000320335us-gaap:OtherInsuranceProductLineMember2025-01-012025-03-310000320335us-gaap:OtherInsuranceProductLineMember2024-01-012024-03-310000320335us-gaap:PreferredStockMember2024-12-310000320335us-gaap:CommonStockMember2024-12-310000320335us-gaap:AdditionalPaidInCapitalMember2024-12-310000320335us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310000320335us-gaap:RetainedEarningsMember2024-12-310000320335us-gaap:TreasuryStockCommonMember2024-12-310000320335us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310000320335us-gaap:RetainedEarningsMember2025-01-012025-03-310000320335us-gaap:TreasuryStockCommonMember2025-01-012025-03-310000320335us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310000320335us-gaap:PreferredStockMember2025-03-310000320335us-gaap:CommonStockMember2025-03-310000320335us-gaap:AdditionalPaidInCapitalMember2025-03-310000320335us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-310000320335us-gaap:RetainedEarningsMember2025-03-310000320335us-gaap:TreasuryStockCommonMember2025-03-310000320335us-gaap:PreferredStockMember2023-12-310000320335us-gaap:CommonStockMember2023-12-310000320335us-gaap:AdditionalPaidInCapitalMember2023-12-310000320335us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310000320335us-gaap:RetainedEarningsMember2023-12-310000320335us-gaap:TreasuryStockCommonMember2023-12-3100003203352023-12-310000320335us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310000320335us-gaap:RetainedEarningsMember2024-01-012024-03-310000320335us-gaap:TreasuryStockCommonMember2024-01-012024-03-310000320335us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310000320335us-gaap:PreferredStockMember2024-03-310000320335us-gaap:CommonStockMember2024-03-310000320335us-gaap:AdditionalPaidInCapitalMember2024-03-310000320335us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310000320335us-gaap:RetainedEarningsMember2024-03-310000320335us-gaap:TreasuryStockCommonMember2024-03-3100003203352024-03-3100003203352025-01-010000320335us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-12-310000320335gl:FuturePolicyBenefitsMember2024-12-310000320335us-gaap:AccumulatedTranslationAdjustmentMember2024-12-310000320335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-12-310000320335us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2025-01-012025-03-310000320335gl:FuturePolicyBenefitsMember2025-01-012025-03-310000320335us-gaap:AccumulatedTranslationAdjustmentMember2025-01-012025-03-310000320335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2025-01-012025-03-310000320335us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2025-03-310000320335gl:FuturePolicyBenefitsMember2025-03-310000320335us-gaap:AccumulatedTranslationAdjustmentMember2025-03-310000320335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2025-03-310000320335us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-12-310000320335gl:FuturePolicyBenefitsMember2023-12-310000320335us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310000320335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-12-310000320335us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-01-012024-03-310000320335gl:FuturePolicyBenefitsMember2024-01-012024-03-310000320335us-gaap:AccumulatedTranslationAdjustmentMember2024-01-012024-03-310000320335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-01-012024-03-310000320335us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-03-310000320335gl:FuturePolicyBenefitsMember2024-03-310000320335us-gaap:AccumulatedTranslationAdjustmentMember2024-03-310000320335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-03-310000320335us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310000320335us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310000320335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310000320335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310000320335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310000320335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310000320335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310000320335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310000320335us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310000320335us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310000320335gl:USGovernmentDirectGuaranteedAndGovernmentSponsoredEnterprisesMember2025-03-310000320335us-gaap:USStatesAndPoliticalSubdivisionsMember2025-03-310000320335us-gaap:ForeignGovernmentDebtSecuritiesMember2025-03-310000320335gl:IndustrialsMemberus-gaap:CorporateDebtSecuritiesMember2025-03-310000320335gl:FinancialMemberus-gaap:CorporateDebtSecuritiesMember2025-03-310000320335gl:UtilitiesMemberus-gaap:CorporateDebtSecuritiesMember2025-03-310000320335us-gaap:CorporateDebtSecuritiesMember2025-03-310000320335us-gaap:CollateralizedDebtObligationsMember2025-03-310000320335gl:OtherAssetBackedSecuritiesMember2025-03-310000320335gl:USGovernmentDirectGuaranteedAndGovernmentSponsoredEnterprisesMember2024-12-310000320335us-gaap:USStatesAndPoliticalSubdivisionsMember2024-12-310000320335us-gaap:ForeignGovernmentDebtSecuritiesMember2024-12-310000320335gl:IndustrialsMemberus-gaap:CorporateDebtSecuritiesMember2024-12-310000320335gl:FinancialMemberus-gaap:CorporateDebtSecuritiesMember2024-12-310000320335gl:UtilitiesMemberus-gaap:CorporateDebtSecuritiesMember2024-12-310000320335us-gaap:CorporateDebtSecuritiesMember2024-12-310000320335us-gaap:CollateralizedDebtObligationsMember2024-12-310000320335gl:OtherAssetBackedSecuritiesMember2024-12-310000320335us-gaap:FixedMaturitiesMember2025-03-310000320335us-gaap:FixedMaturitiesMember2024-12-310000320335gl:RealEstateInvestmentTrustMemberus-gaap:FixedMaturitiesMemberus-gaap:CorporateDebtSecuritiesMember2025-03-310000320335gl:RealEstateInvestmentTrustMemberus-gaap:FixedMaturitiesMemberus-gaap:CorporateDebtSecuritiesMember2024-12-310000320335us-gaap:FixedMaturitiesMember2025-01-012025-03-310000320335us-gaap:FixedMaturitiesMember2024-01-012024-03-310000320335us-gaap:PolicyLoansMember2025-01-012025-03-310000320335us-gaap:PolicyLoansMember2024-01-012024-03-310000320335gl:MortgageLoansMember2025-01-012025-03-310000320335gl:MortgageLoansMember2024-01-012024-03-310000320335us-gaap:OtherLongTermInvestmentsMember2025-01-012025-03-310000320335us-gaap:OtherLongTermInvestmentsMember2024-01-012024-03-310000320335us-gaap:ShortTermInvestmentsMember2025-01-012025-03-310000320335us-gaap:ShortTermInvestmentsMember2024-01-012024-03-310000320335us-gaap:FairValueOptionOtherEligibleItemsMember2025-01-012025-03-310000320335us-gaap:FairValueOptionOtherEligibleItemsMember2024-01-012024-03-310000320335us-gaap:FairValueInputsLevel1Membergl:USGovernmentDirectGuaranteedAndGovernmentSponsoredEnterprisesMember2025-03-310000320335us-gaap:FairValueInputsLevel2Membergl:USGovernmentDirectGuaranteedAndGovernmentSponsoredEnterprisesMember2025-03-310000320335us-gaap:FairValueInputsLevel3Membergl:USGovernmentDirectGuaranteedAndGovernmentSponsoredEnterprisesMember2025-03-310000320335us-gaap:FairValueInputsLevel1Memberus-gaap:USStatesAndPoliticalSubdivisionsMember2025-03-310000320335us-gaap:FairValueInputsLevel2Memberus-gaap:USStatesAndPoliticalSubdivisionsMember2025-03-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:USStatesAndPoliticalSubdivisionsMember2025-03-310000320335us-gaap:FairValueInputsLevel1Memberus-gaap:ForeignGovernmentDebtSecuritiesMember2025-03-310000320335us-gaap:FairValueInputsLevel2Memberus-gaap:ForeignGovernmentDebtSecuritiesMember2025-03-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:ForeignGovernmentDebtSecuritiesMember2025-03-310000320335us-gaap:FairValueInputsLevel1Membergl:IndustrialsMemberus-gaap:CorporateDebtSecuritiesMember2025-03-310000320335us-gaap:FairValueInputsLevel2Membergl:IndustrialsMemberus-gaap:CorporateDebtSecuritiesMember2025-03-310000320335us-gaap:FairValueInputsLevel3Membergl:IndustrialsMemberus-gaap:CorporateDebtSecuritiesMember2025-03-310000320335us-gaap:FairValueInputsLevel1Membergl:FinancialMemberus-gaap:CorporateDebtSecuritiesMember2025-03-310000320335us-gaap:FairValueInputsLevel2Membergl:FinancialMemberus-gaap:CorporateDebtSecuritiesMember2025-03-310000320335us-gaap:FairValueInputsLevel3Membergl:FinancialMemberus-gaap:CorporateDebtSecuritiesMember2025-03-310000320335us-gaap:FairValueInputsLevel1Membergl:UtilitiesMemberus-gaap:CorporateDebtSecuritiesMember2025-03-310000320335us-gaap:FairValueInputsLevel2Membergl:UtilitiesMemberus-gaap:CorporateDebtSecuritiesMember2025-03-310000320335us-gaap:FairValueInputsLevel3Membergl:UtilitiesMemberus-gaap:CorporateDebtSecuritiesMember2025-03-310000320335us-gaap:FairValueInputsLevel1Memberus-gaap:CorporateDebtSecuritiesMember2025-03-310000320335us-gaap:FairValueInputsLevel2Memberus-gaap:CorporateDebtSecuritiesMember2025-03-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2025-03-310000320335us-gaap:FairValueInputsLevel1Memberus-gaap:CollateralizedDebtObligationsMember2025-03-310000320335us-gaap:FairValueInputsLevel2Memberus-gaap:CollateralizedDebtObligationsMember2025-03-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:CollateralizedDebtObligationsMember2025-03-310000320335us-gaap:FairValueInputsLevel1Membergl:OtherAssetBackedSecuritiesMember2025-03-310000320335us-gaap:FairValueInputsLevel2Membergl:OtherAssetBackedSecuritiesMember2025-03-310000320335us-gaap:FairValueInputsLevel3Membergl:OtherAssetBackedSecuritiesMember2025-03-310000320335us-gaap:FairValueInputsLevel1Member2025-03-310000320335us-gaap:FairValueInputsLevel2Member2025-03-310000320335us-gaap:FairValueInputsLevel3Member2025-03-310000320335us-gaap:FairValueInputsLevel1Membergl:USGovernmentDirectGuaranteedAndGovernmentSponsoredEnterprisesMember2024-12-310000320335us-gaap:FairValueInputsLevel2Membergl:USGovernmentDirectGuaranteedAndGovernmentSponsoredEnterprisesMember2024-12-310000320335us-gaap:FairValueInputsLevel3Membergl:USGovernmentDirectGuaranteedAndGovernmentSponsoredEnterprisesMember2024-12-310000320335us-gaap:FairValueInputsLevel1Memberus-gaap:USStatesAndPoliticalSubdivisionsMember2024-12-310000320335us-gaap:FairValueInputsLevel2Memberus-gaap:USStatesAndPoliticalSubdivisionsMember2024-12-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:USStatesAndPoliticalSubdivisionsMember2024-12-310000320335us-gaap:FairValueInputsLevel1Memberus-gaap:ForeignGovernmentDebtSecuritiesMember2024-12-310000320335us-gaap:FairValueInputsLevel2Memberus-gaap:ForeignGovernmentDebtSecuritiesMember2024-12-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:ForeignGovernmentDebtSecuritiesMember2024-12-310000320335us-gaap:FairValueInputsLevel1Membergl:IndustrialsMemberus-gaap:CorporateDebtSecuritiesMember2024-12-310000320335us-gaap:FairValueInputsLevel2Membergl:IndustrialsMemberus-gaap:CorporateDebtSecuritiesMember2024-12-310000320335us-gaap:FairValueInputsLevel3Membergl:IndustrialsMemberus-gaap:CorporateDebtSecuritiesMember2024-12-310000320335us-gaap:FairValueInputsLevel1Membergl:FinancialMemberus-gaap:CorporateDebtSecuritiesMember2024-12-310000320335us-gaap:FairValueInputsLevel2Membergl:FinancialMemberus-gaap:CorporateDebtSecuritiesMember2024-12-310000320335us-gaap:FairValueInputsLevel3Membergl:FinancialMemberus-gaap:CorporateDebtSecuritiesMember2024-12-310000320335us-gaap:FairValueInputsLevel1Membergl:UtilitiesMemberus-gaap:CorporateDebtSecuritiesMember2024-12-310000320335us-gaap:FairValueInputsLevel2Membergl:UtilitiesMemberus-gaap:CorporateDebtSecuritiesMember2024-12-310000320335us-gaap:FairValueInputsLevel3Membergl:UtilitiesMemberus-gaap:CorporateDebtSecuritiesMember2024-12-310000320335us-gaap:FairValueInputsLevel1Memberus-gaap:CorporateDebtSecuritiesMember2024-12-310000320335us-gaap:FairValueInputsLevel2Memberus-gaap:CorporateDebtSecuritiesMember2024-12-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2024-12-310000320335us-gaap:FairValueInputsLevel1Memberus-gaap:CollateralizedDebtObligationsMember2024-12-310000320335us-gaap:FairValueInputsLevel2Memberus-gaap:CollateralizedDebtObligationsMember2024-12-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:CollateralizedDebtObligationsMember2024-12-310000320335us-gaap:FairValueInputsLevel1Membergl:OtherAssetBackedSecuritiesMember2024-12-310000320335us-gaap:FairValueInputsLevel2Membergl:OtherAssetBackedSecuritiesMember2024-12-310000320335us-gaap:FairValueInputsLevel3Membergl:OtherAssetBackedSecuritiesMember2024-12-310000320335us-gaap:FairValueInputsLevel1Member2024-12-310000320335us-gaap:FairValueInputsLevel2Member2024-12-310000320335us-gaap:FairValueInputsLevel3Member2024-12-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:AssetBackedSecuritiesMember2024-12-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:AssetBackedSecuritiesMember2025-01-012025-03-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:CollateralizedDebtObligationsMember2025-01-012025-03-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2025-01-012025-03-310000320335us-gaap:FairValueInputsLevel3Member2025-01-012025-03-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:AssetBackedSecuritiesMember2025-03-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:AssetBackedSecuritiesMember2023-12-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:CollateralizedDebtObligationsMember2023-12-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2023-12-310000320335us-gaap:FairValueInputsLevel3Member2023-12-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:AssetBackedSecuritiesMember2024-01-012024-03-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:CollateralizedDebtObligationsMember2024-01-012024-03-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2024-01-012024-03-310000320335us-gaap:FairValueInputsLevel3Member2024-01-012024-03-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:AssetBackedSecuritiesMember2024-03-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:CollateralizedDebtObligationsMember2024-03-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2024-03-310000320335us-gaap:FairValueInputsLevel3Member2024-03-310000320335us-gaap:AssetBackedSecuritiesMember2025-01-012025-03-310000320335us-gaap:CollateralizedDebtObligationsMember2025-01-012025-03-310000320335us-gaap:CorporateDebtSecuritiesMember2025-01-012025-03-310000320335us-gaap:AssetBackedSecuritiesMember2024-01-012024-03-310000320335us-gaap:CollateralizedDebtObligationsMember2024-01-012024-03-310000320335us-gaap:CorporateDebtSecuritiesMember2024-01-012024-03-310000320335us-gaap:FairValueInputsLevel3Membergl:PrivatePlacementNotesMember2025-03-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMemberus-gaap:CollateralizedDebtObligationsMember2025-03-310000320335srt:WeightedAverageMemberus-gaap:CollateralizedDebtObligationsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2025-03-310000320335us-gaap:ExternalCreditRatingInvestmentGradeMembergl:USGovernmentDirectGuaranteedAndGovernmentSponsoredEnterprisesMember2025-03-310000320335us-gaap:ExternalCreditRatingInvestmentGradeMemberus-gaap:USStatesAndPoliticalSubdivisionsMember2025-03-310000320335us-gaap:ExternalCreditRatingInvestmentGradeMemberus-gaap:ForeignGovernmentDebtSecuritiesMember2025-03-310000320335gl:IndustrialsMemberus-gaap:ExternalCreditRatingInvestmentGradeMemberus-gaap:CorporateDebtSecuritiesMember2025-03-310000320335gl:FinancialMemberus-gaap:ExternalCreditRatingInvestmentGradeMemberus-gaap:CorporateDebtSecuritiesMember2025-03-310000320335gl:UtilitiesMemberus-gaap:ExternalCreditRatingInvestmentGradeMemberus-gaap:CorporateDebtSecuritiesMember2025-03-310000320335us-gaap:ExternalCreditRatingInvestmentGradeMemberus-gaap:CorporateDebtSecuritiesMember2025-03-310000320335us-gaap:ExternalCreditRatingInvestmentGradeMembergl:OtherAssetBackedSecuritiesMember2025-03-310000320335us-gaap:ExternalCreditRatingInvestmentGradeMember2025-03-310000320335gl:IndustrialsMemberus-gaap:ExternalCreditRatingNonInvestmentGradeMemberus-gaap:CorporateDebtSecuritiesMember2025-03-310000320335gl:FinancialMemberus-gaap:ExternalCreditRatingNonInvestmentGradeMemberus-gaap:CorporateDebtSecuritiesMember2025-03-310000320335gl:UtilitiesMemberus-gaap:ExternalCreditRatingNonInvestmentGradeMemberus-gaap:CorporateDebtSecuritiesMember2025-03-310000320335us-gaap:ExternalCreditRatingNonInvestmentGradeMemberus-gaap:CorporateDebtSecuritiesMember2025-03-310000320335us-gaap:ExternalCreditRatingNonInvestmentGradeMembergl:OtherAssetBackedSecuritiesMember2025-03-310000320335us-gaap:ExternalCreditRatingNonInvestmentGradeMember2025-03-310000320335us-gaap:ExternalCreditRatingInvestmentGradeMembergl:USGovernmentDirectGuaranteedAndGovernmentSponsoredEnterprisesMember2024-12-310000320335us-gaap:ExternalCreditRatingInvestmentGradeMemberus-gaap:USStatesAndPoliticalSubdivisionsMember2024-12-310000320335us-gaap:ExternalCreditRatingInvestmentGradeMemberus-gaap:ForeignGovernmentDebtSecuritiesMember2024-12-310000320335gl:IndustrialsMemberus-gaap:ExternalCreditRatingInvestmentGradeMemberus-gaap:CorporateDebtSecuritiesMember2024-12-310000320335gl:FinancialMemberus-gaap:ExternalCreditRatingInvestmentGradeMemberus-gaap:CorporateDebtSecuritiesMember2024-12-310000320335gl:UtilitiesMemberus-gaap:ExternalCreditRatingInvestmentGradeMemberus-gaap:CorporateDebtSecuritiesMember2024-12-310000320335us-gaap:ExternalCreditRatingInvestmentGradeMemberus-gaap:CorporateDebtSecuritiesMember2024-12-310000320335us-gaap:ExternalCreditRatingInvestmentGradeMembergl:OtherAssetBackedSecuritiesMember2024-12-310000320335us-gaap:ExternalCreditRatingInvestmentGradeMember2024-12-310000320335gl:IndustrialsMemberus-gaap:ExternalCreditRatingNonInvestmentGradeMemberus-gaap:CorporateDebtSecuritiesMember2024-12-310000320335gl:FinancialMemberus-gaap:ExternalCreditRatingNonInvestmentGradeMemberus-gaap:CorporateDebtSecuritiesMember2024-12-310000320335gl:UtilitiesMemberus-gaap:ExternalCreditRatingNonInvestmentGradeMemberus-gaap:CorporateDebtSecuritiesMember2024-12-310000320335us-gaap:ExternalCreditRatingNonInvestmentGradeMemberus-gaap:CorporateDebtSecuritiesMember2024-12-310000320335us-gaap:ExternalCreditRatingNonInvestmentGradeMembergl:OtherAssetBackedSecuritiesMember2024-12-310000320335us-gaap:ExternalCreditRatingNonInvestmentGradeMember2024-12-310000320335gl:SeniorLoansInDefaultAndOnNonAccrualStatusMember2025-01-012025-03-310000320335gl:SeniorLoansInDefaultAndOnNonAccrualStatusMember2024-01-012024-12-310000320335gl:SeniorLoansInDefaultAndOnNonAccrualStatusMember2024-12-310000320335gl:SeniorLoansInDefaultAndOnNonAccrualStatusMember2025-03-310000320335srt:IndustrialPropertyMember2025-03-310000320335srt:IndustrialPropertyMember2024-12-310000320335srt:MultifamilyMember2025-03-310000320335srt:MultifamilyMember2024-12-310000320335gl:HospitalityMember2025-03-310000320335gl:HospitalityMember2024-12-310000320335gl:RetailPropertyMember2025-03-310000320335gl:RetailPropertyMember2024-12-310000320335gl:MixedUseMember2025-03-310000320335gl:MixedUseMember2024-12-310000320335srt:OfficeBuildingMember2025-03-310000320335srt:OfficeBuildingMember2024-12-310000320335stpr:FL2025-03-310000320335stpr:FL2024-12-310000320335stpr:TX2025-03-310000320335stpr:TX2024-12-310000320335stpr:NJ2025-03-310000320335stpr:NJ2024-12-310000320335stpr:CA2025-03-310000320335stpr:CA2024-12-310000320335stpr:AL2025-03-310000320335stpr:AL2024-12-310000320335stpr:NY2025-03-310000320335stpr:NY2024-12-310000320335gl:OtherGeographicalLocationMember2025-03-310000320335gl:OtherGeographicalLocationMember2024-12-310000320335gl:DebtServiceCoverageRatioLessThan1.00xMembergl:LTVLessThan70PercentMember2025-03-310000320335gl:DebtServiceCoverageRatio1.00x1.20xMembergl:LTVLessThan70PercentMember2025-03-310000320335gl:DebtServiceCoverageRatioGreaterThan1.20xMembergl:LTVLessThan70PercentMember2025-03-310000320335gl:LTVLessThan70PercentMember2025-03-310000320335gl:DebtServiceCoverageRatioLessThan1.00xMembergl:LTV70PercentTo80PercentMember2025-03-310000320335gl:DebtServiceCoverageRatio1.00x1.20xMembergl:LTV70PercentTo80PercentMember2025-03-310000320335gl:DebtServiceCoverageRatioGreaterThan1.20xMembergl:LTV70PercentTo80PercentMember2025-03-310000320335gl:LTV70PercentTo80PercentMember2025-03-310000320335gl:DebtServiceCoverageRatioLessThan1.00xMembergl:LTV81PercentTo90PercentMember2025-03-310000320335gl:DebtServiceCoverageRatio1.00x1.20xMembergl:LTV81PercentTo90PercentMember2025-03-310000320335gl:DebtServiceCoverageRatioGreaterThan1.20xMembergl:LTV81PercentTo90PercentMember2025-03-310000320335gl:LTV81PercentTo90PercentMember2025-03-310000320335gl:DebtServiceCoverageRatioLessThan1.00xMembergl:LTVGreaterThan90PercentMember2025-03-310000320335gl:DebtServiceCoverageRatio1.00x1.20xMembergl:LTVGreaterThan90PercentMember2025-03-310000320335gl:DebtServiceCoverageRatioGreaterThan1.20xMembergl:LTVGreaterThan90PercentMember2025-03-310000320335gl:LTVGreaterThan90PercentMember2025-03-310000320335gl:DebtServiceCoverageRatioLessThan1.00xMember2025-03-310000320335gl:DebtServiceCoverageRatio1.00x1.20xMember2025-03-310000320335gl:DebtServiceCoverageRatioGreaterThan1.20xMember2025-03-310000320335gl:DebtServiceCoverageRatioLessThan1.00xMembergl:LTVLessThan70PercentMember2024-12-310000320335gl:DebtServiceCoverageRatio1.00x1.20xMembergl:LTVLessThan70PercentMember2024-12-310000320335gl:DebtServiceCoverageRatioGreaterThan1.20xMembergl:LTVLessThan70PercentMember2024-12-310000320335gl:LTVLessThan70PercentMember2024-12-310000320335gl:DebtServiceCoverageRatioLessThan1.00xMembergl:LTV70PercentTo80PercentMember2024-12-310000320335gl:DebtServiceCoverageRatio1.00x1.20xMembergl:LTV70PercentTo80PercentMember2024-12-310000320335gl:DebtServiceCoverageRatioGreaterThan1.20xMembergl:LTV70PercentTo80PercentMember2024-12-310000320335gl:LTV70PercentTo80PercentMember2024-12-310000320335gl:DebtServiceCoverageRatioLessThan1.00xMembergl:LTV81PercentTo90PercentMember2024-12-310000320335gl:DebtServiceCoverageRatio1.00x1.20xMembergl:LTV81PercentTo90PercentMember2024-12-310000320335gl:DebtServiceCoverageRatioGreaterThan1.20xMembergl:LTV81PercentTo90PercentMember2024-12-310000320335gl:LTV81PercentTo90PercentMember2024-12-310000320335gl:DebtServiceCoverageRatioLessThan1.00xMembergl:LTVGreaterThan90PercentMember2024-12-310000320335gl:DebtServiceCoverageRatio1.00x1.20xMembergl:LTVGreaterThan90PercentMember2024-12-310000320335gl:DebtServiceCoverageRatioGreaterThan1.20xMembergl:LTVGreaterThan90PercentMember2024-12-310000320335gl:LTVGreaterThan90PercentMember2024-12-310000320335gl:DebtServiceCoverageRatioLessThan1.00xMember2024-12-310000320335gl:DebtServiceCoverageRatio1.00x1.20xMember2024-12-310000320335gl:DebtServiceCoverageRatioGreaterThan1.20xMember2024-12-310000320335gl:CollaterallyDependentLoansMemberus-gaap:CommercialPortfolioSegmentMember2025-03-310000320335gl:CollaterallyDependentLoansMemberus-gaap:CommercialPortfolioSegmentMember2025-01-012025-03-310000320335gl:ForeclosedLoansMemberus-gaap:CommercialPortfolioSegmentMember2025-03-310000320335gl:LoansInProcessOfForeclosureMemberus-gaap:CommercialPortfolioSegmentMember2025-03-310000320335gl:NonaccrualLoansMemberus-gaap:CommercialPortfolioSegmentMember2025-03-310000320335gl:NonaccrualLoansMemberus-gaap:CommercialPortfolioSegmentMember2024-12-310000320335us-gaap:UnfundedLoanCommitmentMemberus-gaap:CommercialPortfolioSegmentMember2025-03-310000320335gl:CompanyOwnedLifeInsuranceMember2025-03-310000320335gl:CompanyOwnedLifeInsuranceMember2024-12-310000320335us-gaap:OtherInvestmentsMember2025-03-310000320335us-gaap:OtherInvestmentsMember2024-12-310000320335us-gaap:CommercialMortgageBackedSecuritiesMember2025-03-310000320335us-gaap:CommercialMortgageBackedSecuritiesMember2024-12-310000320335gl:OpportunisticAndPrivateCreditMember2025-03-310000320335gl:OpportunisticAndPrivateCreditMember2024-12-310000320335gl:InfrastructureMember2025-03-310000320335gl:InfrastructureMember2024-12-310000320335srt:PartnershipInterestMember2025-03-310000320335srt:PartnershipInterestMember2024-12-310000320335srt:MinimumMember2025-01-012025-03-310000320335srt:MaximumMember2025-01-012025-03-310000320335srt:PartnershipInterestMember2025-01-012025-03-310000320335us-gaap:LetterOfCreditMember2025-03-3100003203352024-04-302024-04-3000003203352024-11-1400003203352024-11-252024-11-2500003203352024-09-262024-09-260000320335gl:AmericanIncomeExclusiveMembergl:LifeSegmentMember2023-12-310000320335gl:DirectToConsumerMembergl:LifeSegmentMember2023-12-310000320335gl:LibertyNationalExclusiveMembergl:LifeSegmentMember2023-12-310000320335us-gaap:OtherInsuranceProductLineMembergl:LifeSegmentMember2023-12-310000320335gl:LifeSegmentMember2023-12-310000320335gl:AmericanIncomeExclusiveMembergl:LifeSegmentMember2024-01-012024-03-310000320335gl:DirectToConsumerMembergl:LifeSegmentMember2024-01-012024-03-310000320335gl:LibertyNationalExclusiveMembergl:LifeSegmentMember2024-01-012024-03-310000320335us-gaap:OtherInsuranceProductLineMembergl:LifeSegmentMember2024-01-012024-03-310000320335gl:LifeSegmentMember2024-01-012024-03-310000320335gl:AmericanIncomeExclusiveMembergl:LifeSegmentMember2024-03-310000320335gl:DirectToConsumerMembergl:LifeSegmentMember2024-03-310000320335gl:LibertyNationalExclusiveMembergl:LifeSegmentMember2024-03-310000320335us-gaap:OtherInsuranceProductLineMembergl:LifeSegmentMember2024-03-310000320335gl:LifeSegmentMember2024-03-310000320335gl:AmericanIncomeExclusiveMembergl:LifeSegmentMember2024-12-310000320335gl:DirectToConsumerMembergl:LifeSegmentMember2024-12-310000320335gl:LibertyNationalExclusiveMembergl:LifeSegmentMember2024-12-310000320335us-gaap:OtherInsuranceProductLineMembergl:LifeSegmentMember2024-12-310000320335gl:LifeSegmentMember2024-12-310000320335gl:AmericanIncomeExclusiveMembergl:LifeSegmentMember2025-01-012025-03-310000320335gl:DirectToConsumerMembergl:LifeSegmentMember2025-01-012025-03-310000320335gl:LibertyNationalExclusiveMembergl:LifeSegmentMember2025-01-012025-03-310000320335us-gaap:OtherInsuranceProductLineMembergl:LifeSegmentMember2025-01-012025-03-310000320335gl:LifeSegmentMember2025-01-012025-03-310000320335gl:AmericanIncomeExclusiveMembergl:LifeSegmentMember2025-03-310000320335gl:DirectToConsumerMembergl:LifeSegmentMember2025-03-310000320335gl:LibertyNationalExclusiveMembergl:LifeSegmentMember2025-03-310000320335us-gaap:OtherInsuranceProductLineMembergl:LifeSegmentMember2025-03-310000320335gl:LifeSegmentMember2025-03-310000320335gl:UnitedAmericanIndependentMembergl:HealthSegmentMember2023-12-310000320335gl:FamilyHeritageMembergl:HealthSegmentMember2023-12-310000320335gl:LibertyNationalExclusiveMembergl:HealthSegmentMember2023-12-310000320335gl:AmericanIncomeExclusiveMembergl:HealthSegmentMember2023-12-310000320335gl:DirectToConsumerMembergl:HealthSegmentMember2023-12-310000320335gl:HealthSegmentMember2023-12-310000320335gl:UnitedAmericanIndependentMembergl:HealthSegmentMember2024-01-012024-03-310000320335gl:FamilyHeritageMembergl:HealthSegmentMember2024-01-012024-03-310000320335gl:LibertyNationalExclusiveMembergl:HealthSegmentMember2024-01-012024-03-310000320335gl:AmericanIncomeExclusiveMembergl:HealthSegmentMember2024-01-012024-03-310000320335gl:DirectToConsumerMembergl:HealthSegmentMember2024-01-012024-03-310000320335gl:HealthSegmentMember2024-01-012024-03-310000320335gl:UnitedAmericanIndependentMembergl:HealthSegmentMember2024-03-310000320335gl:FamilyHeritageMembergl:HealthSegmentMember2024-03-310000320335gl:LibertyNationalExclusiveMembergl:HealthSegmentMember2024-03-310000320335gl:AmericanIncomeExclusiveMembergl:HealthSegmentMember2024-03-310000320335gl:DirectToConsumerMembergl:HealthSegmentMember2024-03-310000320335gl:HealthSegmentMember2024-03-310000320335gl:UnitedAmericanIndependentMembergl:HealthSegmentMember2024-12-310000320335gl:FamilyHeritageMembergl:HealthSegmentMember2024-12-310000320335gl:LibertyNationalExclusiveMembergl:HealthSegmentMember2024-12-310000320335gl:AmericanIncomeExclusiveMembergl:HealthSegmentMember2024-12-310000320335gl:DirectToConsumerMembergl:HealthSegmentMember2024-12-310000320335gl:HealthSegmentMember2024-12-310000320335gl:UnitedAmericanIndependentMembergl:HealthSegmentMember2025-01-012025-03-310000320335gl:FamilyHeritageMembergl:HealthSegmentMember2025-01-012025-03-310000320335gl:LibertyNationalExclusiveMembergl:HealthSegmentMember2025-01-012025-03-310000320335gl:AmericanIncomeExclusiveMembergl:HealthSegmentMember2025-01-012025-03-310000320335gl:DirectToConsumerMembergl:HealthSegmentMember2025-01-012025-03-310000320335gl:HealthSegmentMember2025-01-012025-03-310000320335gl:UnitedAmericanIndependentMembergl:HealthSegmentMember2025-03-310000320335gl:FamilyHeritageMembergl:HealthSegmentMember2025-03-310000320335gl:LibertyNationalExclusiveMembergl:HealthSegmentMember2025-03-310000320335gl:AmericanIncomeExclusiveMembergl:HealthSegmentMember2025-03-310000320335gl:DirectToConsumerMembergl:HealthSegmentMember2025-03-310000320335gl:HealthSegmentMember2025-03-310000320335gl:GainLossFromExperienceMembergl:AmericanIncomeExclusiveMembergl:LifeSegmentMember2025-01-012025-03-310000320335gl:GainLossFromExperienceMembergl:AmericanIncomeExclusiveMembergl:LifeSegmentMember2024-01-012024-03-310000320335gl:GainLossFromExperienceMembergl:DirectToConsumerMembergl:LifeSegmentMember2025-01-012025-03-310000320335gl:GainLossFromExperienceMembergl:DirectToConsumerMembergl:LifeSegmentMember2024-01-012024-03-310000320335gl:GainLossFromExperienceMembergl:LibertyNationalExclusiveMembergl:LifeSegmentMember2025-01-012025-03-310000320335gl:GainLossFromExperienceMembergl:LibertyNationalExclusiveMembergl:LifeSegmentMember2024-01-012024-03-310000320335gl:GainLossFromExperienceMemberus-gaap:OtherInsuranceProductLineMembergl:LifeSegmentMember2025-01-012025-03-310000320335gl:GainLossFromExperienceMemberus-gaap:OtherInsuranceProductLineMembergl:LifeSegmentMember2024-01-012024-03-310000320335gl:GainLossFromExperienceMembergl:LifeSegmentMember2025-01-012025-03-310000320335gl:GainLossFromExperienceMembergl:LifeSegmentMember2024-01-012024-03-310000320335gl:GainLossFromUnlockingAssumptionsMembergl:AmericanIncomeExclusiveMembergl:LifeSegmentMember2025-01-012025-03-310000320335gl:GainLossFromUnlockingAssumptionsMembergl:AmericanIncomeExclusiveMembergl:LifeSegmentMember2024-01-012024-03-310000320335gl:GainLossFromUnlockingAssumptionsMembergl:DirectToConsumerMembergl:LifeSegmentMember2025-01-012025-03-310000320335gl:GainLossFromUnlockingAssumptionsMembergl:DirectToConsumerMembergl:LifeSegmentMember2024-01-012024-03-310000320335gl:GainLossFromUnlockingAssumptionsMembergl:LibertyNationalExclusiveMembergl:LifeSegmentMember2025-01-012025-03-310000320335gl:GainLossFromUnlockingAssumptionsMembergl:LibertyNationalExclusiveMembergl:LifeSegmentMember2024-01-012024-03-310000320335gl:GainLossFromUnlockingAssumptionsMemberus-gaap:OtherInsuranceProductLineMembergl:LifeSegmentMember2025-01-012025-03-310000320335gl:GainLossFromUnlockingAssumptionsMemberus-gaap:OtherInsuranceProductLineMembergl:LifeSegmentMember2024-01-012024-03-310000320335gl:GainLossFromUnlockingAssumptionsMembergl:LifeSegmentMember2025-01-012025-03-310000320335gl:GainLossFromUnlockingAssumptionsMembergl:LifeSegmentMember2024-01-012024-03-310000320335gl:GainLossFromExperienceMembergl:UnitedAmericanIndependentMembergl:HealthSegmentMember2025-01-012025-03-310000320335gl:GainLossFromExperienceMembergl:UnitedAmericanIndependentMembergl:HealthSegmentMember2024-01-012024-03-310000320335gl:GainLossFromExperienceMembergl:FamilyHeritageMembergl:HealthSegmentMember2025-01-012025-03-310000320335gl:GainLossFromExperienceMembergl:FamilyHeritageMembergl:HealthSegmentMember2024-01-012024-03-310000320335gl:GainLossFromExperienceMembergl:LibertyNationalExclusiveMembergl:HealthSegmentMember2025-01-012025-03-310000320335gl:GainLossFromExperienceMembergl:LibertyNationalExclusiveMembergl:HealthSegmentMember2024-01-012024-03-310000320335gl:GainLossFromExperienceMembergl:AmericanIncomeExclusiveMembergl:HealthSegmentMember2025-01-012025-03-310000320335gl:GainLossFromExperienceMembergl:AmericanIncomeExclusiveMembergl:HealthSegmentMember2024-01-012024-03-310000320335gl:GainLossFromExperienceMembergl:DirectToConsumerMembergl:HealthSegmentMember2025-01-012025-03-310000320335gl:GainLossFromExperienceMembergl:DirectToConsumerMembergl:HealthSegmentMember2024-01-012024-03-310000320335gl:GainLossFromExperienceMembergl:HealthSegmentMember2025-01-012025-03-310000320335gl:GainLossFromExperienceMembergl:HealthSegmentMember2024-01-012024-03-310000320335gl:GainLossFromUnlockingAssumptionsMembergl:UnitedAmericanIndependentMembergl:HealthSegmentMember2025-01-012025-03-310000320335gl:GainLossFromUnlockingAssumptionsMembergl:UnitedAmericanIndependentMembergl:HealthSegmentMember2024-01-012024-03-310000320335gl:GainLossFromUnlockingAssumptionsMembergl:FamilyHeritageMembergl:HealthSegmentMember2025-01-012025-03-310000320335gl:GainLossFromUnlockingAssumptionsMembergl:FamilyHeritageMembergl:HealthSegmentMember2024-01-012024-03-310000320335gl:GainLossFromUnlockingAssumptionsMembergl:LibertyNationalExclusiveMembergl:HealthSegmentMember2025-01-012025-03-310000320335gl:GainLossFromUnlockingAssumptionsMembergl:LibertyNationalExclusiveMembergl:HealthSegmentMember2024-01-012024-03-310000320335gl:GainLossFromUnlockingAssumptionsMembergl:AmericanIncomeExclusiveMembergl:HealthSegmentMember2025-01-012025-03-310000320335gl:GainLossFromUnlockingAssumptionsMembergl:AmericanIncomeExclusiveMembergl:HealthSegmentMember2024-01-012024-03-310000320335gl:GainLossFromUnlockingAssumptionsMembergl:DirectToConsumerMembergl:HealthSegmentMember2025-01-012025-03-310000320335gl:GainLossFromUnlockingAssumptionsMembergl:DirectToConsumerMembergl:HealthSegmentMember2024-01-012024-03-310000320335gl:GainLossFromUnlockingAssumptionsMembergl:HealthSegmentMember2025-01-012025-03-310000320335gl:GainLossFromUnlockingAssumptionsMembergl:HealthSegmentMember2024-01-012024-03-310000320335us-gaap:InterestSensitiveLifeMember2024-12-310000320335us-gaap:DeferredFixedAnnuityMember2024-12-310000320335us-gaap:OtherInsuranceProductLineMember2024-12-310000320335us-gaap:InterestSensitiveLifeMember2023-12-310000320335us-gaap:DeferredFixedAnnuityMember2023-12-310000320335us-gaap:OtherInsuranceProductLineMember2023-12-310000320335us-gaap:InterestSensitiveLifeMember2025-01-012025-03-310000320335us-gaap:DeferredFixedAnnuityMember2025-01-012025-03-310000320335us-gaap:InterestSensitiveLifeMember2024-01-012024-03-310000320335us-gaap:DeferredFixedAnnuityMember2024-01-012024-03-310000320335us-gaap:InterestSensitiveLifeMember2025-03-310000320335us-gaap:DeferredFixedAnnuityMember2025-03-310000320335us-gaap:OtherInsuranceProductLineMember2025-03-310000320335us-gaap:InterestSensitiveLifeMember2024-03-310000320335us-gaap:DeferredFixedAnnuityMember2024-03-310000320335us-gaap:OtherInsuranceProductLineMember2024-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Memberus-gaap:InterestSensitiveLifeMember2025-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Memberus-gaap:DeferredFixedAnnuityMember2025-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Memberus-gaap:OtherInsuranceProductLineMember2025-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Memberus-gaap:InterestSensitiveLifeMembersrt:MinimumMember2025-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Memberus-gaap:InterestSensitiveLifeMembersrt:MaximumMember2025-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Memberus-gaap:InterestSensitiveLifeMember2025-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Memberus-gaap:DeferredFixedAnnuityMember2025-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Memberus-gaap:OtherInsuranceProductLineMember2025-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Memberus-gaap:InterestSensitiveLifeMembersrt:MinimumMember2025-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Memberus-gaap:InterestSensitiveLifeMembersrt:MaximumMember2025-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Memberus-gaap:InterestSensitiveLifeMember2025-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Memberus-gaap:DeferredFixedAnnuityMember2025-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Memberus-gaap:OtherInsuranceProductLineMember2025-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMemberus-gaap:InterestSensitiveLifeMember2025-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMemberus-gaap:DeferredFixedAnnuityMember2025-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMemberus-gaap:OtherInsuranceProductLineMember2025-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:InterestSensitiveLifeMember2025-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:DeferredFixedAnnuityMember2025-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:OtherInsuranceProductLineMember2025-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Membersrt:MinimumMember2025-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Membersrt:MaximumMember2025-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Memberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Memberus-gaap:InterestSensitiveLifeMember2025-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Memberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Memberus-gaap:DeferredFixedAnnuityMember2025-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Memberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Memberus-gaap:OtherInsuranceProductLineMember2025-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Memberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Memberus-gaap:InterestSensitiveLifeMembersrt:MinimumMember2025-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Memberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Memberus-gaap:InterestSensitiveLifeMembersrt:MaximumMember2025-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Memberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Memberus-gaap:InterestSensitiveLifeMember2025-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Memberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Memberus-gaap:DeferredFixedAnnuityMember2025-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Memberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Memberus-gaap:OtherInsuranceProductLineMember2025-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Membergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Memberus-gaap:InterestSensitiveLifeMembersrt:MinimumMember2025-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Membergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Memberus-gaap:InterestSensitiveLifeMembersrt:MaximumMember2025-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Membergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Memberus-gaap:InterestSensitiveLifeMember2025-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Membergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Memberus-gaap:DeferredFixedAnnuityMember2025-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Membergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Memberus-gaap:OtherInsuranceProductLineMember2025-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Membergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMemberus-gaap:InterestSensitiveLifeMember2025-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Membergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMemberus-gaap:DeferredFixedAnnuityMember2025-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Membergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMemberus-gaap:OtherInsuranceProductLineMember2025-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Memberus-gaap:InterestSensitiveLifeMember2025-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Memberus-gaap:DeferredFixedAnnuityMember2025-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Memberus-gaap:OtherInsuranceProductLineMember2025-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Memberus-gaap:InterestSensitiveLifeMember2024-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Memberus-gaap:DeferredFixedAnnuityMember2024-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Memberus-gaap:OtherInsuranceProductLineMember2024-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Memberus-gaap:InterestSensitiveLifeMembersrt:MinimumMember2024-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Memberus-gaap:InterestSensitiveLifeMembersrt:MaximumMember2024-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Memberus-gaap:InterestSensitiveLifeMember2024-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Memberus-gaap:DeferredFixedAnnuityMember2024-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Memberus-gaap:OtherInsuranceProductLineMember2024-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Memberus-gaap:InterestSensitiveLifeMembersrt:MinimumMember2024-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Memberus-gaap:InterestSensitiveLifeMembersrt:MaximumMember2024-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Memberus-gaap:InterestSensitiveLifeMember2024-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Memberus-gaap:DeferredFixedAnnuityMember2024-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Memberus-gaap:OtherInsuranceProductLineMember2024-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMemberus-gaap:InterestSensitiveLifeMember2024-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMemberus-gaap:DeferredFixedAnnuityMember2024-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMemberus-gaap:OtherInsuranceProductLineMember2024-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:InterestSensitiveLifeMember2024-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:DeferredFixedAnnuityMember2024-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:OtherInsuranceProductLineMember2024-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Membersrt:MinimumMember2024-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Membersrt:MaximumMember2024-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Memberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Memberus-gaap:InterestSensitiveLifeMember2024-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Memberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Memberus-gaap:DeferredFixedAnnuityMember2024-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Memberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Memberus-gaap:OtherInsuranceProductLineMember2024-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Memberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Memberus-gaap:InterestSensitiveLifeMembersrt:MinimumMember2024-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Memberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Memberus-gaap:InterestSensitiveLifeMembersrt:MaximumMember2024-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Memberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Memberus-gaap:InterestSensitiveLifeMember2024-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Memberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Memberus-gaap:DeferredFixedAnnuityMember2024-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Memberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Memberus-gaap:OtherInsuranceProductLineMember2024-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Membergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Memberus-gaap:InterestSensitiveLifeMembersrt:MinimumMember2024-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Membergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Memberus-gaap:InterestSensitiveLifeMembersrt:MaximumMember2024-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Membergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Memberus-gaap:InterestSensitiveLifeMember2024-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Membergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Memberus-gaap:DeferredFixedAnnuityMember2024-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Membergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Memberus-gaap:OtherInsuranceProductLineMember2024-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Membergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMemberus-gaap:InterestSensitiveLifeMember2024-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Membergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMemberus-gaap:DeferredFixedAnnuityMember2024-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Membergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMemberus-gaap:OtherInsuranceProductLineMember2024-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Memberus-gaap:InterestSensitiveLifeMember2024-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Memberus-gaap:DeferredFixedAnnuityMember2024-03-310000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Memberus-gaap:OtherInsuranceProductLineMember2024-03-310000320335gl:AnnuitySegmentMember2025-03-310000320335gl:AnnuitySegmentMember2024-03-310000320335us-gaap:HealthInsuranceProductLineMember2024-12-310000320335us-gaap:HealthInsuranceProductLineMember2023-12-310000320335us-gaap:HealthInsuranceProductLineMember2024-01-012024-12-310000320335us-gaap:HealthInsuranceProductLineMember2025-03-310000320335us-gaap:LifeInsuranceSegmentMember2025-03-310000320335us-gaap:LifeInsuranceSegmentMember2024-12-310000320335us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:ExchangeTradedFundsMember2025-03-310000320335us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:ExchangeTradedFundsMember2025-03-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:ExchangeTradedFundsMember2025-03-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:ExchangeTradedFundsMember2025-03-310000320335us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMembergl:EquityExchangeTradedFundMember2025-03-310000320335us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMembergl:EquityExchangeTradedFundMember2025-03-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMembergl:EquityExchangeTradedFundMember2025-03-310000320335us-gaap:PensionPlansDefinedBenefitMembergl:EquityExchangeTradedFundMember2025-03-310000320335us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember2025-03-310000320335us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember2025-03-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember2025-03-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember2025-03-310000320335us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMembergl:OtherBondsMember2025-03-310000320335us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMembergl:OtherBondsMember2025-03-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMembergl:OtherBondsMember2025-03-310000320335us-gaap:PensionPlansDefinedBenefitMembergl:OtherBondsMember2025-03-310000320335us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMembergl:GuaranteedAnnuityContractMember2025-03-310000320335us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMembergl:GuaranteedAnnuityContractMember2025-03-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMembergl:GuaranteedAnnuityContractMember2025-03-310000320335us-gaap:PensionPlansDefinedBenefitMembergl:GuaranteedAnnuityContractMember2025-03-310000320335us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:ShortTermInvestmentsMember2025-03-310000320335us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:ShortTermInvestmentsMember2025-03-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:ShortTermInvestmentsMember2025-03-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:ShortTermInvestmentsMember2025-03-310000320335us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMembergl:OtherMember2025-03-310000320335us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMembergl:OtherMember2025-03-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMembergl:OtherMember2025-03-310000320335us-gaap:PensionPlansDefinedBenefitMembergl:OtherMember2025-03-310000320335us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2025-03-310000320335us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMember2025-03-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2025-03-310000320335us-gaap:FairValueInputsLevel12And3Memberus-gaap:PensionPlansDefinedBenefitMember2025-03-310000320335us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:PensionPlansDefinedBenefitMember2025-03-310000320335us-gaap:PensionPlansDefinedBenefitMember2025-03-310000320335us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:ExchangeTradedFundsMember2024-12-310000320335us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:ExchangeTradedFundsMember2024-12-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:ExchangeTradedFundsMember2024-12-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:ExchangeTradedFundsMember2024-12-310000320335us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMembergl:EquityExchangeTradedFundMember2024-12-310000320335us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMembergl:EquityExchangeTradedFundMember2024-12-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMembergl:EquityExchangeTradedFundMember2024-12-310000320335us-gaap:PensionPlansDefinedBenefitMembergl:EquityExchangeTradedFundMember2024-12-310000320335us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember2024-12-310000320335us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember2024-12-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember2024-12-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember2024-12-310000320335us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMembergl:OtherBondsMember2024-12-310000320335us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMembergl:OtherBondsMember2024-12-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMembergl:OtherBondsMember2024-12-310000320335us-gaap:PensionPlansDefinedBenefitMembergl:OtherBondsMember2024-12-310000320335us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMembergl:GuaranteedAnnuityContractMember2024-12-310000320335us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMembergl:GuaranteedAnnuityContractMember2024-12-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMembergl:GuaranteedAnnuityContractMember2024-12-310000320335us-gaap:PensionPlansDefinedBenefitMembergl:GuaranteedAnnuityContractMember2024-12-310000320335us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:ShortTermInvestmentsMember2024-12-310000320335us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:ShortTermInvestmentsMember2024-12-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:ShortTermInvestmentsMember2024-12-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:ShortTermInvestmentsMember2024-12-310000320335us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMembergl:OtherMember2024-12-310000320335us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMembergl:OtherMember2024-12-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMembergl:OtherMember2024-12-310000320335us-gaap:PensionPlansDefinedBenefitMembergl:OtherMember2024-12-310000320335us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2024-12-310000320335us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMember2024-12-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2024-12-310000320335us-gaap:FairValueInputsLevel12And3Memberus-gaap:PensionPlansDefinedBenefitMember2024-12-310000320335us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:PensionPlansDefinedBenefitMember2024-12-310000320335us-gaap:PensionPlansDefinedBenefitMember2024-12-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:QualifiedPlanMember2025-03-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:QualifiedPlanMember2024-12-310000320335us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMemberus-gaap:NonqualifiedPlanMember2025-03-310000320335us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMemberus-gaap:NonqualifiedPlanMember2024-12-310000320335gl:SeniorNotesDue2028Member2025-03-310000320335gl:SeniorNotesDue2028Member2024-12-310000320335gl:SeniorNotesDue2030Member2025-03-310000320335gl:SeniorNotesDue2030Member2024-12-310000320335gl:SeniorNotesDue2032Member2025-03-310000320335gl:SeniorNotesDue2032Member2024-12-310000320335gl:SeniorNotesDue2034Member2025-03-310000320335gl:SeniorNotesDue2034Member2024-12-310000320335gl:JuniorSubordinatedDebenturesDue2057Member2025-03-310000320335gl:JuniorSubordinatedDebenturesDue2057Member2024-12-310000320335gl:JuniorSubordinatedDebenturesDue2061Member2025-03-310000320335gl:JuniorSubordinatedDebenturesDue2061Member2024-12-310000320335gl:TermLoanDue2027Member2025-03-310000320335gl:TermLoanDue2027Member2024-12-310000320335us-gaap:FederalHomeLoanBankBorrowingsMember2025-03-310000320335us-gaap:FederalHomeLoanBankBorrowingsMember2024-12-310000320335us-gaap:CommercialPaperMember2025-03-310000320335us-gaap:CommercialPaperMember2024-12-310000320335srt:SubsidiariesMembergl:SeniorNotesDue2032Membersrt:ConsolidationEliminationsMember2025-03-310000320335gl:JuniorSubordinatedDebenturesDue2057Member2025-01-012025-03-310000320335us-gaap:SeniorNotesMember2025-01-012025-03-310000320335gl:JuniorSubordinatedDebenturesDue2056Member2025-03-310000320335us-gaap:LineOfCreditMember2025-03-310000320335us-gaap:LineOfCreditMember2024-03-290000320335us-gaap:LineOfCreditMember2024-03-292024-03-290000320335us-gaap:ShortTermDebtMember2025-03-310000320335us-gaap:ShortTermDebtMember2024-12-310000320335us-gaap:ShortTermDebtMember2024-03-310000320335us-gaap:CommercialPaperMember2025-01-012025-03-310000320335us-gaap:CommercialPaperMember2024-01-012024-03-310000320335us-gaap:FederalHomeLoanBankBorrowingsMember2025-03-310000320335us-gaap:AssetPledgedAsCollateralMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2025-03-310000320335us-gaap:FederalHomeLoanBankBorrowingsMember2024-12-310000320335us-gaap:FederalHomeLoanBankBorrowingsMember2024-03-3100003203352024-01-012024-09-3000003203352024-10-012024-12-310000320335gl:AmericanIncomeExclusiveMember2025-01-012025-03-310000320335gl:DirectResponseMembergl:LifeSegmentMember2025-01-012025-03-310000320335gl:DirectResponseMembergl:HealthSegmentMember2025-01-012025-03-310000320335gl:DirectResponseMember2025-01-012025-03-310000320335gl:LibertyNationalExclusiveMember2025-01-012025-03-310000320335gl:UnitedAmericanIndependentMembergl:LifeSegmentMember2025-01-012025-03-310000320335gl:UnitedAmericanIndependentMember2025-01-012025-03-310000320335gl:FamilyHeritageMembergl:LifeSegmentMember2025-01-012025-03-310000320335gl:FamilyHeritageMember2025-01-012025-03-310000320335gl:DistributionChannelOtherMembergl:LifeSegmentMember2025-01-012025-03-310000320335gl:DistributionChannelOtherMembergl:HealthSegmentMember2025-01-012025-03-310000320335gl:DistributionChannelOtherMember2025-01-012025-03-310000320335gl:AmericanIncomeExclusiveMember2024-01-012024-03-310000320335gl:DirectResponseMembergl:LifeSegmentMember2024-01-012024-03-310000320335gl:DirectResponseMembergl:HealthSegmentMember2024-01-012024-03-310000320335gl:DirectResponseMember2024-01-012024-03-310000320335gl:LibertyNationalExclusiveMember2024-01-012024-03-310000320335gl:UnitedAmericanIndependentMembergl:LifeSegmentMember2024-01-012024-03-310000320335gl:UnitedAmericanIndependentMember2024-01-012024-03-310000320335gl:FamilyHeritageMembergl:LifeSegmentMember2024-01-012024-03-310000320335gl:FamilyHeritageMember2024-01-012024-03-310000320335gl:DistributionChannelOtherMembergl:LifeSegmentMember2024-01-012024-03-310000320335gl:DistributionChannelOtherMembergl:HealthSegmentMember2024-01-012024-03-310000320335gl:DistributionChannelOtherMember2024-01-012024-03-310000320335gl:InvestmentSegmentMember2025-01-012025-03-310000320335gl:InvestmentSegmentMember2024-01-012024-03-310000320335us-gaap:OperatingSegmentsMembergl:LifeSegmentMember2025-03-310000320335us-gaap:OperatingSegmentsMembergl:HealthSegmentMember2025-03-310000320335us-gaap:OperatingSegmentsMembergl:InvestmentSegmentMember2025-03-310000320335us-gaap:OperatingSegmentsMember2025-03-310000320335us-gaap:CorporateNonSegmentMember2025-03-310000320335us-gaap:OperatingSegmentsMembergl:LifeSegmentMember2024-12-310000320335us-gaap:OperatingSegmentsMembergl:HealthSegmentMember2024-12-310000320335us-gaap:OperatingSegmentsMembergl:InvestmentSegmentMember2024-12-310000320335us-gaap:OperatingSegmentsMember2024-12-310000320335us-gaap:CorporateNonSegmentMember2024-12-31
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark one)
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2025
or
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _____ to ________
Commission File Number: 001-08052
GLOBE LIFE INC.
(Exact name of registrant as specified in its charter)
Delaware   63-0780404
(State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification No.)
3700 South Stonebridge Drive, McKinney, Texas 75070
(Address of principal executive offices) (Zip Code)

(972) 569-4000
(Registrant’s telephone number, including area code)

NONE
(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $1.00 par value per share GL New York Stock Exchange
4.250% Junior Subordinated Debentures GL PRD New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.                                 Yes    ☒   No   ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).                                             Yes   ☒   No   ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer ☒ Accelerated filer ☐
Non-accelerated filer ☐ Smaller reporting company ☐
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).     Yes   ☐   No   ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
Class   Outstanding at April 30, 2025
Common Stock, $1.00 Par Value   82,542,877
GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Table of Contents
Page
PART I. FINANCIAL INFORMATION
Item 1.
Item 2.
Item 3.
Item 4.
PART II. OTHER INFORMATION
Item 1.
Item 1A.
Item 2.
Item 5.
Item 6.



As used in this Form 10-Q, “Globe Life,” the “Company,” “we,” “our” and “us” refer to Globe Life Inc., a Delaware corporation incorporated in 1979, its subsidiaries and affiliates.
GL Q1 2025 FORM 10-Q
Table of Contents
PART I—FINANCIAL INFORMATION
Item 1. Condensed Consolidated Financial Statements

Globe Life Inc.
Condensed Consolidated Balance Sheets
(Unaudited)
(Dollar amounts in thousands, except per share data)
March 31,
2025		 December 31, 2024
Assets:
Investments:
Fixed maturities—available for sale, at fair value (amortized cost: 2025—$18,974,367;
2024—$18,835,809, allowance for credit losses: 2025— $10,355; 2024— $10,395)
 $ 17,504,967  $ 17,155,012 
Mortgage loans 426,174  396,088 
Policy loans 708,175  699,669 
Other long-term investments (includes: 2025—$989,027; 2024—$986,766 under the fair value option)
 1,236,624  1,235,759 
Short-term investments 134,066  85,035 
Total investments 20,010,006  19,571,563 
Cash 232,270  165,325 
Accrued investment income 287,562  269,791 
Other receivables 691,523  691,907 
Deferred acquisition costs 6,623,644  6,495,589 
Goodwill 490,446  490,446 
Other assets 1,369,808  1,391,560 
Total assets $ 29,705,259  $ 29,076,181 
Liabilities:
Future policy benefits at current discount rates: (at original discount rates: 2025—$17,719,841; 2024—$17,552,564)
 $ 18,756,844  $ 18,457,263 
Unearned and advance premium 273,887  257,631 
Policy claims and other benefits payable 546,670  532,832 
Other policyholders' funds 463,148  468,604 
Total policy liabilities 20,040,549  19,716,330 
Current and deferred income taxes 807,735  731,255 
Short-term debt 476,891  415,401 
Long-term debt (estimated fair value: 2025—$2,150,340; 2024—$2,122,772)
 2,324,945  2,324,251 
Other liabilities 629,723  583,424 
Total liabilities 24,279,843  23,770,661 
Commitments and Contingencies (Note 5)
Shareholders' equity:
Preferred stock, par value $1 per share—5,000,000 shares authorized; outstanding: 0 in 2025 and 2024
 —  — 
Common stock, par value $1 per share—320,000,000 shares authorized; outstanding: (2025—97,218,183 issued; 2024—97,218,183 issued)
 97,218  97,218 
Additional paid-in-capital 524,041  527,795 
Accumulated other comprehensive income (loss) (1,970,873) (2,029,720)
Retained earnings 8,224,948  8,002,521 
Treasury stock, at cost: (2025—14,297,002 shares; 2024—13,240,616 shares)
 (1,449,918) (1,292,294)
Total shareholders' equity 5,425,416  5,305,520 
Total liabilities and shareholders' equity $ 29,705,259  $ 29,076,181 
See accompanying Notes to Condensed Consolidated Financial Statements.
1
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Condensed Consolidated Statements of Operations
(Unaudited)
(Dollar amounts in thousands, except per share data)
Three Months Ended
March 31,
2025 2024
Revenue:
Life premium $ 829,863  $ 804,265 
Health premium 369,791  341,019 
Total premium 1,199,654  1,145,284 
Net investment income 280,614  282,578 
Realized gains (losses) 85  (11,799)
Other income 69  76 
Total revenue 1,480,422  1,416,139 
Benefits and expenses:
Life policyholder benefits(1)
 509,756  519,871 
Health policyholder benefits(2)
 233,929  202,327 
Other policyholder benefits 7,080  9,595 
Total policyholder benefits 750,765  731,793 
Amortization of deferred acquisition costs 105,515  99,478 
Commissions, premium taxes, and non-deferred acquisition costs 164,323  148,110 
Other operating expense 108,746  93,214 
Interest expense 34,992  28,621 
Total benefits and expenses 1,164,341  1,101,216 
Income before income taxes 316,081  314,923 
Income tax benefit (expense) (61,518) (60,706)
Net income
$ 254,563  $ 254,217 
Basic net income per common share
$ 3.05  $ 2.71 
Diluted net income per common share
$ 3.01  $ 2.67 

(1) Net of a remeasurement gain of $8.5 million for the three months ended March 31, 2025, and a remeasurement gain of $4.9 million for the same period in 2024.
(2)    Net of a remeasurement gain of $444 thousand for the three months ended March 31, 2025 and a remeasurement gain of $3.2 million for the same period in 2024.








See accompanying Notes to Condensed Consolidated Financial Statements.
2
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Condensed Consolidated Statements of Comprehensive Income (Loss)
(Unaudited)
(Dollar amounts in thousands)
Three Months Ended
March 31,
2025 2024
Net income
$ 254,563  $ 254,217 
Other comprehensive income (loss):
Investments:
Unrealized gains (losses) on fixed maturities:
Unrealized holding gains (losses) arising during period 215,128  (305,016)
Other reclassification adjustments included in net income (3,341) (2,412)
Foreign exchange adjustment on fixed maturities recorded at fair value (430) 1,617 
Total unrealized investment gains (losses) 211,357  (305,811)
Less applicable tax (expense) benefit (44,387) 64,222 
Unrealized gains (losses) on investments, net of tax 166,970  (241,589)
Future Policy Benefits:
Change in discount rate on future policy benefits (139,352) 704,596 
Less applicable tax (expense) benefit 29,263  (147,964)
Future policy benefit adjustments, net of tax (110,089) 556,632 
Foreign exchange translation:
Foreign exchange translation adjustments, other than securities 2,421  (12,597)
Less applicable tax (expense) benefit (508) 2,646 
Foreign exchange translation adjustments, other than securities, net of tax 1,913  (9,951)
Pension:
Pension adjustments 68  118 
Less applicable tax (expense) benefit (15) (27)
Pension adjustments, net of tax 53  91 
Other comprehensive income (loss) 58,847  305,183 
Comprehensive income (loss)
$ 313,410  $ 559,400 













See accompanying Notes to Condensed Consolidated Financial Statements.
3
        GL Q1 2025 FORM 10-Q
Table of Contents

Globe Life Inc.
Condensed Consolidated Statements of Shareholders' Equity
(Unaudited)
(Dollar amounts in thousands, except per share data)


Preferred Stock Common Stock Additional Paid-In Capital Accumulated Other Comprehensive Income (Loss) Retained Earnings Treasury Stock Total Shareholders' Equity
Balance at December 31, 2024
$ —  $ 97,218  $ 527,795  $ (2,029,720) $ 8,002,521  $ (1,292,294) $ 5,305,520 
Comprehensive income (loss) —  —  —  58,847  254,563  —  313,410 
Common dividends declared
($0.2700 per share)
 —  —  —  —  (22,383) —  (22,383)
Acquisition of treasury stock —  —  —  —  —  (264,544) (264,544)
Stock-based compensation —  —  (3,754) —  —  15,773  12,019 
Exercise of stock options —  —  —  —  (9,753) 91,147  81,394 
Balance at March 31, 2025
—  97,218  524,041  (1,970,873) 8,224,948  (1,449,918) 5,425,416 



Preferred Stock Common Stock Additional Paid-In Capital Accumulated Other Comprehensive Income (Loss) Retained Earnings Treasury Stock Total Shareholders' Equity
Balance at December 31, 2023
$ —  $ 102,218  $ 532,474  $ (2,772,419) $ 7,478,813  $ (854,283) $ 4,486,803 
Comprehensive income (loss) —  —  —  305,183  254,217  —  559,400 
Common dividends declared
($0.2400 per share)
 —  —  —  —  (22,603) —  (22,603)
Acquisition of treasury stock —  —  —  —  —  (23,469) (23,469)
Stock-based compensation —  —  (5,612) —  (438) 15,317  9,267 
Exercise of stock options —  —  —  —  (3,334) 33,097  29,763 
Balance at March 31, 2024
—  102,218  526,862  (2,467,236) 7,706,655  (829,338) 5,039,161 






















See accompanying Notes to Condensed Consolidated Financial Statements.
4
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Condensed Consolidated Statements of Cash Flows
(Unaudited)
(Dollar amounts in thousands)
Three Months Ended
March 31,
2025 2024
Cash provided from (used for) operating activities
$ 431,887  $ 350,806 
Cash provided from (used for) investing activities:
Investments sold or matured:
Fixed maturities available for sale—sold 53,911  27,853 
Fixed maturities available for sale—matured or other redemptions 58,796  59,871 
Mortgage loans 6,237  7,896 
Other long-term investments 18,927  573 
Total investments sold or matured 137,871  96,193 
Acquisition of investments:
Fixed maturities—available for sale (236,058) (682,427)
Mortgage loans (35,471) (58,406)
Other long-term investments (15,889) (80,468)
Total investments acquired (287,418) (821,301)
Net (increase) decrease in policy loans (8,506) (7,621)
Net (increase) decrease in short-term investments (49,031) 23,327 
Additions to property and equipment (11,746) (9,106)
Investments in low-income housing interests (21,124) (13,428)
Cash provided from (used for) investing activities
(239,954) (731,936)
Cash provided from (used for) financing activities:
Issuance of common stock 81,394  29,763 
Cash dividends paid to shareholders (20,146) (21,117)
Net borrowing from Federal Home Loan Bank (FHLB)
70,000  242,000 
Net borrowing (repayment) of commercial paper (58,474) 5,304 
Proceeds from commercial paper with original maturities greater than 90 days 184,470  — 
Repayment of commercial paper with original maturities greater than 90 days (134,506) — 
Acquisition of treasury stock (264,544) (23,469)
Net receipts (payments) from deposit-type products 17,342  124,475 
Cash provided from (used for) financing activities
(124,464) 356,956 
Effect of foreign exchange rate changes on cash (524) 4,565 
Net increase (decrease) in cash 66,945  (19,609)
Cash at beginning of year 165,325  103,156 
Cash at end of period $ 232,270  $ 83,547 






See accompanying Notes to Condensed Consolidated Financial Statements.
5
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)

Note 1—Significant Accounting Policies

Business: (Globe Life), (the Company), refers to Globe Life Inc., an insurance holding company incorporated in Delaware in 1979, and Globe Life Inc. subsidiaries and affiliates. Globe Life Inc.'s direct or indirect primary subsidiaries are Globe Life And Accident Insurance Company, American Income Life Insurance Company, Liberty National Life Insurance Company, Family Heritage Life Insurance Company of America, and United American Insurance Company. The underwriting companies are owned by their ultimate corporate parent, Globe Life Inc. (Parent Company).

Globe Life provides a variety of life and supplemental health insurance products to a broad base of customers. The Company is organized into three reportable segments: life insurance, supplemental health insurance, and investments.

Globe Life markets its insurance products through a number of distribution channels, each of which sells the products of one or more of Globe Life's insurance segments. Our distribution channels consist of the following exclusive agencies: American Income Life Division (American Income), Liberty National Division (Liberty National) and Family Heritage Division (Family Heritage); an independent agency, United American Division (United American); and our Direct to Consumer Division (DTC).

Basis of Presentation: The accompanying condensed consolidated financial statements of Globe Life have been prepared in accordance with the instructions to Form 10-Q. Therefore, they do not include all of the disclosures required by accounting principles generally accepted in the United States of America (GAAP) for annual financial statements. However, in the opinion of management, these statements include all adjustments, consisting of normal recurring adjustments, which are necessary for a fair presentation of the condensed consolidated financial position at March 31, 2025, and the condensed consolidated results of operations, comprehensive income, and cash flows for the periods ended March 31, 2025 and 2024. The interim period condensed consolidated financial statements should be read in conjunction with the Consolidated Financial Statements that were included in the Form 10-K filed with the Securities Exchange Commission (SEC) on February 26, 2025.

Use of Estimates: The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. See further documentation in the significant accounting policies or the accompanying notes.

Reinsurance and Recapture: In the normal course of business, Globe Life insurance subsidiaries will enter into reinsurance agreements to limit their exposure to the risk of loss as well as enhance their capital position. The Company entered into a coinsurance transaction with funds withheld agreement with a third-party reinsurer on March 6, 2025, with an agreement effective date of January 1, 2025. Under the terms of the agreement Globe Life ceded 100% of the liabilities, net of existing reinsurance, associated with certain term and whole life insurance policies. The contract will be accounted for under deposit accounting as it did not pass the risk transfer requirements for reinsurance treatment on a GAAP basis. Since the agreement is subject to deposit accounting and meets the right of offset conditions outlined in the accounting policy the Company recorded the initial coinsurance, ceding commission and funds withheld balance on a net basis. At inception, no cash was exchanged between the parties and subsequently, a risk charge was recorded as a component of net investment income in the Condensed Consolidated Statement of Operations, with net cash settlements occurring quarterly between the parties.
6
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
On March 31, 2025, the Company entered into a recapture and termination agreement with a third-party reinsurer to recapture certain policies that had previously been ceded under a reinsurance agreement dated November 12, 2001. The recapture was executed to accomplish common objectives between the Company and the reinsurer. As a result of the transaction, the Company received net proceeds of $39 million, which are reflected as operating cash flows in the Condensed Consolidated Statement of Cash Flows. The Company also recognized a gain of approximately $14 million in policy holder benefits in the Condensed Consolidated Statement of Operations.

Note 2—New Accounting Standards

Accounting Pronouncements Yet to be Adopted: ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, adds disclosure requirements to disaggregate information related to the effective tax rate reconciliation and information on income taxes paid. The disclosures will enhance the assessment of an entity’s operations and related tax risks.

This standard is effective for the Company for annual periods beginning on January 1, 2025, and will be implemented on a prospective basis. The Company does not expect the standard will have a material impact on the condensed consolidated financial statements. The guidance requires only additional disclosure, as a result there will be no effects on our financial position, results of operations or cash flows.

ASU No. 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, adds disclosure requirements to disaggregate information related to an entity's income statement. The disclosures will allow for enhanced transparency of an entity's expenses.

This standard is effective for the Company for annual periods beginning on January 1, 2027. The Company is evaluating the standard.


7
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Note 3—Supplemental Information about Changes to Accumulated Other Comprehensive Income

  Three Months Ended March 31, 2025
  Available
for Sale
Assets		 Future Policy Benefits Foreign
Exchange		 Pension
Adjustments		 Total
Balance at January 1, 2025
$ (1,319,618) $ (709,042) $ (21,757) $ 20,697  $ (2,029,720)
Other comprehensive income (loss) before reclassifications, net of tax 169,609  (110,089) 1,913  —  61,433 
Reclassifications, net of tax (2,639) —  —  53  (2,586)
Other comprehensive income (loss) 166,970  (110,089) 1,913  53  58,847 
Balance at March 31, 2025
$ (1,152,648) $ (819,131) $ (19,844) $ 20,750  $ (1,970,873)

  Three Months Ended March 31, 2024
  Available
for Sale
Assets		 Future Policy Benefits Foreign
Exchange		 Pension
Adjustments		 Total
Balance at January 1, 2024
$ (827,596) $ (1,947,391) $ 4,719  $ (2,151) $ (2,772,419)
Other comprehensive income (loss) before reclassifications, net of tax (239,684) 556,632  (9,951) —  306,997 
Reclassifications, net of tax (1,905) —  —  91  (1,814)
Other comprehensive income (loss) (241,589) 556,632  (9,951) 91  305,183 
Balance at March 31, 2024
$ (1,069,185) $ (1,390,759) $ (5,232) $ (2,060) $ (2,467,236)

Reclassification Adjustments: Reclassification adjustments out of accumulated other comprehensive income are presented below for the three month periods ended March 31, 2025 and 2024.
   Three Months Ended March 31, Affected line items in the Statements of Operations
Component Line Item 2025 2024
Unrealized investment (gains) losses on available for sale assets:
Realized (gains) losses $ (828) $ (228) Realized (gains) losses
Amortization of (discount) premium (2,513) (2,184) Net investment income
Total before tax (3,341) (2,412)
Tax 702  507  Income taxes
Total after-tax (2,639) (1,905)
Pension adjustments:
Amortization of prior service cost 292  269  Other operating expense
Amortization of actuarial (gain) loss (224) (151) Other operating expense
Total before tax 68  118 
Tax (15) (27) Income taxes
Total after-tax 53  91 
Total reclassification (after-tax)
$ (2,586) $ (1,814)
8
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Note 4—Investments

Portfolio Composition: Summaries of fixed maturities available for sale by amortized cost, fair value, and allowance for credit losses at March 31, 2025 and December 31, 2024, and the corresponding amounts of gross unrealized gains and losses recognized in accumulated other comprehensive income (loss) are as follows. Redeemable preferred stock is included within "Corporates, by sector."
At March 31, 2025

Amortized
Cost		 Allowance for Credit Losses Gross
Unrealized
Gains		 Gross
Unrealized
Losses
Fair
 Value(1)
% of Total
Fixed
Maturities(2)
Fixed maturities available for sale:
U.S. Government direct, guaranteed, and government-sponsored enterprises $ 407,846  $ —  $ 61  $ (31,928) $ 375,979  2 
States, municipalities, and political subdivisions 3,295,133  —  27,554  (561,706) 2,760,981  16 
Foreign governments 37,681  —  20  (9,320) 28,381  — 
Corporates, by sector:
Industrials 7,971,906  (7,058) 138,014  (717,612) 7,385,250  42 
Financial 5,026,161  —  107,057  (371,016) 4,762,202  27 
Utilities 2,104,309  —  57,954  (101,935) 2,060,328  12 
Total corporates 15,102,376  (7,058) 303,025  (1,190,563) 14,207,780  81 
Collateralized debt obligations 36,609  —  5,046  —  41,655  — 
Other asset-backed securities 94,722  (3,297) 69  (1,303) 90,191  1 
Total fixed maturities
$ 18,974,367  $ (10,355) $ 335,775  $ (1,794,820) $ 17,504,967  100 
(1)Amount reported in the balance sheet.
(2)At fair value.

At December 31, 2024
Amortized
Cost		 Allowance for Credit Losses Gross
Unrealized
Gains		 Gross
Unrealized
Losses
Fair
 Value(1)
% of Total
Fixed
Maturities(2)
Fixed maturities available for sale:
U.S. Government direct, guaranteed, and government-sponsored enterprises $ 401,753  $ —  $ 1  $ (42,794) $ 358,960  2 
States, municipalities, and political subdivisions 3,300,901  —  20,662  (534,759) 2,786,804  16 
Foreign governments 36,883  —  18  (8,870) 28,031  — 
Corporates, by sector:
Industrials
 7,889,074  (7,098) 105,610  (805,330) 7,182,256  42 
Financial 5,006,375  —  82,598  (413,043) 4,675,930  27 
Utilities 2,081,366  —  39,716  (118,007) 2,003,075  12 
Total corporates 14,976,815  (7,098) 227,924  (1,336,380) 13,861,261  81 
Collateralized debt obligations 36,923  —  5,943  —  42,866  — 
Other asset-backed securities 82,534  (3,297) 39  (2,186) 77,090  1 
Total fixed maturities
$ 18,835,809  $ (10,395) $ 254,587  $ (1,924,989) $ 17,155,012  100 
(1)Amount reported in the balance sheet.
(2)At fair value.

The Company had unfunded commitments of $155 million and $167 million in fixed maturities at March 31, 2025 and December 31, 2024, respectively.
9
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The Company has exposure to real estate investment trusts with an average rating of BBB+, which had a fair value of $397 million (2% of the total fixed maturity portfolio) and $405 million (2% of the total fixed maturity portfolio) at March 31, 2025 and December 31, 2024, respectively.

A schedule of fixed maturities available for sale by contractual maturity date at March 31, 2025, is shown below on an amortized cost basis, net of allowance for credit losses, and on a fair value basis. Actual disposition dates could differ from contractual maturities due to call or prepayment provisions.
At March 31, 2025
Amortized
Cost, net		 Fair
Value
Fixed maturities available for sale:
Due in one year or less $ 117,643  $ 117,820 
Due after one year through five years 767,696  787,970 
Due after five years through ten years 1,925,094  1,963,237 
Due after ten years through twenty years 8,804,536  8,303,529 
Due after twenty years 7,221,009  6,200,565 
Mortgage-backed and asset-backed securities 128,034  131,846 
$ 18,964,012  $ 17,504,967 

Analysis of Investment Operations: "Net investment income" for the three month periods ended March 31, 2025 and 2024 is summarized as follows:
Three Months Ended
March 31,
2025 2024 % Change
Fixed maturities available for sale $ 242,210  $ 246,098  (2)
Policy loans 13,658  12,816  7 
Mortgage loans 6,668  6,760  (1)
Other long-term investments(1)
 23,079  19,663  17 
Short-term investments 1,476  1,688 
287,091  287,025  — 
Less investment expense (6,477) (4,447) 46 
Net investment income
$ 280,614  $ 282,578  (1)
(1)For the three months ended March 31, 2025 and 2024, the investment funds, accounted for under the fair value option method, recorded $19.2 million and $18.9 million, respectively, in net investment income. Refer to Other Long-Term Investments below for further discussion on the investment funds.

Selected information about sales of fixed maturities available for sale is as follows:
Three Months Ended
March 31,
2025 2024
Fixed maturities available for sale:
Proceeds from sales(1)
 $ 53,911  $ 27,853 
Gross realized gains 1,478  175 
Gross realized losses (1,464) (35)
(1)As of March 31, 2025 and 2024, the Company had $0 million and $0 of unsettled trades, respectively.

10
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
An analysis of "realized gains (losses)" is as follows:
Three Months Ended
March 31,
2025 2024
Realized investment gains (losses):
Fixed maturities available for sale:
Sales and other(1)
 $ 788  $ 140 
Provision for credit losses 40  88 
Fair value option—change in fair value 2,371  (15,403)
Mortgage loans
 433  (874)
Other investments (1,078) 314 
Realized gains (losses) from investments
2,554  (15,735)
Other gains (losses) (2,469) 3,936 
Total realized gains (losses)
85  (11,799)
Applicable tax (18) 2,478 
Realized gains (losses), net of tax
$ 67  $ (9,321)
(1)During the three months ended March 31, 2025 and 2024, the Company recorded $55.7 million and $66.9 million of issuer-initiated exchanges of fixed maturities (noncash transactions) that resulted in no realized gains (losses) in either period.
11
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Fair Value Measurements: The following tables represent the fair value of fixed maturities measured on a recurring basis at March 31, 2025 and December 31, 2024:
Fair Value Measurement at March 31, 2025:
Quoted Prices in
Active Markets
for Identical
Assets (Level 1)		 Significant Other
Observable
Inputs (Level 2)		 Significant
Unobservable
Inputs (Level 3)		 Total Fair
Value
Fixed maturities available for sale
U.S. Government direct, guaranteed, and government-sponsored enterprises $ —  $ 375,979  $ —  $ 375,979 
States, municipalities, and political subdivisions —  2,760,981  —  2,760,981 
Foreign governments —  28,381  —  28,381 
Corporates, by sector:
Industrials
 —  7,204,316  180,934  7,385,250 
Financial —  4,632,305  129,897  4,762,202 
Utilities
 —  1,944,973  115,355  2,060,328 
Total corporates —  13,781,594  426,186  14,207,780 
Collateralized debt obligations —  —  41,655  41,655 
Other asset-backed securities —  66,598  23,593  90,191 
Total fixed maturities
$ —  $ 17,013,533  $ 491,434  $ 17,504,967 
Percentage of total —  % 97  % 3  % 100  %

Fair Value Measurement at December 31, 2024:
Quoted Prices in
Active Markets
for Identical
Assets (Level 1)		 Significant Other
Observable
Inputs (Level 2)		 Significant
Unobservable
Inputs (Level 3)		 Total Fair
Value
Fixed maturities available for sale
U.S. Government direct, guaranteed, and government-sponsored enterprises $ —  $ 358,960  $ —  $ 358,960 
States, municipalities, and political subdivisions —  2,786,804  —  2,786,804 
Foreign governments —  28,031  —  28,031 
Corporates, by sector:
Industrials
 —  6,998,900  183,356  7,182,256 
Financial —  4,551,737  124,193  4,675,930 
Utilities —  1,890,559  112,516  2,003,075 
Total corporates —  13,441,196  420,065  13,861,261 
Collateralized debt obligations —  —  42,866  42,866 
Other asset-backed securities —  65,907  11,183  77,090 
Total fixed maturities
$ —  $ 16,680,898  $ 474,114  $ 17,155,012 
Percentage of total —  % 97  % 3  % 100  %

12
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following tables represent changes in fixed maturities measured at fair value on a recurring basis using significant unobservable inputs (Level 3):
Analysis of Changes in Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
Asset-
backed Securities
 Collateralized
Debt
Obligations		 Corporates Total
Balance at January 1, 2025
$ 11,183  $ 42,866  $ 420,065  $ 474,114 
Included in realized gains / losses —  —  (1) (1)
Included in other comprehensive income 30  5,046  (7,000) (1,924)
Acquisitions 12,380  —  9,200  21,580 
Sales —  —  —  — 
Amortization —  1,136  (3) 1,133 
Other(1)
 —  (7,393) 3,925  (3,468)
Transfers into Level 3(2)
 —  —  —  — 
Transfers out of Level 3(2)
 —  —  —  — 
Balance at March 31, 2025
$ 23,593  $ 41,655  $ 426,186  $ 491,434 
Percent of total fixed maturities —  % —  % 3  % 3  %
(1)Includes capitalized interest, foreign exchange adjustments, and principal repayments. 
(2)Considered to be transferred at the end of the period. Transfers into Level 3 occur when observable inputs are no longer available. Transfers out of Level 3 occur when observable inputs become available.

Analysis of Changes in Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
Asset-
backed Securities
 Collateralized
Debt
Obligations		 Corporates Total
Balance at January 1, 2024
$ —  $ 42,146  $ 454,733  $ 496,879 
Included in realized gains / losses —  —  —  — 
Included in other comprehensive income —  (2,035) (5,996) (8,031)
Acquisitions —  —  7,800  7,800 
Sales —  —  —  — 
Amortization —  1,141  (4) 1,137 
Other(1)
 —  (1,521) (18,969) (20,490)
Transfers into Level 3(2)
 —  —  —  — 
Transfers out of Level 3(2)
 —  —  —  — 
Balance at March 31, 2024
$ —  $ 39,731  $ 437,564  $ 477,295 
Percent of total fixed maturities —  % —  % 3  % 3  %
(1)Includes capitalized interest, foreign exchange adjustments, and principal repayments. 
(2)Considered to be transferred at the end of the period. Transfers into Level 3 occur when observable inputs are no longer available. Transfers out of Level 3 occur when observable inputs become available.

13
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following table presents changes in unrealized gains and losses for the period included in accumulated other comprehensive income for assets held at the end of the reporting period for Level 3 classification:
Changes in Unrealized Gains (Losses) included in Accumulated Other Comprehensive Income for Assets Held at the End of the Period
Asset-
backed Securities		 Collateralized
Debt
Obligations		 Corporates Total
At March 31, 2025
 $ 30  $ 5,046  $ (7,000) $ (1,924)
At March 31, 2024
 —  (2,035) (5,996) (8,031)

Transfers between levels within the hierarchy occur when there are changes in the observability of the inputs and market data. Transfers into Level 3 occur when there is little unobservable market activity for the asset/liability as of the measurement date and the Company is required to rely upon internally-developed assumptions or third parties. Transfers out of Level 3 occur when quoted prices in active markets becomes available for identical assets/ liabilities or the ability to corroborate by observable market data.

The following table represents quantitative information about Level 3 fair value measurements:
Quantitative Information about Level 3 Fair Value Measurements
March 31, 2025
Fair Value Valuation
Techniques		 Significant Unobservable
Input		 Range
Weighted-
Average(1)
Private placement fixed maturities $ 426,186  Determination of credit spread Credit rating
B to AA
 BBB+
Collateralized debt obligations 41,655  Discounted cash flows Discount rate
12.00%
 12.00%
Asset-backed securities 23,593  Determination of credit spread Credit rating
CC - BBB
 BB+
$ 491,434 
(1)Unobservable inputs were weighted by the relative fair value of the instruments.

Private placement fixed maturities and asset-backed securities are valued based on the contractual cash flows discounted by a yield determined as a treasury benchmark rate adjusted for a credit spread. The credit spread is developed from observable indices for similar securities and unobservable indices for private securities or private comparable securities for corresponding credit ratings. The credit ratings for the securities may be considered unobservable inputs, as they are private letter ratings issued by a nationally recognized statistical rating organization or are assigned by the third-party investment manager based on a quantitative and qualitative assessment of the credit underwritten. A higher (lower) credit rating would result in a higher (lower) valuation.

The collateral underlying the collateralized debt obligations consists primarily of trust preferred securities issued by banks and insurance companies. Collateralized debt obligations are valued at the present value of expected future cash flows using an unobservable discount rate. Expected cash flows are determined by scheduling the projected repayment of the collateral assuming no future defaults, deferrals, or recoveries. The discount rate is risk-adjusted to take these items into account. A significant increase (decrease) in the discount rate will produce a significant decrease (increase) in fair value. Additionally, a significant increase (decrease) in the cash flow expectations would result in a significant increase (decrease) in fair value. For more information regarding valuation procedures, please refer to Note 1—Significant Accounting Policies under the caption Fair Value Measurements, Investments in Securities disclosed in the Form 10-K.
 
14
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Unrealized Loss Analysis: The following table discloses information about fixed maturities available for sale in an unrealized loss position.
Less than Twelve Months Twelve Months or Longer Total
Number of issues (CUSIPs) held:
As of March 31, 2025 584  1,499  2,083 
As of December 31, 2024 705  1,498  2,203 
 
Globe Life's entire fixed maturity portfolio consisted of 2,571 issues by 1,018 different issuers at March 31, 2025 and 2,552 issues by 1,014 different issuers at December 31, 2024. The weighted-average quality rating of all unrealized loss positions at amortized cost was A- as of March 31, 2025 and December 31, 2024.

The following tables disclose unrealized investment losses by class and major sector of fixed maturities available for sale at March 31, 2025 and December 31, 2024.

Analysis of Gross Unrealized Investment Losses
At March 31, 2025
Less than Twelve Months Twelve Months or Longer Total
Fair
Value		 Unrealized
Loss		 Fair
Value		 Unrealized
Loss		 Fair
Value		 Unrealized
Loss
Fixed maturities available for sale:
Investment grade securities:
U.S. Government direct, guaranteed, and government-sponsored enterprises $ 4,901  $ (218) $ 361,306  $ (31,710) $ 366,207  $ (31,928)
States, municipalities, and political subdivisions 591,622  (25,816) 1,533,423  (535,890) 2,125,045  (561,706)
Foreign governments —  —  25,227  (9,320) 25,227  (9,320)
Corporates, by sector:
Industrials
 1,292,072  (58,960) 3,486,110  (630,367) 4,778,182  (689,327)
Financial 748,292  (42,463) 1,809,982  (312,039) 2,558,274  (354,502)
Utilities
 359,881  (15,222) 546,222  (80,061) 906,103  (95,283)
Total corporates 2,400,245  (116,645) 5,842,314  (1,022,467) 8,242,559  (1,139,112)
Other asset-backed securities 41,588  (162) 24,974  (1,141) 66,562  (1,303)
Total investment grade securities 3,038,356  (142,841) 7,787,244  (1,600,528) 10,825,600  (1,743,369)
Below investment grade securities:
Corporates, by sector:
Industrials 60,152  (873) 153,494  (27,412) 213,646  (28,285)
Financial 7,133  (113) 101,771  (16,401) 108,904  (16,514)
Utilities 27,442  (1,867) 24,905  (4,785) 52,347  (6,652)
Total corporates 94,727  (2,853) 280,170  (48,598) 374,897  (51,451)
Other asset-backed securities —  —  —  —  —  — 
Total below investment grade securities 94,727  (2,853) 280,170  (48,598) 374,897  (51,451)
Total fixed maturities
$ 3,133,083  $ (145,694) $ 8,067,414  $ (1,649,126) $ 11,200,497  $ (1,794,820)

15
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Gross unrealized losses may fluctuate quarter over quarter due to factors in the market that affect our holdings, such as changes in interest rates or credit spreads. The Company considers many factors when determining whether an allowance for a credit loss should be recorded. While the Company holds securities that may be in an unrealized loss position from time to time, Globe Life does not generally intend to sell and it is unlikely that the Company will be required to sell the fixed maturities prior to their anticipated recovery or maturity due to the strong cash flows generated by its insurance operations.

Analysis of Gross Unrealized Investment Losses
At December 31, 2024
Less than Twelve Months Twelve Months or Longer Total
Fair
Value		 Unrealized
Loss		 Fair
Value		 Unrealized
Loss		 Fair
Value		 Unrealized
Loss
Fixed maturities available for sale:
Investment grade securities:
U.S. Government direct, guaranteed, and government-sponsored enterprises $ 11,268  $ (290) $ 347,527  $ (42,504) $ 358,795  $ (42,794)
States, municipalities, and political subdivisions 778,244  (32,894) 1,532,264  (501,865) 2,310,508  (534,759)
Foreign governments —  —  24,925  (8,870) 24,925  (8,870)
Corporates, by sector:
Industrials 1,487,940  (73,404) 3,433,034  (690,920) 4,920,974  (764,324)
Financial 961,932  (52,946) 1,785,130  (333,873) 2,747,062  (386,819)
Utilities 546,965  (20,214) 540,077  (90,996) 1,087,042  (111,210)
Total corporates 2,996,837  (146,564) 5,758,241  (1,115,789) 8,755,078  (1,262,353)
Other asset-backed securities 23,231  (95) 42,639  (2,091) 65,870  (2,186)
Total investment grade securities 3,809,580  (179,843) 7,705,596  (1,671,119) 11,515,176  (1,850,962)
Below investment grade securities:
Corporates, by sector:
Industrials 54,199  (2,656) 142,638  (38,350) 196,837  (41,006)
Financial 2,990  (53) 126,811  (26,171) 129,801  (26,224)
Utilities 19,263  (1,113) 24,003  (5,684) 43,266  (6,797)
Total corporates 76,452  (3,822) 293,452  (70,205) 369,904  (74,027)
Other asset-backed securities —  —  2,198  —  2,198  — 
Total below investment grade securities 76,452  (3,822) 295,650  (70,205) 372,102  (74,027)
Total fixed maturities
$ 3,886,032  $ (183,665) $ 8,001,246  $ (1,741,324) $ 11,887,278  $ (1,924,989)

16
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Fixed Maturities, Allowance for Credit Losses: A summary of the activity in the allowance for credit losses is as follows.
Three Months Ended
March 31,
2025 2024
Allowance for credit losses beginning balance
$ 10,395  $ 7,115 
Additions to allowance for which credit losses were not previously recorded —  — 
Additions (reductions) to allowance for fixed maturities that previously had an allowance (40) (88)
Reduction of allowance for which the Company intends to sell or more likely than not will be required to sell or sold during the period —  — 
Allowance for credit losses ending balance
$ 10,355  $ 7,027 

As of March 31, 2025 and December 31, 2024, the Company had one fixed maturity security in non-accrual status with an amortized cost of $5.5 million and an allowance of $3.3 million.

Mortgage Loans (commercial mortgage loans): Summaries of commercial mortgage loans by property type and geographical location at March 31, 2025 and December 31, 2024 are as follows:
March 31, 2025 December 31, 2024
Carrying Value % of Total Carrying Value % of Total
Property type:
Industrial $ 128,598  30  $ 110,456  28 
Multi-family 111,566  26  111,234  28 
Hospitality 87,700  21  73,931  19 
Retail 66,021  16  65,612  16 
Mixed use 35,959  8  35,960  9 
Office 3,061  1  6,539  2 
Total recorded investment 432,905  102  403,732  102 
Less allowance for credit losses (6,731) (2) (7,644) (2)
Carrying value, net of allowance for credit losses
$ 426,174  100  $ 396,088  100 

March 31, 2025 December 31, 2024
Carrying Value % of Total Carrying Value % of Total
Geographic location:
Florida $ 80,308  19  $ 63,308  16 
Texas 72,214  17  75,131  19 
New Jersey 55,912  13  51,744  13 
California 48,380  11  48,371  12 
Alabama 35,884  9  35,850  9 
New York 31,883  8  34,975  9 
Other 108,324  25  94,353  24 
Total recorded investment 432,905  102  403,732  102 
Less allowance for credit losses (6,731) (2) (7,644) (2)
Carrying value, net of allowance for credit losses
$ 426,174  100  $ 396,088  100 
17
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following tables are reflective of the key factors, debt service coverage ratios, and loan-to-value (LTV) ratios that are utilized by management to monitor the performance of the portfolios. The Company only makes new investments in commercial mortgage loans that have a LTV ratio less than 80%. LTV ratios that exceed 80% are generally a result of decreases in the valuation of the underlying property. Generally, a higher LTV ratio and a lower debt service coverage ratio equates to higher risk of loss.
March 31, 2025
Recorded Investment
Debt Service Coverage Ratios(1)
<1.00x 1.00x—1.20x >1.20x Total % of Gross Total
Loan-to-value ratio(2):
Less than 70% $ 66,631  $ 46,976  $ 268,913  $ 382,520  88 
70% to 80% —  —  —  —  — 
81% to 90% —  —  —  —  — 
Greater than 90% 12,657  37,728  —  50,385  12 
Total $ 79,288  $ 84,704  $ 268,913  432,905  100 
Less allowance for credit losses (6,731)
Total, net of allowance for credit losses
$ 426,174 
(1)Annual net operating income divided by annual mortgage debt service (principal and interest).
(2)Loan balance divided by stabilized appraised value at origination, including planned renovations and stabilized occupancy. Updated internal valuations are used when a loan is materially underperforming.
December 31, 2024
Recorded Investment
Debt Service Coverage Ratios(1)
<1.00x 1.00x—1.20x >1.20x Total % of Gross Total
Loan-to-value ratio(2):
Less than 70% $ 88,507  $ 64,494  $ 196,867  $ 349,868  87 
70% to 80% —  —  —  —  — 
81% to 90% —  —  —  —  — 
Greater than 90% 16,136  37,728  —  53,864  13 
Total $ 104,643  $ 102,222  $ 196,867  403,732  100 
Less allowance for credit losses (7,644)
Total, net of allowance for credit losses
$ 396,088 
(1)Annual net operating income divided by annual mortgage debt service (principal and interest).
(2)Loan balance divided by stabilized appraised value at origination, including planned renovations and stabilized occupancy. Updated internal valuations are used when a loan is materially underperforming.

As of March 31, 2025, the Company had 36 loans in the portfolio. During the quarter, the Company evaluated the commercial mortgage loan portfolio on both an individual and pooling basis to determine the allowance for credit losses and determined five loans were collateral dependent or likely to foreclose. The allowance for credit losses on the five loans was determined using the practical expedient which was based on an estimate of fair value of the underlying collateral plus costs to sell the asset. The total principal balance of the five loans was $50.4 million and the allowance for these loans using the practical expedient was $3.2 million as of March 31, 2025. During the quarter, one loan with an outstanding principal value of $3.5 million was removed from the evaluation as a result of foreclosure. Additionally, there were three commercial mortgage loans in the process of foreclosure, with an outstanding par value of $42.2 million and outstanding interest due of $1.9 million as of March 31, 2025. For the three months ended March 31, 2025, the allowance for credit losses decreased by $913 thousand to $6.7 million. The provision for credit losses is included in "Realized gains (losses)" in the Condensed Consolidated Statements of Operations.
18
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Three Months Ended
March 31,
2025 2024
Allowance for credit losses beginning balance
$ 7,644  $ 3,672 
Provision (reversal) for credit losses (248) 874 
Reduction in allowance due to dispositions
 (665) — 
Allowance for credit losses ending balance
$ 6,731  $ 4,546 

As of March 31, 2025, the Company had four commercial mortgage loans in non-accrual status with a principal balance of $49 million. As of December 31, 2024, the Company had five commercial mortgage loans in non-accrual status with a principal balance of $53 million. The Company's unfunded commitment balance to commercial loan borrowers was $21 million as of March 31, 2025.

Other Long-Term Investments: Other long-term investments consist of the following assets:
March 31,
March 31,
2025		 December 31, 2024
Investment funds $ 989,027  $ 986,766 
Company-owned life insurance(1)
 205,331  202,734 
Other 42,266  46,259 
Total
$ 1,236,624  $ 1,235,759 
(1) Company-owned life insurance (COLI) is reported at cash surrender value.

The following table presents additional information about the Company's investment funds as of March 31, 2025 and December 31, 2024 at fair value:
Fair Value
Unfunded Commitments(2)
Investment Category March 31,
2025		 December 31, 2024 March 31,
2025
Redemption Term/Notice(1)
Commercial mortgage loans $ 560,271  $ 566,142  $ 192,336  Fully redeemable and non-redeemable with varying terms.
Opportunistic and private credit
 212,692  202,008  179,305  Fully redeemable and non-redeemable with varying terms.
Infrastructure 179,980  179,627  25,000  Fully redeemable and non-redeemable with varying terms.
Other 36,084  38,989  59,098  Non-redeemable with varying terms
Total investment funds $ 989,027  $ 986,766  $ 455,739 
(1) Non-redeemable funds generally have an expected life of 7 to 12 years from fund closing with extension options of 1 to 4 years. Redemptions are paid out throughout the life of the funds at the General Partner's discretion. Redeemable funds can generally be redeemed over 6 to 36 months upon request from limited partners.
(2) Unfunded commitments include unfunded balances during the investment period. After an investment period ends, the fund can call capital based on limited and specified reasons. As of March 31, 2025, unfunded commitments totaled $595 million, including funds past the investment period.

The Company had $19 million of capital called during the period from existing investment funds. The Company's unfunded commitments were $456 million as of March 31, 2025.


Note 5—Commitments and Contingencies

19
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Guarantees: At March 31, 2025, Globe Life had no guarantee agreements which were either Parent Company guarantees of subsidiary obligations to a third party or Parent Company guarantees of obligations between wholly-owned subsidiaries. As of March 31, 2025, Globe Life had no liability with respect to these guarantees.

Letters of credit — The Parent Company has guaranteed letters of credit with a group of banks in connection with its credit facility. The letters of credit were issued by TMK Re, Ltd., a wholly-owned subsidiary, to secure TMK Re, Ltd.’s obligation for claims on certain policies reinsured by TMK Re, Ltd. that were sold by other Globe Life insurance subsidiaries. These letters of credit facilitate TMK Re, Ltd.’s ability to reinsure the business of Globe Life's insurance carriers. The credit facility was amended on March 29, 2024 and now expires in 2029. The maximum amount of letters of credit available is $250 million. The Parent Company would be liable to the extent that TMK Re, Ltd. does not pay the reinsured party. The amount of letters of credit outstanding at March 31, 2025 was $115 million.

Litigation: Globe Life Inc. and its subsidiaries, in common with the insurance industry in general, are subject to litigation, including: putative class action litigation; alleged breaches of contract; torts, including bad faith and fraud claims based on alleged wrongful or fraudulent acts of agents of the Parent Company's insurance subsidiaries; alleged employment discrimination; alleged worker misclassification; and miscellaneous other causes of action. Based upon information presently available, and in light of legal and other factual defenses available to the Parent Company and its subsidiaries, management does not believe that it is reasonably possible that such litigation will have a material adverse effect on Globe Life Inc.'s financial condition, future operating results or liquidity; however, assessing the eventual outcome of litigation necessarily involves forward-looking speculation as to judgments to be made by judges, juries and appellate courts in the future. This bespeaks caution, particularly in states with reputations for high punitive damage verdicts.

On April 4, 2023, putative class action litigation was filed against National Income Life Insurance Company (“National Income”) in New York Supreme Court by plaintiffs Melissa K. Goppert, Sarah Valente, James O’Neill, Jennifer Abe, and Emily Herendeen (“Plaintiffs”) (Goppert, et al. v. National Income Life Insurance Company, Index No. 153096/2023). Plaintiffs are former National Income independent sales agents who allege they should have been classified as employees and assert claims under New York state law on behalf of a putative class of former independent sales agents and individuals who trained to become independent sale agents since March 2017. Plaintiffs make claims under New York’s Minimum Wage Law (NYLL § 633 and 12 NYCRR § 142-2.1); Overtime Compensation Law (NYLL § 633 and 12 NYCRR § 142-2.2); and “Spread of Hours” Law (12 NYCRR § 142-2.4) for the alleged failure to pay minimum wages and overtime pay, including for time spent in training, and attorney’s fees and costs. National Income filed a motion to compel arbitration of each Plaintiff’s claims on an individual basis, which the Court granted in full on January 11, 2024, and on February 7, 2024, Plaintiffs filed a notice of appeal of the Court’s order. On November 21, 2024, the Court’s order compelling arbitration was affirmed.

On September 1, 2023, plaintiff Miné Caglar Cost (“Plaintiff”) filed a complaint against American Income Life Insurance Company in the Superior Court of the State of California for the County of Los Angeles, asserting a single claim for violation of the Private Attorneys General Act (“PAGA”) (Cost v. American Income Life Insurance Company, et al., Case No. 23SMCV04113). Plaintiff is a former California independent insurance sales agent who alleges one cause of action for civil penalties under PAGA arising out of alleged violations of the wage-and-hour provisions of the California Labor Code stemming from American Income Life Insurance Company's alleged misclassification of Plaintiff and other California-based sales agents as independent contractors. American Income Life Insurance Company filed a motion to compel arbitration on an individual basis and stay the representative component of Plaintiff’s claims, to which Plaintiff stipulated. On December 12, 2023, the Court approved the parties’ stipulation to compel the matter to individual arbitration and stayed the case pending the completion of the individual arbitration, to commence on October 27, 2025.

On November 30, 2023, Globe Life Inc. and its subsidiary, American Income Life Insurance Company, received subpoenas from the U.S. Attorney’s Office for the Western District of Pennsylvania, seeking documents relating to sales practices by certain independent sales agents contracted to sell American Income Life Insurance Company policies. Globe Life Inc. and American Income Life Insurance Company continue to fully cooperate in responding to the Department of Justice’s requests.
20
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The Department of Justice has not asserted any claims or made allegations against Globe Life Inc. and American Income Life Insurance Company, and Globe Life Inc. currently is not aware that any legal proceedings are contemplated by governmental authorities. While no assurances can be made, at present management does not believe that it is reasonably possible or probable that this matter will result in a material loss.

In April 2024, Globe Life Inc. received an inquiry from the SEC's Fort Worth Regional Office requesting information related to recent short seller reports making allegations about Globe Life Inc. Globe Life Inc. has provided information in response to the SEC’s requests and continues to cooperate fully with the SEC. At this time, the SEC has not asserted any claims against Globe Life Inc. or indicated that it intends to do so. While no assurances can be made, at present management does not believe that it is reasonably possible or probable that this matter will result in a material loss.

On April 30, 2024, a putative securities class action was filed against Globe Life Inc. and six of its current/former executives and directors in the United States District Court for the Eastern District of Texas (City of Miami Gen. Emp. & Sanitation Emp. Ret. Trust, et al. v. Globe Life Inc., et al., Case No. 4:24-cv-00376). On July 24, 2024, the Court appointed Lead Plaintiffs and Lead Counsel for the putative class of shareholders. The Lead Plaintiffs filed a Consolidated Complaint on October 4, 2024 that asserts claims under §§ 10(b), 20(a), and 20(A) of the Securities Exchange Act of 1934 and SEC Rules 10b-5(a), 10b-5(b), and 10b-5(c) promulgated thereunder, on behalf of a putative class of purchasers of Globe Life Inc.'s securities from May 8, 2019 through April 10, 2024. The Consolidated Complaint adds four additional executives as defendants and alleges that certain of Globe Life Inc.'s disclosures about financial performance and certain other public statements during the putative class period were materially false or misleading. Defendants filed a motion to dismiss the litigation on December 3, 2024. Globe Life Inc. plans to vigorously defend against the lawsuit. Pursuant to Globe Life Inc.'s Restated Certificate of Incorporation and indemnification agreements with the named defendants, Globe Life Inc. has agreed to indemnify those defendants for all expenses and losses related to the litigation, subject to the terms of those indemnification agreements. The outcome of litigation of this type is inherently uncertain, and there is always the possibility that a Court rules in a manner that is adverse to the interests of Globe Life Inc. and the individual defendants. However, the amount of any such loss in that outcome cannot be reasonably estimated at this time. Further, management cannot reasonably estimate whether an outcome on the putative class action will be resolved in the near term.

Also pending in the Eastern District of Texas is a consolidated shareholder derivative suit that is closely related to the putative securities class action disclosed above (the “City of Miami Matter”). On November 7, 2024, Globe Life Inc. shareholder Jui Cheng Hsiao filed a shareholder derivative complaint against Globe Life Inc. as a nominal defendant, as well as certain current and former Globe Life Inc. executives and members of its Board of Directors. On November 14, 2024, Globe Life Inc. shareholder Gautam Jadhav filed a shareholder derivative complaint against the same set of defendants. Each shareholder derivative complaint asserts one claim for breach of fiduciary duty against the individual defendants and alleges that the individual defendants breached their fiduciary duties to Globe Life Inc. by causing or permitting Globe Life Inc. to make misleading statements about its performance and financial results. The allegations are substantially similar to the allegations made in the City of Miami Matter and derive from the Fuzzy Panda short seller report. On November 25, 2024, the two shareholder plaintiffs moved to consolidate the two actions into one action and the Court granted the motion on January 3, 2025 (In re Globe Life Inc. Stockholder Derivative Litigation, Lead Case No. 4:24-cv-00993-ALM (E.D. Tex.)). The case is before the same Court as the City of Miami Matter. On January 16, 2025, the parties filed a joint motion to stay such proceedings pending the Court’s resolution of the motion to dismiss filed by Globe Life Inc. in the City of Miami Matter. The Court granted such joint motion to stay the proceedings on January 25, 2025.

On September 26, 2024, Globe Life Inc. and its subsidiary, American Income Life Insurance Company, were notified by the Equal Employment Opportunity Commission (EEOC) that the EEOC conducted an investigation of charges filed against Globe Life Inc. and/or American Income Life Insurance Company by five former sales agents and one then-current sales agent. The EEOC asserts that there is reasonable cause to believe the six complainants were employees, not independent contractors, of Globe Life Inc. and/or American Income Life Insurance Company and were discriminated against on the basis of sex, and that one complainant was also discriminated against on the basis of race. In addition, the EEOC asserts that there is reasonable cause to believe that a class of female workers were employees, not independent contractors, and were subject to unlawful conduct which also constitutes a pattern-or-practice of discrimination.
21
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The EEOC’s investigative findings are not binding on Globe Life Inc. The EEOC’s procedures provide for a conciliation process that has concluded without achieving a resolution. The EEOC may elect to file a lawsuit in federal court on behalf of the workers based on the alleged statutory violations. The EEOC has not filed any legal proceedings at this time. In the event the EEOC elects to pursue any claims in court, Globe Life Inc. intends to defend against any such lawsuit vigorously. The outcome of litigation of this type would be inherently uncertain and cannot be reasonably estimated or determined at this time. There is always the possibility that a Court rules in a manner that is adverse to the interests of Globe Life Inc.
22
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Note 6—Policy Liabilities

The liability for future policy benefits is determined based on the net level premium method, which requires the liability be calculated as the present value of estimated future policyholder benefits and the related termination expenses, less the present value of estimated future net premiums to be collected from policyholders.

The following tables summarize balances and changes in the net liability for future policy benefits, before reinsurance, for traditional life long-duration contracts for the three month periods ended March 31, 2025 and 2024:
Life
Present value of expected future net premiums
American Income DTC Liberty National Other Total
Balance at January 1, 2024
$ 4,681,888  $ 6,052,651  $ 1,129,716  $ 478,052  $ 12,342,307 
Beginning balance at original discount rates 4,523,329  5,664,259  1,077,831  443,949  11,709,368 
Effect of changes in assumptions on future cash flows
 —  —  —  —  — 
Effect of actual variances from expected experience (48,248) (36,229) (10,448) (1,851) (96,776)
Adjusted balance at January 1, 2024
4,475,081  5,628,030  1,067,383  442,098  11,612,592 
Issuances(1)
 211,847  149,231  26,164  5,931  393,173 
Interest accrual(2)
 53,823  73,420  13,839  5,764  146,846 
Net premiums collected(3)
 (135,686) (152,631) (33,901) (11,401) (333,619)
Effect of changes in the foreign exchange rate (8,927) —  —  —  (8,927)
Ending balance at original discount rates 4,596,138  5,698,050  1,073,485  442,392  11,810,065 
Effect of change from original to current discount rates 56,533  247,209  28,724  21,777  354,243 
Balance at March 31, 2024
$ 4,652,671  $ 5,945,259  $ 1,102,209  $ 464,169  $ 12,164,308 
Balance at January 1, 2025
$ 4,645,917  $ 5,622,906  $ 1,048,447  $ 440,047  $ 11,757,317 
Beginning balance at original discount rates 4,656,710  5,504,912  1,047,020  430,276  11,638,918 
Effect of changes in assumptions on future cash flows
 —  —  —  —  — 
Effect of actual variances from expected experience (51,617) (38,917) (7,916) (3,689) (102,139)
Adjusted balance at January 1, 2025
4,605,093  5,465,995  1,039,104  426,587  11,536,779 
Issuances(1)
 195,634  121,780  25,780  5,210  348,404 
Interest accrual(2)
 56,466  72,207  13,521  5,625  147,819 
Net premiums collected(3)
 (139,565) (147,711) (33,262) (10,986) (331,524)
Effect of changes in the foreign exchange rate 2,105  —  —  —  2,105 
Ending balance at original discount rates 4,719,733  5,512,271  1,045,143  426,436  11,703,583 
Effect of change from original to current discount rates 37,311  173,844  13,553  13,834  238,542 
Balance at March 31, 2025
$ 4,757,044  $ 5,686,115  $ 1,058,696  $ 440,270  $ 11,942,125 
(1)Issuances represent the present value, using the original discount rate, of the expected net premiums related to new policies issued during each respective period.
(2)The interest accrual is the interest earned on the beginning present value of the expected net premiums, as well as the interest on actual net premiums earned during the period, using the original interest rate.
(3)Net premiums collected represent the product of the current period net premium ratio and the gross premiums collected during the period on the in force business.
23
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Life
Present value of expected future policy benefits
American Income DTC Liberty National Other Total
Balance at January 1, 2024
$ 10,163,627  $ 9,714,516  $ 3,605,392  $ 4,239,623  $ 27,723,158 
Beginning balance at original discount rates 9,061,833  8,656,752  3,338,252  3,506,859  24,563,696 
Effect of changes in assumptions on future cash flows —  —  —  —  — 
Effect of actual variances from expected experience (52,221) (36,444) (10,449) (2,867) (101,981)
Adjusted balance at January 1, 2024
9,009,612  8,620,308  3,327,803  3,503,992  24,461,715 
Issuances(1)
 211,847  149,231  26,164  5,931  393,173 
Interest accrual(2)
 120,201  117,925  44,554  52,136  334,816 
Benefit payments(3)
 (104,758) (159,061) (58,109) (34,177) (356,105)
Effect of changes in the foreign exchange rate (20,637) —  —  —  (20,637)
Ending balance at original discount rates 9,216,265  8,728,403  3,340,412  3,527,882  24,812,962 
Effect of change from original to current discount rates 741,828  771,812  159,330  576,010  2,248,980 
Balance at March 31, 2024
$ 9,958,093  $ 9,500,215  $ 3,499,742  $ 4,103,892  $ 27,061,942 
Balance at January 1, 2025
$ 9,870,692  $ 9,125,112  $ 3,377,517  $ 3,960,963  $ 26,334,284 
Beginning balance at original discount rates 9,508,588  8,660,948  3,340,219  3,582,068  25,091,823 
Effect of changes in assumptions on future cash flows —  —  —  —  — 
Effect of actual variances from expected experience (55,814) (41,948) (8,711) (5,447) (111,920)
Adjusted balance at January 1, 2025
9,452,774  8,619,000  3,331,508  3,576,621  24,979,903 
Issuances(1)
 195,633  121,779  25,780  5,211  348,403 
Interest accrual(2)
 127,459  119,194  44,736  53,386  344,775 
Benefit payments(3)
 (109,126) (150,039) (54,594) (34,896) (348,655)
Effect of changes in the foreign exchange rate 4,347  —  —  —  4,347 
Ending balance at original discount rates 9,671,087  8,709,934  3,347,430  3,600,322  25,328,773 
Effect of change from original to current discount rates 441,809  543,806  68,427  409,657  1,463,699 
Balance at March 31, 2025
$ 10,112,896  $ 9,253,740  $ 3,415,857  $ 4,009,979  $ 26,792,472 
(1)Issuances represent the present value, using the original discount rate, of the expected future policy benefits related to new policies issued during each respective period.
(2)The interest accrual is the interest earned on the beginning present value of the expected future policy benefits, as well as the interest on actual benefits and expenses paid during the period, using the original interest rate.
(3)Benefit payments represent the release of the present value, using the original discount rate, of the actual future policy benefits incurred during the period due to death, surrender, and maturity benefit payments based on the expected assumptions.



24
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Life
Net liability for future policy benefits as of March 31, 2024
American Income DTC Liberty National Other Total
Net liability for future policy benefits at original discount rates
$ 4,620,127  $ 3,030,353  $ 2,266,927  $ 3,085,490  $ 13,002,897 
Effect of changes in discount rate assumptions 685,295  524,603  130,606  554,233  1,894,737 
Other adjustments(1)
 287  3,549  5,418  85  9,339 
Net liability for future policy benefits, after other adjustments, at current discount rates
5,305,709  3,558,505  2,402,951  3,639,808  14,906,973 
Reinsurance recoverable
 (170) —  (7,787) (36,564) (44,521)
Net liability for future policy benefits, after reinsurance recoverable, at current discount rates
$ 5,305,539  $ 3,558,505  $ 2,395,164  $ 3,603,244  $ 14,862,452 
(1)Other adjustments include the Company's effects of capping and flooring the liability (guidance requires an amount not less than zero at the calculation level of the liability for future policy benefits).



Life
Net liability for future policy benefits as of March 31, 2025
American Income DTC Liberty National Other Total
Net liability for future policy benefits at original discount rates
$ 4,951,354  $ 3,197,663  $ 2,302,287  $ 3,173,886  $ 13,625,190 
Effect of changes in discount rate assumptions 404,498  369,962  54,874  395,823  1,225,157 
Other adjustments(1)
 224  208  —  75  507 
Net liability for future policy benefits, after other adjustments, at current discount rates
5,356,076  3,567,833  2,357,161  3,569,784  14,850,854 
Reinsurance recoverable
 (186) —  (7,922) (14) (8,122)
Net liability for future policy benefits, after reinsurance recoverable, at current discount rates
$ 5,355,890  $ 3,567,833  $ 2,349,239  $ 3,569,770  $ 14,842,732 
(1)Other adjustments include the Company's effects of flooring the liability (guidance requires an amount not less than zero at the calculation level of the liability for future policy benefits).



25
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following tables summarize balances and changes in the net liability for future policy benefits for long-duration health contracts for the three month periods ended March 31, 2025 and 2024:
Health
Present value of expected future net premiums
United American Family Heritage Liberty National American Income DTC Total
Balance at January 1, 2024
$ 3,697,771  $ 1,711,741  $ 358,472  $ 206,381  $ 115,363  $ 6,089,728 
Beginning balance at original discount rates 3,625,803  1,783,173  348,570  201,869  109,880  6,069,295 
Effect of changes in assumptions on future cash flows
 —  —  —  —  —  — 
Effect of actual variances from expected experience (40,531) (17,092) (11,410) (3,550) (2,316) (74,899)
Adjusted balance at January 1, 2024
3,585,272  1,766,081  337,160  198,319  107,564  5,994,396 
Issuances(1)
 104,603  64,008  13,558  9,949  4,609  196,727 
Interest accrual(2)
 41,822  18,103  4,227  2,283  1,368  67,803 
Net premiums collected(3)
 (70,249) (46,400) (12,780) (5,839) (2,678) (137,946)
Effect of changes in the foreign exchange rate —  —  —  (862) —  (862)
Ending balance at original discount rates 3,661,448  1,801,792  342,165  203,850  110,863  6,120,118 
Effect of change from original to current discount rates (8,053) (107,766) 3,276  (55) 3,016  (109,582)
Balance at March 31, 2024
$ 3,653,395  $ 1,694,026  $ 345,441  $ 203,795  $ 113,879  $ 6,010,536 
Balance at January 1, 2025
$ 3,885,530  $ 1,734,875  $ 337,119  $ 223,247  $ 133,377  $ 6,314,148 
Beginning balance at original discount rates 3,948,856  1,867,873  338,275  225,141  131,919  6,512,064 
Effect of changes in assumptions on future cash flows
 —  —  —  —  —  — 
Effect of actual variances from expected experience (28,215) (13,901) (10,720) (4,881) (1,415) (59,132)
Adjusted balance at January 1, 2025
3,920,641  1,853,972  327,555  220,260  130,504  6,452,932 
Issuances(1)
 117,625  64,760  12,657  10,441  6,662  212,145 
Interest accrual(2)
 46,870  19,640  4,090  2,643  1,681  74,924 
Net premiums collected(3)
 (79,516) (49,418) (13,120) (6,714) (3,435) (152,203)
Effect of changes in the foreign exchange rate —  —  —  222  —  222 
Ending balance at original discount rates 4,005,620  1,888,954  331,182  226,852  135,412  6,588,020 
Effect of change from original to current discount rates (11,927) (111,603) 1,749  421  2,971  (118,389)
Balance at March 31, 2025
$ 3,993,693  $ 1,777,351  $ 332,931  $ 227,273  $ 138,383  $ 6,469,631 
(1)Issuances represent the present value, using the original discount rate, of the expected net premiums related to new policies issued during each respective period.
(2)The interest accrual is the interest earned on the beginning present value of the expected net premiums, as well as the interest on actual net premiums earned during the period, using the original interest rate.
(3)Net premiums collected represent the product of the current period net premium ratio and the gross premiums collected during the period on the in force business.





26
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Health
Present value of expected future policy benefits
United American Family Heritage Liberty National American Income DTC Total
Balance at January 1, 2024
$ 3,814,328  $ 3,315,880  $ 865,808  $ 335,504  $ 109,482  $ 8,441,002 
Beginning balance at original discount rates 3,741,530  3,506,689  816,819  315,431  104,501  8,484,970 
Effect of changes in assumptions on future cash flows —  —  —  —  —  — 
Effect of actual variances from expected experience (40,325) (19,049) (12,821) (4,002) (2,321) (78,518)
Adjusted balance at January 1, 2024
3,701,205  3,487,640  803,998  311,429  102,180  8,406,452 
Issuances(1)
 104,431  64,008  13,349  9,949  4,598  196,335 
Interest accrual(2)
 43,444  35,663  10,833  3,937  1,368  95,245 
Benefit payments(3)
 (82,085) (33,037) (23,864) (6,402) (3,096) (148,484)
Effect of changes in the foreign exchange rate —  —  —  (1,548) —  (1,548)
Ending balance at original discount rates 3,766,995  3,554,274  804,316  317,365  105,050  8,548,000 
Effect of change from original to current discount rates (10,461) (282,670) 29,690  11,418  2,725  (249,298)
Balance at March 31, 2024
$ 3,756,534  $ 3,271,604  $ 834,006  $ 328,783  $ 107,775  $ 8,298,702 
Balance at January 1, 2025
$ 3,960,432  $ 3,336,546  $ 804,695  $ 355,303  $ 129,277  $ 8,586,253 
Beginning balance at original discount rates 4,026,860  3,712,044  791,141  348,711  127,975  9,006,731 
Effect of changes in assumptions on future cash flows —  —  —  —  —  — 
Effect of actual variances from expected experience (25,054) (15,756) (11,005) (6,195) (1,191) (59,201)
Adjusted balance at January 1, 2025
4,001,806  3,696,288  780,136  342,516  126,784  8,947,530 
Issuances(1)
 117,400  64,760  12,478  10,441  6,630  211,709 
Interest accrual(2)
 47,983  38,756  10,470  4,456  1,681  103,346 
Benefit payments(3)
 (100,534) (38,334) (24,422) (5,320) (4,273) (172,883)
Effect of changes in the foreign exchange rate —  —  —  352  —  352 
Ending balance at original discount rates 4,066,655  3,761,470  778,662  352,445  130,822  9,090,054 
Effect of change from original to current discount rates (15,333) (330,868) 20,778  10,095  2,741  (312,587)
Balance at March 31, 2025
$ 4,051,322  $ 3,430,602  $ 799,440  $ 362,540  $ 133,563  $ 8,777,467 
(1)Issuances represent the present value, using the original discount rate, of the expected future policy benefits related to new policies issued during each respective period.
(2)The interest accrual is the interest earned on the beginning present value of the expected future policy benefits, as well as the interest on actual benefits and expenses paid during the period, using the original interest rate.
(3)Benefit payments represent the release of the present value, using the original discount rate, of the actual future policy benefits incurred during the period based on the expected assumptions.

27
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Health
Net liability for future policy benefits as of March 31, 2024
United American Family Heritage Liberty National American Income Direct to Consumer Total
Net liability for future policy benefits at original discount rates
$ 105,547  $ 1,752,482  $ 462,151  $ 113,515  $ (5,813) $ 2,427,882 
Effect of changes in discount rate assumptions (2,408) (174,904) 26,414  11,473  (291) (139,716)
Other adjustments(1)
 14,449  444  11,254  749  6,838  33,734 
Net liability for future policy benefits, after other adjustments, at current discount rates
117,588  1,578,022  499,819  125,737  734  2,321,900 
Reinsurance recoverable
 (3,096) (10,577) (1,224) —  —  (14,897)
Net liability for future policy benefits, after reinsurance recoverable, at current discount rates
$ 114,492  $ 1,567,445  $ 498,595  $ 125,737  $ 734  $ 2,307,003 
(1)Other adjustments include the effects of capping and flooring the liability (guidance requires an amount not less than zero at the calculation level of the liability for future policy benefits).

Health
Net liability for future policy benefits as of March 31, 2025
United American Family Heritage Liberty National American Income Direct to Consumer Total
Net liability for future policy benefits at original discount rates
61,035  1,872,516  447,480  125,593  (4,590) 2,502,034 
Effect of changes in discount rate assumptions (3,406) (219,265) 19,029  9,674  (230) (194,198)
Other adjustments(1)
 34,570  1,315  11,363  699  5,575  53,522 
Net liability for future policy benefits, after other adjustments, at current discount rates
92,199  1,654,566  477,872  135,966  755  2,361,358 
Reinsurance recoverable
 (2,511) —  (988) —  —  (3,499)
Net liability for future policy benefits, after reinsurance recoverable, at current discount rates
$ 89,688  $ 1,654,566  $ 476,884  $ 135,966  $ 755  $ 2,357,859 
(1)Other adjustments include the effects of flooring the liability (guidance requires an amount not less than zero at the calculation level of the liability for future policy benefits).

28
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following tables include the total remeasurement gain or loss, bifurcated between the gain or loss due to differences between actual and expected experience and the amount due to assumption updates, for three months ended March 31, 2025 and 2024:
Three Months Ended
March 31,
2025 2024
Life Remeasurement Gain (Loss)—Experience:
American Income $ 4,179  $ 3,972 
Direct to Consumer 2,980  166 
Liberty National 182  112 
Other 1,184  606 
Total Life Remeasurement Gain (Loss)—Experience
8,525  4,856 
Life Remeasurement Gain (Loss)—Assumption Updates(1):
American Income —  — 
Direct to Consumer —  — 
Liberty National —  — 
Other —  — 
Total Life Remeasurement Gain (Loss)—Assumption Updates
—  — 
Total Life Remeasurement Gain (Loss)
8,525  4,856 
Health Remeasurement Gain (Loss)—Experience:
United American (3,820) (336)
Family Heritage 1,836  1,883 
Liberty National 1,183  1,211 
American Income 1,249  430 
Direct to Consumer (4) 20 
Total Health Remeasurement Gain (Loss)—Experience
444  3,208 
Health Remeasurement Gain (Loss)—Assumption Updates(1):
United American —  — 
Family Heritage —  — 
Liberty National —  — 
American Income —  — 
Direct to Consumer —  — 
Health Remeasurement Gain (Loss)—Assumption Updates
—  — 
Total Health Remeasurement Gain (Loss)
$ 444  $ 3,208 
(1)Changes to the judgments, assumptions, and methods used in measuring the liability for future policy benefits occur annually. There were no changes to the judgments, assumptions, and methods used in measuring the liability for future policy benefits during the three months ended March 31, 2025 and 2024.

29
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following table reconciles the liability for future policy benefits to the Condensed Consolidated Balance Sheets as of March 31, 2025 and 2024:

At Original Discount Rates At Current Discount Rates
As of March 31, As of March 31,
2025 2024 2025 2024
Life(1):
American Income $ 4,951,442  $ 4,620,358  $ 5,356,076  $ 5,305,709 
Direct to Consumer 3,197,663  3,030,353  3,567,833  3,558,505 
Liberty National 2,302,287  2,265,329  2,357,161  2,402,951 
Other 3,173,917  3,085,512  3,569,784  3,639,808 
Net liability for future policy benefits—long duration life 13,625,309  13,001,552  14,850,854  14,906,973 
Health(1):
United American 92,197  117,042  92,199  117,588 
Family Heritage 1,872,606  1,752,138  1,654,566  1,578,022 
Liberty National 458,182  472,140  477,872  499,819 
American Income 126,186  114,146  135,966  125,737 
Direct to Consumer 722  707  755  734 
Net liability for future policy benefits—long duration health 2,549,893  2,456,173  2,361,358  2,321,900 
Deferred profit liability 179,229  174,605  179,229  174,605 
Deferred annuity 636,219  739,019  636,219  739,019 
Interest sensitive life 720,269  729,721  720,269  729,721 
Other 8,922  9,810  8,915  9,805 
Total future policy benefits
$ 17,719,841  $ 17,110,880  $ 18,756,844  $ 18,882,023 
(1)Balances are presented net of the effects of capping and flooring the liability (guidance requires an amount not less than zero at the calculation level of the liability for future policy benefits).



30
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following tables provide the weighted-average original and current discount rates for the liability for future policy benefits and the additional insurance liabilities as of March 31, 2025 and 2024:
As of March 31,
2025 2024
Original discount rate Current discount rate Original discount rate Current discount rate
Life
American Income 5.7  % 5.4  % 5.7  % 5.2  %
Direct to Consumer 5.9  % 5.4  % 6.0  % 5.2  %
Liberty National 5.6  % 5.4  % 5.6  % 5.2  %
Other 6.2  % 5.5  % 6.2  % 5.2  %
Health
United American 5.1  % 5.1  % 5.1  % 5.0  %
Family Heritage 4.2  % 5.2  % 4.2  % 5.1  %
Liberty National 5.8  % 5.3  % 5.8  % 5.2  %
American Income 5.8  % 5.1  % 5.8  % 5.0  %
Direct to Consumer 5.1  % 5.1  % 5.1  % 5.0  %

The following table provides the weighted-average durations of the liability for future policy benefits and the additional insurance liabilities as of March 31, 2025 and 2024:
As of March 31,
2025 2024
At original discount rates At current discount rates At original discount rates At current discount rates
Life
American Income 22.67 22.59 23.05 23.33
Direct to Consumer 19.17 20.11 19.57 21.01
Liberty National 15.32 15.27 15.16 15.60
Other 15.90 16.74 16.18 17.59
Health
United American 11.70 10.60 11.53 10.74
Family Heritage 15.31 14.16 15.07 14.34
Liberty National 9.37 9.24 9.23 9.39
American Income 12.47 12.50 12.28 12.67
Direct to Consumer 11.70 10.60 11.53 10.74
31
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following tables summarize the amount of gross premiums and interest related to long duration life and health contracts that are recognized in the Condensed Consolidated Statements of Operations for the three months ended March 31, 2025 and 2024:
Life
Three Months Ended
March 31, 2025		 Three Months Ended
March 31, 2024
Gross
Premiums
Interest
Expense
 Gross
Premiums
Interest
Expense
American Income $ 437,449  $ 70,993  $ 413,759  $ 66,379 
Direct to Consumer 242,870  46,967  245,194  44,460 
Liberty National 95,300  31,049  89,871  30,542 
Other 49,914  47,285  51,069  45,917 
Total $ 825,533  $ 196,294  $ 799,893  $ 187,298 
Health
Three Months Ended
March 31, 2025		 Three Months Ended
March 31, 2024
Gross
Premiums
Interest
Expense
 Gross
Premiums
Interest
Expense
United American $ 116,396  $ 1,049  $ 104,097  $ 1,567 
Family Heritage 112,354  19,116  103,391  17,431 
Liberty National 47,753  6,355  47,434  6,583 
American Income 29,754  1,812  28,919  1,655 
Direct to Consumer 4,136  —  3,657  — 
Total $ 310,393  $ 28,332  $ 287,498  $ 27,236 
Gross premiums are included within life and health premium on the Condensed Consolidated Statements of Operations, while the related interest expense is included in life and health policyholder benefits.
32
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following tables provide the undiscounted and discounted expected future net premiums, expected future gross premiums, and expected future policy benefits, at both original and current discount rates, for life and health contracts for the three months ended March 31, 2025 and 2024:
Life
As of March 31, 2025 As of March 31, 2024
Not discounted At original discount rates At current discount rates Not discounted At original discount rates At current discount rates
American Income
PV of expected future gross premiums $ 25,905,546  $ 14,643,965  $ 14,852,317  $ 24,668,992  $ 13,924,819  $ 14,181,177 
PV of expected future net premiums 8,346,487  4,719,733  4,757,044  8,131,005  4,596,138  4,652,671 
PV of expected future policy benefits 32,329,867  9,671,087  10,112,896  31,114,756  9,216,265  9,958,093 
DTC
PV of expected future gross premiums $ 17,440,657  $ 9,119,222  $ 9,393,586  $ 17,617,001  $ 9,214,360  $ 9,597,417 
PV of expected future net premiums 10,487,810  5,512,271  5,686,115  10,831,408  5,698,050  5,945,259 
PV of expected future policy benefits 25,953,052  8,709,934  9,253,740  25,909,464  8,728,403  9,500,215 
Liberty National
PV of expected future gross premiums $ 4,865,443  $ 2,833,738  $ 2,827,949  $ 4,667,397  $ 2,725,502  $ 2,739,275 
PV of expected future net premiums 1,844,879  1,045,143  1,058,696  1,888,084  1,073,485  1,102,209 
PV of expected future policy benefits 9,102,330  3,347,430  3,415,857  8,916,134  3,340,412  3,499,742 
Other
PV of expected future gross premiums $ 3,595,733  $ 1,830,596  $ 1,946,761  $ 3,701,248  $ 1,879,815  $ 2,027,187 
PV of expected future net premiums 877,282  426,436  440,270  906,921  442,392  464,169 
PV of expected future policy benefits 12,457,676  3,600,322  4,009,979  12,437,133  3,527,882  4,103,892 
Total
PV of expected future gross premiums $ 51,807,379  $ 28,427,521  $ 29,020,613  $ 50,654,638  $ 27,744,496  $ 28,545,056 
PV of expected future net premiums 21,556,458  11,703,583  11,942,125  21,757,418  11,810,065  12,164,308 
PV of expected future policy benefits 79,842,925  25,328,773  26,792,472  78,377,487  24,812,962  27,061,942 

As of March 31, 2025, for the life segment using current discount rates, the Company anticipates $29.0 billion of expected future gross premiums and $11.9 billion of expected future net premiums. As of March 31, 2024, using current discount rates, the Company anticipated $28.5 billion of expected future gross premiums and $12.2 billion in expected future net premiums. For each respective period, only expected future net premiums are included in the determination of the liability for future policy benefits on the balance sheet, while the difference between the expected future gross premiums and the expected future net premiums of $17.1 billion and $16.3 billion for March 31, 2025 and 2024, respectively, is not.

33
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Health
As of March 31, 2025 As of March 31, 2024
Not discounted At original discount rates At current discount rates Not discounted At original discount rates At current discount rates
United American
PV of expected future gross premiums $ 9,431,321  $ 5,798,787  $ 5,779,686  $ 8,757,778  $ 5,349,917  $ 5,334,881 
PV of expected future net premiums 6,522,325  4,005,620  3,993,693  6,002,434  3,661,448  3,653,395 
PV of expected future policy benefits 6,644,012  4,066,655  4,051,322  6,186,167  3,766,995  3,756,534 
Family Heritage
PV of expected future gross premiums $ 7,377,322  $ 4,282,970  $ 4,048,299  $ 6,854,106  $ 4,037,762  $ 3,816,256 
PV of expected future net premiums 3,236,121  1,888,954  1,777,351  3,039,406  1,801,792  1,694,026 
PV of expected future policy benefits 7,307,684  3,761,470  3,430,602  6,769,500  3,554,274  3,271,604 
Liberty National
PV of expected future gross premiums $ 2,018,796  $ 1,285,073  $ 1,314,976  $ 2,073,015  $ 1,315,879  $ 1,353,262 
PV of expected future net premiums 491,199  331,182  332,931  509,069  342,165  345,441 
PV of expected future policy benefits 1,358,567  778,662  799,440  1,395,561  804,316  834,006 
American Income
PV of expected future gross premiums $ 1,782,370  $ 998,794  $ 1,029,082  $ 1,768,477  $ 991,946  $ 1,024,262 
PV of expected future net premiums 404,090  226,852  227,273  362,982  203,850  203,795 
PV of expected future policy benefits 717,506  352,445  362,540  644,293  317,365  328,783 
Direct to Consumer
PV of expected future gross premiums $ 251,621  $ 159,881  $ 163,737  $ 238,499  $ 150,065  $ 154,223 
PV of expected future net premiums 213,954  135,412  138,383  176,500  110,863  113,879 
PV of expected future policy benefits 209,022  130,822  133,563  164,347  105,050  107,775 
Total
PV of expected future gross premiums $ 20,861,430  $ 12,525,505  $ 12,335,780  $ 19,691,875  $ 11,845,569  $ 11,682,884 
PV of expected future net premiums 10,867,689  6,588,020  6,469,631  10,090,391  6,120,118  6,010,536 
PV of expected future policy benefits 16,236,791  9,090,054  8,777,467  15,159,868  8,548,000  8,298,702 

As of March 31, 2025, for the health segment using current discount rates, the Company anticipates $12.3 billion of expected future gross premiums and $6.5 billion of expected future net premiums. As of March 31, 2024, using current discount rates, the Company anticipated $11.7 billion of expected future gross premiums and $6.0 billion in expected future net premiums. For each respective period, only expected future net premiums are included in the determination of the liability for future policy benefits on the balance sheet, while the difference between the expected future gross premiums and the expected future net premiums of $5.8 billion and $5.7 billion for March 31, 2025 and 2024, respectively, is not.

34
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following table summarizes the balances of, and changes in, policyholders’ account balances as of March 31, 2025 and 2024:
Policyholders' Account Balances
2025 2024
Interest Sensitive Life
Deferred Annuity(1)
 Other Policy-holders' Funds Interest Sensitive Life Deferred Annuity Other Policy-holders' Funds
Balance at January 1,
$ 723,389  $ 656,573  $ 468,604  $ 732,948  $ 773,039  $ 236,958 
Issuances —  171  —  —  198  — 
Premiums and deposits received
 5,250  3,766  86,885  5,624  3,573  166,700 
Policy charges (2,986) —  —  (3,111) —  — 
Surrenders and withdrawals (5,966) (16,531) (93,128) (6,309) (31,563) (3,517)
Benefit payments (8,329) (12,831) —  (9,140) (12,771) — 
Interest credited 6,875  5,373  5,443  7,016  6,243  3,521 
Other 2,036  (302) (4,656) 2,693  300  (2,393)
Balance at March 31,
$ 720,269  $ 636,219  $ 463,148  $ 729,721  $ 739,019  $ 401,269 

Weighted-average credit rate 3.86  % 3.37  % 4.76  % 3.89  % 3.34  % 4.49  %
Net amount at risk $ 1,636,687  N/A N/A $ 1,740,325  N/A N/A
Cash surrender value $ 674,838  $ 636,138  $ 463,148  $ 669,721  $ 739,019  $ 401,269 
(1) At March 31, 2025, $439 million has been reinsured with third-party reinsurers under existing reinsurance agreements.

The following tables present the policyholders' account balances by range of guaranteed minimum crediting rates and the related range of difference, if any, in basis points between rates being credited to policyholders and the respective guaranteed minimums as of March 31, 2025 and 2024:
At March 31, 2025
Range of guaranteed minimum crediting rates Interest Sensitive Life Deferred Annuity Other Policyholders' Funds
At guaranteed minimum:
Less than 3.00%
 $ —  $ 1,866  $ 368,459 
3.00%-3.99%
 29,408  455,618  3,145 
4.00%-4.99%
 601,367  178,735  55,767 
Greater than 5.00%
 89,494  —  35,777 
Total
720,269  636,219  463,148 
51-150 basis points above:
Less than 3.00%
 —  —  — 
3.00%-3.99%
 —  —  — 
4.00%-4.99%
 —  —  — 
Greater than 5.00%
 —  —  — 
Total
—  —  — 
Grand Total
$ 720,269  $ 636,219  $ 463,148 


35
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
At March 31, 2024
Range of guaranteed minimum crediting rates Interest Sensitive Life Deferred Annuity Other Policyholders' Funds
At guaranteed minimum:
Less than 3.00%
 $ —  $ 1,796  $ 303,935 
3.00%-3.99%
 29,176  545,598  3,521 
4.00%-4.99%
 610,643  191,625  6,745 
Greater than 5.00%
 89,902  —  37,384 
Total
729,721  739,019  351,585 
51-150 basis points above:
Less than 3.00%
 —  —  — 
3.00%-3.99%
 —  —  — 
4.00%-4.99%
 —  —  49,684 
Greater than 5.00%
 —  —  — 
Total
—  —  49,684 
Grand Total
$ 729,721  $ 739,019  $ 401,269 
36
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Note 7—Deferred Acquisition Costs

The following tables roll forward the deferred policy acquisition costs for the three month periods ended March 31, 2025 and 2024:
Life
American Income DTC Liberty National Other Total
Balance at January 1, 2024
$ 2,573,370  $ 1,737,117  $ 666,419  $ 294,869  $ 5,271,775 
Capitalizations 127,443  42,125  26,065  3,013  198,646 
Amortization expense (42,976) (25,058) (13,599) (4,135) (85,768)
Foreign exchange adjustment (5,828) —  —  —  (5,828)
Balance at March 31, 2024
$ 2,652,009  $ 1,754,184  $ 678,885  $ 293,747  $ 5,378,825 
Balance at January 1, 2025
$ 2,900,229  $ 1,781,230  $ 728,790  $ 290,506  $ 5,700,755 
Capitalizations 133,870  37,148  29,591  2,807  203,416 
Amortization expense (49,374) (25,588) (14,993) (678) (90,633)
Foreign exchange adjustment 1,282  —  —  —  1,282 
Balance at March 31, 2025
$ 2,986,007  $ 1,792,790  $ 743,388  $ 292,635  $ 5,814,820 


Health
United American Family Heritage Liberty National American Income DTC Total
Balance at January 1, 2024
$ 73,489  $ 452,843  $ 139,941  $ 66,783  $ 1,679  $ 734,735 
Capitalizations 496  16,690  7,979  3,530  1  28,696 
Amortization expense (1,381) (7,187) (3,607) (1,099) (37) (13,311)
Foreign exchange adjustment —  —  —  (276) —  (276)
Balance at March 31, 2024
$ 72,604  $ 462,346  $ 144,313  $ 68,938  $ 1,643  $ 749,844 
Balance at January 1, 2025
$ 70,530  $ 496,119  $ 148,920  $ 76,319  $ 1,533  $ 793,421 
Capitalizations 616  18,531  5,919  3,732  —  28,798 
Amortization expense (1,391) (7,938) (3,862) (1,291) (37) (14,519)
Foreign exchange adjustment —  —  —  73  —  73 
Balance at March 31, 2025
$ 69,755  $ 506,712  $ 150,977  $ 78,833  $ 1,496  $ 807,773 
37
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following table presents a reconciliation of deferred policy acquisition costs to the Condensed Consolidated Balance Sheets for the three months ended March 31, 2025 and 2024:
March 31,
2025 2024
Life
American Income $ 2,986,007  $ 2,652,009 
Direct to Consumer 1,792,790  1,754,184 
Liberty National 743,388  678,885 
Other 292,635  293,747 
Total DAC—Life
5,814,820  5,378,825 
Health
United American 69,755  72,604 
Family Heritage 506,712  462,346 
Liberty National 150,977  144,313 
American Income 78,833  68,938 
Direct to Consumer 1,496  1,643 
Total DAC—Health
807,773  749,844 
Annuity
1,051  2,568 
Total
$ 6,623,644  $ 6,131,237 
38
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Note 8—Liability for Unpaid Claims

Activity in the liability for unpaid health claims is summarized as follows:
March 31,
2025		 December 31,
2024
Balance at beginning of period
$ 210,994  $ 194,809 
Less reinsurance recoverables
 (1,521) (2,157)
Net balance at beginning of period
209,473  192,652 
Incurred related to:
Current year 210,420  767,076 
Prior years 5,943  (10,460)
Total incurred 216,363  756,616 
Paid related to:
Current year 87,639  587,473 
Prior years 117,573  152,322 
Total paid 205,212  739,795 
Net balance at end of period
220,624  209,473 
Plus reinsurance recoverables
 1,548  1,521 
Balance at end of period
$ 222,172  $ 210,994 

Below is the reconciliation of the liability of "Policy claims and other benefits payable" in the Condensed Consolidated Balance Sheets.
March 31,
2025		 December 31,
2024
Policy claims and other benefits payable:
Life insurance $ 324,498  $ 321,838 
Health insurance 222,172  210,994 
Total $ 546,670  $ 532,832 

39
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Note 9—Postretirement Benefits

Globe Life has qualified noncontributory defined benefit pension plans (Pension Plans) and contributory savings plans that cover substantially all employees. There is also a nonqualified noncontributory supplemental executive retirement plan (SERP) that covers a limited number of officers. The tables included herein will focus on the Pension Plans and SERP.

Pension Assets: The following table presents the assets of the Company's Pension Plans at March 31, 2025 and December 31, 2024.

Pension Assets by Component at March 31, 2025

  Fair Value Determined by:    
 
Quoted Prices in
Active Markets
for Identical
Assets (Level 1)
Significant
Observable
Inputs (Level 2)
 Significant
Unobservable
Inputs (Level 3)
Total
Amount
 % of
Total
Exchange traded fund(4)
 $ 36,019  $ —  $ —  $ 36,019  6 
Equity exchange traded fund(1)
 304,226  —  —  304,226  50 
U.S. Government and Agency —  189,445  —  189,445  31 
Other bonds —  4  —  4  — 
Guaranteed annuity contract(2)
 —  44,029  —  44,029  7 
Short-term investments 2,658  —  —  2,658  1 
Other 2,317  —  —  2,317  — 
$ 345,220  $ 233,478  $ —  578,698  95 
Other long-term investments(3)
 28,746  5 
Total pension assets
$ 607,444  100 
(1)A fund including marketable securities that mirror the S&P 500 index.
(2)Representing a guaranteed annuity contract issued by Globe Life Inc.'s subsidiary, American Income Life Insurance Company, to fund the obligations of the American Income Life Insurance Company Collective Bargaining Agreement Employees Pension Plan.
(3)Includes non-redeemable investment funds that report the Globe Life Inc. Pension Plan's pro-rata share of the limited partnership's net asset value (NAV) per share, or its equivalent, as a practical expedient for fair value. As of March 31, 2025, the Globe Life Inc. Pension Plan owned less than 1% of two long-term investment funds.
(4)A fund including U.S. dollar-denominated investment-grade securities issued by industrial, utility, and financial companies with maturities greater than 10 years.


40
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Pension Assets by Component at December 31, 2024
  Fair Value Determined by:    

Quoted Prices in
Active Markets
for Identical
Assets (Level 1)
Significant
Observable
Inputs (Level 2)
Significant
Unobservable
Inputs (Level 3)
Total
Amount
 % of
Total
Exchange traded fund(4)
 $ 35,483  $ —  $ —  $ 35,483  6 
Equity exchange traded fund(1)
 322,846  —  —  322,846  53 
U.S. Government and Agency —  179,418  —  179,418  29 
Other bonds —  4  —  4  — 
Guaranteed annuity contract(2)
 —  43,893  —  43,893  7 
Short-term investments 1,235  —  —  1,235  — 
Other 1,420  —  —  1,420  — 
$ 360,984  $ 223,315  $ —  584,299  95 
Other long-term investments(3)
 30,546  5 
Total pension assets
$ 614,845  100 
(1)A fund including marketable securities that mirror the S&P 500 index.
(2)Representing a guaranteed annuity contract issued by Globe Life Inc.'s subsidiary, American Income Life Insurance Company, to fund the obligations of the American Income Life Insurance Company Collective Bargaining Agreement Employees Pension Plan.
(3)Includes non-redeemable investment funds that report the Globe Life Inc. Pension Plan's pro-rata share of the limited partnership's net asset value (NAV) per share, or its equivalent, as a practical expedient for fair value. As of December 31, 2024, the Globe Life Inc. Pension Plan owned less than 1% of two long-term investment funds.
(4)A fund including U.S. dollar-denominated investment-grade securities issued by industrial, utility, and financial companies with maturities greater than 10 years.

SERP: The following tables include premiums paid for COLI at March 31, 2025 and 2024 and investments of the Rabbi Trust at March 31, 2025 and December 31, 2024.
Three Months Ended
March 31,
2025 2024
Premiums paid for insurance coverage $ —  $ 443 
March 31,
2025		 December 31,
2024
Total investments:
COLI
 $ 57,632  $ 57,210 
Exchange traded funds 96,573  98,314 
$ 154,205  $ 155,524 

Pension Plans and SERP Liabilities: The following table presents liabilities for the defined benefit pension plans and SERP at March 31, 2025 and December 31, 2024.
March 31,
2025		 December 31,
2024
Pension Plans $ 556,548  $ 561,615 
SERP 73,682  73,441 
Benefit obligation
 $ 630,230  $ 635,056 

41
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Net Periodic Benefit Cost: The following table presents the net periodic benefit costs for the defined benefit pension plans and SERP by expense components for the three month periods ended March 31, 2025 and 2024.

Components of Net Periodic Benefit Cost
Three Months Ended
March 31,
  2025 2024
Service cost—benefits earned during the period $ 6,242  $ 6,221 
Interest cost on projected benefit obligation 9,025  8,267 
Expected return on assets (11,563) (10,646)
Amortization:
Prior service cost 292  269 
Actuarial (gain) loss —  6 
Net periodic benefit cost
$ 3,996  $ 4,117 


Note 10—Earnings Per Share

Earnings per Share: A reconciliation of basic and diluted weighted-average shares outstanding used in the computation of basic and diluted earnings per share is as follows:
Three Months Ended
March 31,
2025 2024
Basic weighted average shares outstanding 83,479,997  93,865,606 
Weighted average dilutive options outstanding 1,000,116  1,248,909 
Diluted weighted average shares outstanding 84,480,113  95,114,515 
Antidilutive shares 635,610  186,359 

Antidilutive shares are excluded from the calculation of diluted earnings per share. All antidilutive shares noted above result from outstanding out-of-the-money employee and Director stock options.
42
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Note 11—Debt

The following table presents information about the terms and outstanding balances of Globe Life's debt.
 
Selected Information about Debt Issues
As of
March 31,
2025		 December 31,
2024
Instrument Issue Date Maturity Date Coupon Rate Par
Value		 Unamortized Discount & Issuance Costs Book
Value		 Fair
Value		 Book
Value
Senior notes
 09/27/2018 09/15/2028 4.550% $ 550,000  $ (2,814) $ 547,186  $ 548,751  $ 546,999 
Senior notes
 08/21/2020 08/15/2030 2.150% 400,000  (2,750) 397,250  346,216  397,132 
Senior notes
 05/19/2022 06/15/2032 4.800% 250,000  (3,623) 246,377  242,348  246,272 
Senior notes
 08/23/2024 09/15/2034 5.850% 450,000  (5,085) 444,915  459,194  444,814 
Junior subordinated debentures 11/17/2017 11/17/2057 5.275% 125,000  (1,552) 123,448  97,340  123,443 
Junior subordinated debentures 06/14/2021 06/15/2061 4.250% 325,000  (7,592) 317,408  208,130  317,387 
Term loan(2)
 05/11/2023 08/15/2027 5.798% 250,000  (1,639) 248,361  248,361  248,204 
Total long-term debt
2,350,000  (25,055) 2,324,945  2,150,340  2,324,251 
FHLB borrowings 70,000  —  70,000  70,000  — 
Commercial paper 409,500  (2,609) 406,891  406,891  415,401 
Total short-term debt
479,500  (2,609) 476,891  476,891  415,401 
Total debt
$ 2,829,500  $ (27,664) $ 2,801,836  $ 2,627,231  $ 2,739,652 
(1)An additional $150 million par value and book value is held by insurance subsidiaries that eliminates in consolidation.
(2)Interest calculated quarterly using Secured Overnight Financing Rate (SOFR) plus 135 basis points.

The commercial paper has the highest priority of all unsecured debt, followed by senior notes then junior subordinated debentures. The senior notes are callable under a make-whole provision, and the junior subordinated debentures are subject to an optional redemption five years from issuance. Interest on the 4.25% junior subordinated debentures and the term loan are payable quarterly while all other long-term debt is payable semi-annually.

Credit facility: Globe Life has in place a credit facility which provides for a $1 billion revolving credit facility that may be increased to $1.25 billion. The credit facility matures March 29, 2029 and may be extended up to two one-year periods upon the Company's request. Pursuant to this agreement, the participating lenders have agreed to make revolving loans to Globe Life and to issue secured or unsecured letters of credit. The Company has not drawn on any of the credit to date.

The facility is further designated as a back-up credit line for a commercial paper program under which the Company may either borrow from the credit line or issue commercial paper at any time, with total commercial paper outstanding not to exceed the facility maximum of $1 billion, less any letters of credit issued. Interest is charged at variable rates. In accordance with the agreement, Globe Life is subject to certain covenants regarding capitalization.

As of March 31, 2025, the Company was in full compliance with these covenants.

43
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following tables present certain information about our commercial paper borrowings.

Credit Facility—Commercial Paper

As of
March 31,
2025		 December 31, 2024 March 31,
2024
Balance of commercial paper at end of period (par value) $ 409,500  $ 419,000  $ 324,000 
Annualized interest rate 5.13  % 5.22  % 5.63  %
Letters of credit outstanding $ 115,000  $ 115,000  $ 115,000 
Remaining amount available under credit line 475,500  466,000  561,000 



Credit Facility—Commercial Paper Activity

  Three Months Ended March 31,
  2025 2024
Average balance of commercial paper outstanding during period (par value) $ 478,950  $ 346,088 
Daily-weighted average interest rate (annualized) 5.08  % 5.68  %
Maximum daily amount outstanding during period (par value) $ 605,500  $ 384,000 
Commercial paper issued during period (par value)
 586,000  404,000 
Commercial paper matured during period (par value) (595,500) (399,000)
Net commercial paper issued (matured) during period (par value)
 (9,500) 5,000 

Federal Home Loan Bank: FHLB membership provides certain of our insurance subsidiaries with access to various low-cost collateralized borrowings and funding agreements. The membership requires ownership of FHLB common stock, as well as the purchase of activity-based common stock equal to approximately 4.1% of outstanding borrowings.

Globe Life owned $31.6 million in FHLB common stock as of March 31, 2025 and $34.5 million as of December 31, 2024. The FHLB stock is restricted for the duration of the membership and recorded at cost (par) as required by applicable guidance. The FHLB stock is included in "Other long-term investments" in the Condensed Consolidated Balance Sheets. Borrowings with the FHLB are subject to the availability of pledged assets at the insurance subsidiaries of Globe Life. As of March 31, 2025, Globe Life's insurance subsidiaries' maximum borrowing capacity under the FHLB facility was approximately $684 million, net of outstanding funding agreements and short-term borrowings, on pledged assets with a fair value of $1.4 billion. As of March 31, 2025, $367 million in funding agreements were outstanding with the FHLB, compared to $372 million as of December 31, 2024. This amount is included in "Other policyholders' funds" in the Condensed Consolidated Balance Sheets. The Company had $70 million and $242 million in short-term borrowings from the FHLB as of March 31, 2025 and 2024, respectively.


44
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Note 12—Business Segments

Globe Life is organized into three operating segments: life, health, and investments.

Globe Life's reportable insurance segments are based on the insurance product lines it markets and administers: life insurance and supplemental health insurance. There is also an investment segment that manages the investment portfolio and cash flow for the insurance segments. The Company's chief operating decision makers ("CODM"), our Co-CEOs, evaluate the overall performance of the operations of the Company in accordance with these segments.

During the fourth quarter of 2024 we entered into a coinsurance agreement to cede a majority of the annuity business to a third-party insurer. This impacted a significant portion of our annuities which had previously been classified as one of our reportable segments. The annuity segment has historically represented less than 1% of revenue and has not been core to the Company's business. We adjusted our segments from four down to three at December 31, 2024. All quarterly presentations of segment information related to prior year have been recast for the periods presented to reflect this change in segments.

Life insurance products marketed by Globe Life include traditional whole life and term life insurance. Health insurance products are generally guaranteed renewable and include Medicare Supplement, cancer, critical illness, accident, and other limited-benefit supplemental hospital and surgical products.

The Company adopted ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, in 2024 which added disclosure requirements to segment expenses, improving the financial reporting of the entity’s overall performance and assessment of future cash flows. The disclosures required more detailed information related to the entity’s reportable segments and the new disclosures are also required prospectively on a quarterly basis. The prior year presentation has been recast to reflect the new disclosures in accordance with this adopted accounting standard.

The following tables present segment premium revenue by each of Globe Life's distribution channels.


Premium Income by Distribution Channel
Three Months Ended March 31, 2025
  Life Health Total
Distribution Channel Amount % of
Total		 Amount % of
Total		 Amount % of
Total
American Income $ 437,866  53  $ 30,691  8  $ 468,557  39 
Direct to Consumer 245,600  30  18,976  5  264,576  22 
Liberty National 96,182  11  47,922  13  144,104  12 
United American 1,592  —  159,848  43  161,440  13 
Family Heritage 1,726  —  112,354  31  114,080  10 
Other 46,897  6  —  —  46,897  4 
$ 829,863  100  $ 369,791  100  $ 1,199,654  100 
45
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)

  Three Months Ended March 31, 2024
  Life Health Total
Distribution Channel Amount
% of
Total
 Amount
% of
Total
 Amount
% of
Total
American Income $ 414,044  52  $ 30,497  9  $ 444,541  39 
Direct to Consumer 248,040  31  17,866  5  265,906  23 
Liberty National 90,777  11  47,630  14  138,407  12 
United American 1,843  —  141,635  42  143,478  13 
Family Heritage 1,616  —  103,391  30  105,007  9 
Other 47,945  6  —  —  47,945  4 
$ 804,265  100  $ 341,019  100  $ 1,145,284  100 


46
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following tables set forth a reconciliation of Globe Life's revenues and operations by segment to its major income statement line items. See Note 1—Significant Accounting Policies for additional information concerning reconciling items of segment profits to pretax income.

Three Months Ended March 31, 2025
Life Health Investment Consolidated
Revenue:
Premium $ 829,863  $ 369,791  $ —  $ 1,199,654 
Net investment income —  —  280,614  280,614 
Segment revenue 829,863  369,791  280,614  1,480,268 
Realized gains (losses) 85 
Other income 69 
Total consolidated revenue
$ 1,480,422 
Expenses:
Policy obligations(1)
 509,756  233,929  5,394  $ 749,079 
Required interest on reserves (208,536) (28,286) 239,350  2,528 
Amortization of acquisition costs 90,633  14,519  —  105,152 
Commissions 45,567  42,887  —  88,454 
Premium taxes 18,011  7,493  —  25,504 
Non-deferred acquisition costs 37,168  14,528  —  51,696 
Segment profit or (loss)
$ 337,264  $ 84,721  $ 35,870  457,855 
Insurance administrative expenses:
Salaries 33,688 
Other employee costs 10,301 
Information technology costs 20,936 
Legal costs 6,249 
Other administrative costs 16,375 
Parent expense 3,050 
Stock-based compensation expense 12,019 
Interest expense 34,992 
Legal proceedings 6,128 
Non-operating expenses — 
Annuity (1,810)
 Total expenses 1,164,341 
Income before income taxes per Condensed Consolidated Statement of Operations
$ 316,081 
(1)Policy obligations are based upon policyholder behavior and impacts related to lapses, mortality, and morbidity. For detailed information, including remeasurement gains and losses, see Note 6—Policy Liabilities.
47
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)

Three Months Ended March 31, 2024
Life Health Investment Consolidated
Revenue:
Premium $ 804,265  $ 341,019  $ —  $ 1,145,284 
Net investment income —  —  282,578  282,578 
Segment revenue 804,265  341,019  282,578  1,427,862 
Realized gains (losses) (11,799)
Other income 76 
Total consolidated revenue $ 1,416,139 
Expenses:
Policy obligations(1)
519,871  202,327  3,468  $ 725,666 
Required interest on reserves (199,707) (27,173) 235,325  8,445 
Amortization of acquisition costs 85,768  13,311  —  99,079 
  Commissions 38,690  39,149  —  77,839 
  Premium taxes 17,086  6,816  —  23,902 
  Non-deferred acquisition costs 33,546  12,819  —  46,365 
Segment profit or (loss)
$ 309,011  $ 93,770  $ 43,785  446,566 
Insurance administrative expenses:
Salaries 31,174 
Other employee costs 10,013 
Information technology costs 18,307 
Legal costs 5,273 
Other administrative costs 15,644 
Parent expense 2,826 
Stock-based compensation expense 9,267 
Interest expense 28,621 
Legal proceedings — 
Non-operating expenses 710 
Annuity
 (1,915)
 Total expenses 1,101,216 
Income before income taxes per Condensed Consolidated Statement of Operations
$ 314,923 
(1)Policy obligations are based upon policyholder behavior and impacts related to lapses, mortality, and morbidity. For detailed information, including remeasurement gains and losses, see Note 6—Policy Liabilities.
48
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Assets for each segment are reported based on a specific identification basis. The insurance segments’ assets contain DAC. The investment segment includes the investment portfolio, cash, and accrued investment income. Goodwill is assigned to the insurance segments at the time of purchase. All other assets are included in the annuity and other corporate category. The tables below reconcile segment assets to total assets as reported on the Condensed Consolidated Balance Sheets.
 
Assets by Segment

  March 31, 2025
  Life Health Investment Consolidated
Cash and invested assets $ —  $ —  $ 20,242,276  $ 20,242,276 
Accrued investment income —  —  287,562  287,562 
Deferred acquisition costs 5,814,820  807,773  —  6,622,593 
Goodwill 309,609  180,837  —  490,446 
Total segment assets
$ 6,124,429  $ 988,610  $ 20,529,838  27,642,877 
Annuity and other corporate
 2,062,382 
Total assets
$ 29,705,259 

  December 31, 2024
  Life Health Investment Consolidated
Cash and invested assets $ —  $ —  $ 19,736,888  $ 19,736,888 
Accrued investment income —  —  269,791  269,791 
Deferred acquisition costs 5,700,755  793,421  —  6,494,176 
Goodwill 309,609  180,837  —  490,446 
Total segment assets
$ 6,010,364  $ 974,258  $ 20,006,679  26,991,301 
Annuity and other corporate
 2,084,880 
Total assets
$ 29,076,181 

49
        GL Q1 2025 FORM 10-Q
Table of Contents
CAUTIONARY STATEMENTS
 
We caution readers regarding certain forward-looking statements contained in the foregoing discussion and elsewhere in this document, and in any other statements made by, or on behalf of Globe Life whether or not in future filings with the Securities and Exchange Commission. Any statement that is not a historical fact, or that might otherwise be considered an opinion or projection concerning the Company or its business, whether express or implied, is meant as and should be considered a forward-looking statement. Such statements represent management's opinions concerning future operations, strategies, financial results or other developments. We specifically disclaim any obligation to update or revise any forward-looking statement because of new information, future developments, or otherwise.
 
Forward-looking statements are based upon estimates and assumptions that are subject to significant business, economic and competitive uncertainties, many of which are beyond our control. If these estimates or assumptions prove to be incorrect, the actual results of Globe Life may differ materially from the forward-looking statements made on the basis of such estimates or assumptions. Whether or not actual results differ materially from forward-looking statements may depend on numerous foreseeable and unforeseeable events or developments, which may be national in scope, related to the insurance industry generally, or applicable to the Company specifically. Such events or developments could include, but are not necessarily limited to:
1.Economic and other conditions, including the impact of inflation, immigration, geopolitical events, escalating tariff and non-tariff trade measures imposed by the U.S. and other countries, and other governmental actions which affect the U.S. economy and/or U.S. consumer confidence, leading to unexpected changes in lapse rates and/or sales of our policies, as well as levels of mortality, morbidity, and/or utilization of health care services that differ from Globe Life's assumptions;
2.Regulatory developments, including changes in accounting standards or governmental regulations (particularly those impacting taxes and changes to the Federal Medicare program that affect Medicare Supplement insurance sales, claims utilization or use);
3.Market trends in the senior-aged health care industry that provide alternatives to traditional Medicare (such as Health Maintenance Organizations and other managed care or private plans) and that affect the sales of traditional Medicare Supplement insurance;
4.Interest rate changes that affect product sales, financing costs, and/or investment yields;
5.General economic, industry sector or individual debt issuers’ financial conditions (including developments and volatility arising from geopolitical events, particularly in certain industries that may comprise part of our investment portfolio) that affect the current market value of securities we own, or that may impair an issuer’s ability to make principal and/or interest payments due on those securities;
6.Changes in the competitiveness of the Company's products and pricing;
7.Litigation or regulatory actions against the Company;
8.Levels of administrative and operational efficiencies that differ from our assumptions (including any reduction in efficiencies resulting from increased costs arising from the impact of higher than anticipated inflation);
9.The ability to obtain timely and appropriate premium rate increases for health insurance policies from our regulators;
10.The customer response to new products and marketing initiatives;
11.Reported amounts in the consolidated financial statements which are based on management estimates and judgments which may differ from the actual amounts ultimately realized;
12.Compromise by a malicious actor or other event that causes a loss of secure data from, or inaccessibility to, our computer and other information technology systems;
13.The impact of reputational damage on the Company including the impact on the Company's ability to attract and retain agents;
14.The severity, magnitude, and impact of natural or man-made catastrophic events, including but not limited to pandemics, tornadoes, hurricanes, earthquakes, war and terrorism, on our operations and personnel, commercial activity, level of claims, and demand for our products; and
15.Globe Life's ability to access the commercial paper and debt markets, particularly if such markets become unpredictable or unstable for a certain period.
Readers are also directed to consider other risks and uncertainties described in other documents on file with the Securities and Exchange Commission, including those described in the "Risk Factors" section of our most recent Annual Report on Form 10-K.
50
        GL Q1 2025 FORM 10-Q
Table of Contents
GLOBE LIFE INC.
Management's Discussion & Analysis
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
 
The following discussion should be read in conjunction with Globe Life's Condensed Consolidated Financial Statements and Notes thereto appearing elsewhere in this report. The following management discussion will only include comparison to prior year.

"Globe Life" and the "Company" refer to Globe Life Inc. and its subsidiaries and affiliates.

Results of Operations

icons2.jpg
How Globe Life Views Its Operations. Globe Life Inc. is the holding company for a group of insurance companies that market primarily individual life and supplemental health insurance to lower middle to middle-income households throughout the United States. We view our operations by segments, which are the insurance product lines of life and supplemental health, and the investment segment that supports the product lines.
icons.jpg
Insurance Product Line Segments. The insurance product line segments involve the marketing, underwriting, and administration of policies. Each product line is further subdivided by the various distribution channels that market the insurance policies. Each distribution channel operates in a niche market offering insurance products designed for that particular market. Whether analyzing profitability of a segment as a whole, or the individual distribution channels within the segment, the measure of profitability used by management is the underwriting margin, as seen below:
 Premium revenue
                                                           (Policy obligations)
                                                           (Policy acquisition costs and commissions)
                                                            Underwriting margin
icons3.jpg
Investment Segment. The investment segment involves the management of our capital resources, including investments and the management of liquidity. Our measure of profitability for the investment segment is excess investment income, as seen below:
 Net investment income
(Required interest on policy liabilities)
                                                           Excess investment income

51
        GL Q1 2025 FORM 10-Q
Table of Contents
GLOBE LIFE INC.
Management's Discussion & Analysis
Current Highlights.
•Net income as a return on equity (ROE) for the three months ended March 31, 2025 was 19.0% and net operating income as an ROE, excluding accumulated other comprehensive income(1) was 14.1%.
•Total premium increased 5% over the same period in the prior year. Life premium increased 3% for the period from $804 million in 2024 to $830 million in 2025.
•Net investment income declined 1% compared with the same period in the prior year.
•Total net sales increased 6% over the same period in the prior year from $204 million in 2024 to $216 million in 2025. The average producing agent count across all of the exclusive agencies increased 5% over the prior year.
•Book value per share increased 22% over the same period in the prior year from $53.03 to $64.50. Book value per share, excluding accumulated other comprehensive income(1), increased 11% over the prior year from $79.00 in 2024 to $87.92 in 2025.
•For the three months ended March 31, 2025, the Company repurchased 1.5 million shares of Globe Life Inc. common stock at a total cost of $177 million for an average share price of $121.70.

The following graphs represent net income and net operating income for the three months ended March 31, 2025.
965 967
(1)As shown in the charts above, net operating income is primarily comprised of insurance underwriting margin plus excess investment income and annuity and other income, offset by operating expenses after tax and, as such, is considered a non-GAAP measure. It has been used consistently by Globe Life's management for many years to evaluate the operating performance of the Company. It differs from net income primarily because it excludes certain non-operating items such as realized gains and losses and certain significant and unusual items included in net income. Net income is the most directly comparable GAAP measure.
Net operating income as an ROE, excluding accumulated other comprehensive income (AOCI), is considered a non-GAAP measure. Management utilizes this measure to view the business without the effect of changes in AOCI, which are primarily attributable to fluctuation in interest rates. The impact of the adjustment to exclude AOCI is $(1.97) billion and $(2.47) billion for the three months ended March 31, 2025 and 2024, respectively.
Book value per share, excluding AOCI, is also considered a non-GAAP measure. Management utilizes this measure to view the book value of the business without the effect of changes in AOCI, which are primarily attributable to fluctuation in interest rates. The impact of the adjustment to exclude AOCI is $(23.42) and $(25.97) for the three months ended March 31, 2025 and 2024, respectively.
Refer to Analysis of Profitability by Segment for non-GAAP reconciliation to GAAP.
52
        GL Q1 2025 FORM 10-Q
Table of Contents
GLOBE LIFE INC.
Management's Discussion & Analysis
Summary of Operations. Net income increased slightly to $255 million during the three months ended March 31, 2025, compared with $254 million in the same period in 2024. On a diluted per common share basis, net income per common share for the three months ended March 31, 2025 increased 13% from $2.67 to $3.01.

Net operating income declined 2% to $259 million for the three months ended March 31, 2025, compared with $264 million for the same period in 2024, due to an 18% decrease in excess investment income offset by a 9% increase in life underwriting margin. On a diluted per common share basis, net operating income per common share for the three months ended March 31, 2025 increased from $2.78 to $3.07, an 10% increase. Net operating income is primarily comprised of insurance underwriting margin plus excess investment income and annuity and other income, offset by operating expenses, after tax and, as such, is considered a non-GAAP measure. Net income is the most directly comparable GAAP measure. We do not consider realized gains and losses to be a component of our core insurance operations or operating segments. Additionally, net income was affected by certain non-operating items. We do not view these items as components of core operating results because they are not indicative of past performance or future prospects of the insurance operations. We remove items such as these that relate to prior periods or are non-operating items when evaluating the results of current operations, and therefore exclude such items from our segment analysis for current periods.

As previously noted, a component of insurance underwriting margin is policy obligations, which includes for each reporting period the change in the liability for future policy benefits (LFPB). The LFPB is determined each reporting period based on the net level premium method. Net level premiums reflect a recomputed net premium ratio using actual experience since the issue date, and expected future experience based on future cash-flow assumptions. See Note 6—Policy Liabilities for additional information. The Company's results for actual variances from expected experience for both life and health produced a $9.0 million net remeasurement gain and a $8.1 million net remeasurement gain for the three months ended March 31, 2025 and 2024, respectively.

Overall, the Company continues to see positive signs in its core operations, including sales and premium growth, and continues to achieve an operating ROE (excluding accumulated other comprehensive income) generally in the mid-teens.
53
        GL Q1 2025 FORM 10-Q
Table of Contents
GLOBE LIFE INC.
Management's Discussion & Analysis
Globe Life's operations on a segment-by-segment basis are discussed in depth below. Net operating income has been used consistently by management for many years to evaluate the operating performance of the Company and is a measure commonly used in the life insurance industry. It differs from GAAP net income primarily because it excludes certain non-operating items such as realized gains and losses and other significant and unusual items included in net income. Management believes an analysis of net operating income is important in understanding the profitability and operating trends of the Company’s business. Net income is the most directly comparable GAAP measure.

Analysis of Profitability by Segment
(Dollar amounts in thousands)
Three Months Ended March 31,
2025 2024 Change %
Life insurance underwriting margin $ 337,264  $ 309,011  $ 28,253  9 
Health insurance underwriting margin 84,721  93,770  (9,049) (10)
Excess investment income 35,870  43,785  (7,915) (18)
Segment profit or (loss) 457,855  446,566  11,289  3 
Annuity and other income 1,879  1,991  (112) (6)
Administrative expense (87,549) (80,411) (7,138) 9 
Other corporate expense (50,061) (40,714) (9,347) 23 
Pre-tax total 322,124  327,432  (5,308) (2)
Applicable taxes (62,787) (63,333) 546  (1)
Net operating income
259,337  264,099  (4,762) (2)
Reconciling items, net of tax:
Realized gains (losses) 67  (9,321) 9,388 
Non-operating expenses —  (561) 561 
Legal proceedings (4,841) —  (4,841)
Net income
$ 254,563  $ 254,217  $ 346  — 

The life insurance segment is our primary segment and is the largest contributor to earnings in each period presented. The life insurance segment underwriting margin increased $28 million compared with the prior period, primarily a result of increased premiums and favorable policy obligations as a percent of premium. Excess investment income declined $8 million compared with the prior period, partly due to lower earned yields on commercial mortgage loans and limited partnerships. The health segment experienced higher policy obligations and declined $9 million in the first three months of 2025 with $85 million of underwriting margin compared with $94 million in the first three months of 2024.
54
        GL Q1 2025 FORM 10-Q
Table of Contents
GLOBE LIFE INC.
Management's Discussion & Analysis
In 2025, the largest contributor of total underwriting margin was the life insurance segment and the primary distribution channel was the American Income Life Division (American Income). The following charts represent the breakdown of total underwriting margin by operating segment and distribution channel for the three months ended March 31, 2025.
325326

Total premium income rose 5% for the three months ended March 31, 2025 to $1.2 billion. Total net sales increased 6% to $216 million, when compared with 2024. Total first-year collected premium (defined in the following section) increased 5% to $169 million for 2025, compared to $161 million in 2024.

Life insurance premium income increased 3% to $830 million over the prior-year total of $804 million. Life net sales fell 1% to $148 million for the first three months of 2025. First-year collected life premium increased 3% to $114 million. Life underwriting margin, as a percent of premium, increased to 41% for 2025 from 38% in 2024. Underwriting margin increased to $337 million in 2025, compared to $309 million in 2024.

Health insurance premium income increased 8% to $370 million over the prior-year total of $341 million. Health net sales rose 24% to $67 million for the first three months of 2025. First-year collected health premium rose 8% to $55 million. Health underwriting margin, as a percent of premium, was 23% for 2025 and 27% for 2024. Health underwriting margin declined to $85 million for the first three months of 2025, compared to $94 million in 2024.

Excess investment income, the measure of profitability of our investment segment, declined 18% during the first three months of 2025 to $35.9 million from $43.8 million in 2024. Excess investment income per common share, reflecting the impact of our share repurchase program, declined 9% to $0.42 from $0.46 when compared with the same period in 2024.

Insurance administrative expenses increased 9% in 2025 when compared with the prior-year period. These expenses were 7.3% as a percent of premium during 2025 compared to 7.0% in 2024.

For the three months ended March 31, 2025, the Company repurchased 1.5 million shares of Globe Life Inc. common stock at a total cost of $177 million for an average share price of $121.70.

55
        GL Q1 2025 FORM 10-Q
Table of Contents
GLOBE LIFE INC.
Management's Discussion & Analysis
The discussions of our segments are presented in the manner we view our operations, as described in Note 12—Business Segments.

We use three measures as indicators of premium growth and sales over the near term: “annualized premium in force,” “net sales,” and “first-year collected premium.”
•Annualized premium in force is defined as the premium income that would be received over the following twelve months at any given date on all active policies if those policies remain in force throughout the 12-month period.
•Net sales is calculated as annualized premium issued, net of cancellations generally in the first 30 days after issue, except in the case of Direct to Consumer, where net sales is annualized premium issued at the time the first full premium is paid after any introductory offer period (typically one month) has expired. Management considers net sales to be a better indicator of the rate of premium growth than annualized premium issued since annualized premium issued excludes cancellations, and cancellations do not contribute to premium income.
•First-year collected premium is defined as the premium collected during the reporting period for all policies in their first policy year. First-year collected premium takes lapses into account in the first year when lapses are more likely to occur, and thus is a useful indicator of how much new premium is expected to be added to premium income in the future. First-year collected premiums are lower than net sales over the prior 12 months because premiums are not collected on lapsed policies after the date of lapse.

Cancellations are not included in lapses.

See further discussion of the distribution channels below for Life and Health.

56
        GL Q1 2025 FORM 10-Q
Table of Contents
GLOBE LIFE INC.
Management's Discussion & Analysis
LIFE INSURANCE

Life insurance is the Company's predominant segment. During 2025, life premium represented 69% of total premium and life underwriting margin represented 80% of the total underwriting margin. Additionally, investments supporting the reserves for life products produce the majority of excess investment income attributable to the investment segment.
 
The following table presents the summary of results of life insurance. Further discussion of the results by distribution channel is included below.

Life Insurance
Summary of Results
(Dollar amounts in thousands)
Three Months Ended March 31, Change
2025 2024
Amount % of Premium Amount % of Premium Amount %
Premium and policy charges $ 829,863  100  $ 804,265  100  $ 25,598  3 
Policy obligations 509,756  61  519,871  65  (10,115) (2)
Required interest on reserves (208,536) (25) (199,707) (25) (8,829) 4 
Net policy obligations 301,220  36  320,164  40  (18,944) (6)
Amortization of acquisition costs 90,633  11  85,768  11  4,865  6 
Commission expense 45,567  6  38,690  5  6,877  18 
Premium taxes 18,011  2  17,086  2  925  5 
Non-deferred acquisition costs 37,168  4  33,546  4  3,622  11 
Total expense 492,599  59  495,254  62  (2,655) (1)
Insurance underwriting margin
$ 337,264  41  $ 309,011  38  $ 28,253  9 

Net policy obligations amounted to 36% of premium for the three months ended March 31, 2025 compared to 40% in the year-ago period.

The table below summarizes life underwriting margin by distribution channel.
 
Life Insurance
Underwriting Margin by Distribution Channel
(Dollar amounts in thousands)
Three Months Ended March 31,
2025 2024
Change
Amount % of Premium Amount % of Premium Amount
%
American Income $ 196,169  45  $ 187,068  45  $ 9,101  5 
Direct to Consumer 64,200  26  58,585  24  5,615  10 
Liberty National 31,772  33  30,713  34  1,059  3 
Other(1)
 45,123  90  32,645  64  12,478  38 
Total
$ 337,264  41  $ 309,011  38  $ 28,253  9 
(1) Includes gain of $14 million related to the recapture of policies as disclosed in Note 1 - Significant Accounting Policies.
57
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

The following table presents Globe Life's life insurance premium by distribution channel.

Life Insurance
Premium by Distribution Channel
(Dollar amounts in thousands)
Three Months Ended March 31, Change
2025 2024
Amount % of Total Amount % of Total Amount %
American Income $ 437,866  53  $ 414,044  52  $ 23,822  6 
Direct to Consumer 245,600  30  248,040  31  (2,440) (1)
Liberty National 96,182  11  90,777  11  5,405  6 
Other 50,215  6  51,404  6  (1,189) (2)
Total
$ 829,863  100  $ 804,265  100  $ 25,598  3 

Annualized life premium in force was $3.34 billion at March 31, 2025, an increase of 4% over $3.23 billion a year earlier.

An analysis of life net sales, an indicator of new business production, by distribution channel is presented below. 

Life Insurance
Net Sales by Distribution Channel
(Dollar amounts in thousands)
Three Months Ended March 31, Change
2025 2024
Amount % of Total Amount % of Total Amount %
American Income $ 98,555  66  $ 97,195  65  $ 1,360  1 
Direct to Consumer 25,175  17  28,563  19  (3,388) (12)
Liberty National 22,469  15  21,605  15  864  4 
Other 2,152  2  2,134  1  18  1 
Total
$ 148,351  100  $ 149,497  100  $ (1,146) (1)


First-year collected life premium by distribution channel is presented in the table below. 

Life Insurance
First-Year Collected Premium by Distribution Channel
(Dollar amounts in thousands)
Three Months Ended March 31, Change
2025 2024
Amount % of Total Amount % of Total Amount %
American Income $ 77,637  68  $ 72,954  66  $ 4,683  6 
Direct to Consumer 15,219  13  17,927  16  (2,708) (15)
Liberty National 19,381  17  17,807  16  1,574  9 
Other 1,868  2  1,992  2  (124) (6)
Total
$ 114,105  100  $ 110,680  100  $ 3,425  3 
58
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

A discussion of life operations by distribution channel follows.

The American Income Life Division markets to members of labor unions and other affinity groups and continues to diversify its lead sources, utilizing internally generated leads, third-party internet vendor leads and referrals to facilitate sustainable growth. This Division is Globe Life's largest contributor of life premium of any distribution channel at 53% of the Company's March 31, 2025 total life premium. For the three months ended March 31, 2025, the average monthly life premium issued per policy was $59 as compared to $58 for the same period in the prior year. Net sales were $99 million for the three months ended March 31, 2025, up from $97 million in the year-ago period. The underwriting margin, as a percent of premium, was 45% for the three months ended March 31, 2025 and 2024.

The average producing agent count increased 3% over the year-ago period. The increase in average producing agent count was driven by an increase in new agent recruiting along with continued improvement in new agent retention. Sales growth in this Division, as well as within our other exclusive agencies, is generally dependent on growth in the size of the agency force.

Below is the average producing agent count as of the indicated periods for the American Income Division. The average producing agent count is based on the actual count at the beginning and end of each week during the year.
At March 31,
 Change
2025 2024 Amount %
American Income
 11,510  11,139  371  3 

American Income Life continues to focus on growing and strengthening the agency force, specifically through emphasis on agency middle-management growth and additional agency openings. In addition to offering financial incentives and training opportunities, the Division has made considerable investments in information technology, including a customer relationship management (CRM) tool for the agency force. This tool is designed to provide dashboards and drive productivity in lead distribution, conservation of business, and new agent recruiting. Additionally, this Division has invested in and successfully implemented technology that allows the agency force to engage in virtual recruiting, training, and sales activity. The agents have shifted to primarily a virtual experience with the customers and have generated a vast majority of sales through virtual presentations. We find this flexibility to be enticing for new recruits as well as a driver of retention in our agency force.

The Direct to Consumer Division (DTC) markets adult and juvenile life insurance through a variety of channels, including direct mail, insert media, and digital marketing. The different media channels support and complement one another in the Division's efforts to provide consumer outreach. All three channels work as part of an omnichannel approach. Sales from the internet and inbound phone calls continue to outpace the activity from direct mail. DTC's long-term growth has been fueled by consistent innovation and brand awareness. Additionally, the DTC Division provides valuable support to our agency business through brand impressions and inquiries that lead to sales in our exclusive agency channels. New initiatives are continuously introduced to help increase response rates, issue rates, and create a seamless customer experience. The juvenile insurance market is an important source of sales as well as a vehicle to reach the parents and grandparents of existing juvenile policyholders, who are more likely to respond favorably to a DTC solicitation for life coverage on themselves in comparison to the general adult population. Additionally, future offerings to juvenile policyholders and their parents and grandparents are sources of lower acquisition-cost life insurance sales in the future.

DTC net sales declined 12% to $25 million for the three months ended March 31, 2025 compared to $29 million for the same period in the prior year. This decline is due primarily to the management of direct mail and print insert marketing activity resulting from the impact of inflation on postage, paper and online advertising costs. While total sales have declined, the focus has been on improving profitability and improving underwriting margin. DTC’s underwriting margin was $64.2 million and 26% as a percent of premium for the three months ended March 31, 2025 compared to $58.6 million and 24% as a percent of premium for the same period in 2024.

59
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

The Liberty National Division markets individual life insurance to middle-income household and worksite customers. Recent investments in new sales technologies as well as recent growth in middle management within the Division are expected to support increased sales. The underwriting margin as a percent of premium was 33% for the three months ended March 31, 2025, down from 34% during the same period a year ago. The decrease is primarily attributable to increased non deferred acquisition and amortization expenses in the first three months of 2025 as compared to the same period in 2024. For the three months ended March 31, 2025, the average monthly life premium per policy issued was $44, the same as the prior-year period.

Net sales rose 4% in the three months ended March 31, 2025 over the same period in 2024 due primarily to increased agent count.

Below is the average producing agent count for the three months ended March 31, 2025 and 2024 for the Liberty National Division. The average producing agent count is based on the actual count at the beginning and end of each week during the year.
At March 31,
 Change
2025 2024 Amount %
Liberty National
 3,688  3,419  269  8 

The Liberty National Division's average producing agent count increased when compared with the prior-year comparable period. This Division continues to execute a long-term plan to grow through expansion from small-town markets in the Southeast to more densely populated areas with larger pools of potential agent recruits and customers in the communities, regions, and cities the Liberty National Division serves. Expansion of this Division’s presence in larger geographic cities, with less penetrated areas will help create long-term sustainable agency growth. Additionally, the Division continues to help improve the ability of agents to develop new worksite marketing business. A CRM platform and enhanced analytical capabilities have helped the agents develop additional worksite marketing opportunities and improve the productivity of agents selling in the individual life market. As the Division gains momentum in its sales and recruiting initiatives, advances in technology and use of the CRM platform, it anticipates continued growth in recruiting activity, average producing agent count, and net sales.

The Other agency distribution channels primarily include non-exclusive independent agencies selling primarily life insurance. The other distribution channels contributed $50 million of life premium income, or 6% of Globe Life's total life premium income in the three months ended March 31, 2025, and contributed 2% of net sales for the period.

HEALTH INSURANCE

Health insurance sold by the Company primarily includes Medicare Supplement insurance as well as retiree health insurance, accident coverage, and other limited-benefit supplemental health products such as cancer, critical illness, heart disease, intensive care, and other health products.

Health premium accounted for 31% of our total premium in 2025, while the health underwriting margin accounted for 20% of total underwriting margin. Health underwriting margin declined to $85 million compared to $94 million in the prior year. While the Company continues to emphasize life insurance sales relative to health, due to life’s superior long-term profitability and its greater contribution to excess investment income, the health business provides a significant contribution to return on equity as it does not require a substantial amount of up-front capital.

60
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

The following table presents underwriting margin data for health insurance.

Health Insurance
Summary of Results
(Dollar amounts in thousands)
  Three Months Ended March 31, Change
  2025 2024
  Amount % of
Premium		 Amount % of
Premium		 Amount %
Premium $ 369,791  100  $ 341,019  100  $ 28,772  8 
Policy obligations 233,929  63  202,327  60  31,602  16 
Required interest on reserves (28,286) (8) (27,173) (8) (1,113) 4 
Net policy obligations 205,643  55  175,154  52  30,489  17 
Amortization of acquisition costs 14,519  4  13,311  4  1,208  9 
Commission expense 42,887  12  39,149  11  3,738  10 
Premium taxes 7,493  2  6,816  2  677  10 
Non-deferred acquisition costs 14,528  4  12,819  4  1,709  13 
Total expense 285,070  77  247,249  73  37,821  15 
Insurance underwriting margin
$ 84,721  23  $ 93,770  27  $ (9,049) (10)

Net policy obligations amounted to 55% of premium for the three months ended March 31, 2025 compared to 52% in the year ago period.

The table below summarizes health underwriting margin by distribution channel.
 
Health Insurance
Underwriting Margin by Distribution Channel
(Dollar amounts in thousands)
Three Months Ended March 31,
2025 2024
Change
Amount % of Premium Amount % of Premium Amount
%
United American $ 1,617  1  $ 11,906  8  $ (10,289) (86)
Family Heritage 39,249  35  35,838  35  3,411  10 
Liberty National 25,982  54  26,672  56  (690) (3)
American Income 19,389  63  19,192  63  197  1 
Direct to Consumer (1,516) (8) 162  1  (1,678) (1,036)
Total
$ 84,721  23  $ 93,770  27  $ (9,049) (10)

61
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

Globe Life markets supplemental health insurance products through a number of distribution channels. The following table is an analysis of our health premium by distribution channel.

Health Insurance
Premium by Distribution Channel
(Dollar amounts in thousands)
  Three Months Ended March 31, Increase
(Decrease)
  2025 2024
Amount % of Total Amount % of Total Amount %
United American $ 159,848  43  $ 141,635  42  $ 18,213  13 
Family Heritage 112,354  31  103,391  30  8,963  9 
Liberty National 47,922  13  47,630  14  292  1 
American Income 30,691  8  30,497  9  194  1 
Direct to Consumer 18,976  5  17,866  5  1,110  6 
Total
$ 369,791  100  $ 341,019  100  $ 28,772  8 

Premiums related to limited-benefit supplemental health products comprise $208 million, or 56%, of the total health premiums for the three months ended March 31, 2025, compared with $192 million, or 56%, in the same period in the prior year. Premium from Medicare Supplement products comprises the remaining $162 million, or 44%, for the three months ended March 31, 2025, compared to $149 million, or 44%, in the same period in the prior year.

Annualized health premium in force was $1.51 billion at March 31, 2025, an increase of 8% over $1.40 billion a year earlier.

Presented below is a table of health net sales by distribution channel.
 
Health Insurance
Net Sales by Distribution Channel
(Dollar amounts in thousands)
  Three Months Ended March 31, Increase
(Decrease)
  2025 2024
Amount % of Total Amount % of Total Amount %
United American $ 27,708  41  $ 16,423  30  $ 11,285  69 
Family Heritage 26,816  40  24,966  46  1,850  7 
Liberty National 7,198  11  7,613  14  (415) (5)
American Income 4,870  7  4,594  8  276  6 
Direct to Consumer 645  1  804  2  (159) (20)
Total
$ 67,237  100  $ 54,400  100  $ 12,837  24 

Health net sales related to limited-benefit supplemental health products comprise $48 million, or 72%, of the total health net sales for the three months ended March 31, 2025, compared with $40 million, or 73%, in the same period in the prior year. Medicare Supplement sales make up the remaining $19 million, or 28%, for 2025 compared to $14 million, or 27%, in the same period in the prior year.

62
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

The following table presents health insurance first-year collected premium by distribution channel.

 Health Insurance
First-Year Collected Premium by Distribution Channel
(Dollar amounts in thousands)
  Three Months Ended March 31, Increase
(Decrease)
  2025 2024
Amount % of Total Amount % of Total Amount %
United American $ 20,162  37  $ 19,181  38  $ 981  5 
Family Heritage 21,476  39  18,983  37  2,493  13 
Liberty National 7,045  13  6,895  14  150  2 
American Income 4,767  9  4,590  9  177  4 
Direct to Consumer 1,089  2  884  2  205  23 
Total
$ 54,539  100  $ 50,533  100  $ 4,006  8 
 
First-year collected premium related to limited-benefit supplemental health products is $38 million, or 69%, of total first-year collected premium for the three months ended March 31, 2025 compared with $37 million, or 73%, in the same period in the prior year. First-year collected premium from Medicare Supplement policies make up the remaining $17 million, or 31%, for the three months ended March 31, 2025 compared to $14 million, or 27%, in the same period in the prior year.

A discussion of health operations by distribution channel follows.
The United American Division consists of non-exclusive independent agencies who may also sell for other companies. The United American Division was Globe Life's largest health agency in terms of health premium income, with net sales up 69% from the same period in the prior year.
This Division includes different units:

•UA General Agency, which primarily sells individual Medicare Supplement insurance through independent agents;
•Special Markets, which markets retiree health insurance to employer and union groups through brokers; and
•Globe Life Group Benefits, which offers group worksite supplemental health insurance through brokers.

The majority of the premium revenue comes from Medicare Supplement. Underwriting margin as a percent of premium for the Division was 1% for the three months ended March 31, 2025 and 8% for the same period in 2024. The decline in underwriting margin as a percent of premium when compared to prior year is primarily attributable to increased claims utilization during the current quarter from Medicare Supplement.

The Family Heritage Division primarily markets limited-benefit supplemental health insurance in small- to medium- sized businesses. Most of its policies include a return of premium feature, where premium paid is returned less any claims paid to the policyholder at the end of a specified period stated within the insurance policy. Underwriting margin as a percent of premium was 35% for the three months ended March 31, 2025 and 2024.
The Division experienced a 7% rise in health net sales as compared with the three-month period a year ago, primarily due to increased agent count. The Division will continue to implement incentive and retention programs to further these increases in the number of producing agents.
63
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

Below is the average producing agent count at the end of the period for the Family Heritage Division. The average producing agent count is based on the actual count at the beginning and end of each week during the year. The average producing agent count increased 9% compared with the same period a year ago. Along with the Division's increased efforts to grow agent count, it is also focused on the further training and development of its middle management. While growth in net sales and earned premium is impacted by agent productivity, growth in the number of average producing agents is what will ultimately be the primary driver of future growth in sales, similar to our other exclusive agencies.
At March 31,
 Change
2025 2024 Amount %
Family Heritage
 1,417  1,295  122  9 

The Liberty National Division represented 13% of all Globe Life health premium income for the three months ended March 31, 2025. The Liberty National Division markets limited-benefit supplemental health products, consisting primarily of cancer, critical illness, and accident insurance. Much of Liberty National's health business is generated through worksite marketing targeting small businesses. Health premium at the Liberty National Division was $47.9 million for the three months ended March 31, 2025 up from $47.6 million for the same period in 2024. Liberty National's first-year collected premium rose 2% to $7.0 million in the three months ended March 31, 2025 compared with $6.9 million for the same period in 2024. Health net sales for the three months ended March 31, 2025 fell 5% from the comparable period in 2024. For the three months ended March 31, 2025, underwriting margin as a percent of premium was 54% compared with 56% in the same period in the prior year.

While both the American Income Life Division and the Direct to Consumer Division sell life insurance, they also market health products. The American Income Life Division primarily markets accident plans. The Direct to Consumer Division primarily markets Medicare Supplement insurance to employer or union-sponsored groups. On a combined basis, these other channels accounted for 13% of health premium for the three months ended March 31, 2025 and 14% for the same period in 2024.


INVESTMENTS

We manage our capital resources, including investments and cash flow, through the investment segment. Excess investment income represents the profit margin attributable to investment operations and is the measure that we use to evaluate the performance of the investment segment as described in Note 12—Business Segments. It is defined as net investment income less the required interest attributable to policy liabilities.

Management views excess investment income per diluted common share as an important and useful measure to evaluate the performance of the investment segment. It is defined as excess investment income divided by the total diluted weighted average shares outstanding, representing the contribution by the investment segment to the consolidated earnings per share of the Company.

64
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

Excess Investment Income. The following table summarizes Globe Life's investment income, excess investment income, and excess investment income per diluted common share.

Analysis of Excess Investment Income
(Dollar amounts in thousands, except for per share data) 
 
Three Months Ended
March 31,		 Change
2025 2024 Amount %
Net investment income $ 280,614  $ 282,578  $ (1,964) (1)
Interest on policy liabilities(1)
 (244,744) (238,793) (5,951) 2 
Excess investment income
$ 35,870  $ 43,785  $ (7,915) (18)
Excess investment income per diluted share
$ 0.42  $ 0.46  $ (0.04) (9)
Mean invested assets (at amortized cost) $ 21,435,420  $ 21,156,813  $ 278,607  1 
Average insurance policy liabilities 17,620,769  17,275,395  345,374  2 
(1)Interest on policy liabilities, at original rates, is a component of total policyholder benefits, a GAAP measure.

Excess investment income declined $7.9 million, or 18%, compared with the year-ago period. Excess investment income per diluted common share was $0.42 for the three months ended March 31, 2025, a decrease of 9% from the prior-year period. Excess investment income per diluted common share generally increases or decreases at a different pace than excess investment income because the number of diluted shares outstanding generally decreases from year to year as a result of our share repurchase program.

Net investment income for the three months ended March 31, 2025 was $281 million, or 1% less than the year-ago period. Mean invested assets increased 1% during the first three months of 2025 over the same period last year. Investment income declined in the current period primarily due to lower earned yields on short term investments, commercial mortgage loans and limited partnerships compared to the prior year. The effective annual yield rate earned on the fixed maturity portfolio was 5.25% in the first three months of 2025, compared to 5.24% a year earlier. In addition to fixed maturities, the Company has also invested in commercial mortgage loans and limited partnerships with debt-like characteristics that diversify risk and enhance risk-adjusted, capital-adjusted returns on the portfolio. The earned yield on the Company's commercial mortgage loans for the three months ended March 31, 2025 was 6.53% compared with 8.70% in the prior year period. The lower earned yield on commercial mortgage loans is partly due to lower floating rates in addition to loans in non-accrual status. The earned yield on limited partnership investments for the three months ended March 31, 2025 was 7.95%. See additional information in Note 4—Investments.

Globe Life's net investment income benefits from higher interest rates on new investments. While increasing interest rates have resulted in a net unrealized loss from our available-for-sale debt securities included in accumulated other comprehensive income (loss) as of March 31, 2025, we are not concerned because we do not generally intend to sell, nor is it likely that we will be required to sell, the fixed maturities prior to their anticipated recovery.

Required interest on insurance policy liabilities reduces excess investment income, as it is the amount of net investment income considered by management necessary to cover the interest-related growth on insurance policy liabilities. As such, it is reclassified from the insurance segment to the investment segment. As discussed in Note 12—Business Segments, management regards this as a more meaningful analysis of the investment and insurance segments. Required interest is based on the original discount rate assumptions for our insurance policies in force.

The vast majority of our life and health insurance policies are fixed interest rate protection policies, not investment products, and are accounted for under current GAAP accounting guidance for long-duration insurance products which mandates that interest rate assumptions for a particular block of business be “locked in” for the life of that block of business. Each calendar year, we set the original discount rate to be used to calculate the benefit reserve liability for all insurance policies issued that year. The liability reported on the balance sheet is updated in subsequent periods using current discount rates as of the end of the relevant reporting period with a corresponding adjustment to other comprehensive income.
65
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Management's Discussion & Analysis


The discount rate used for policies issued in the current year has no impact on the in force policies issued in prior years, as the rates of all prior issue years are also locked in for purposes of recognizing income. As such, the overall original discount rate for the entire in force block of 5.6% is a weighted average of the discount rates being used from all issue years. Changes in the overall weighted-average discount rate over time are caused by changes in the mix of the reserves on the entire block of in force business. Business issued in the current year has little impact on the overall weighted-average original discount rate due to the size of our in force business.

In comparison to the year-ago period, required interest on insurance policy liabilities increased $6 million, or 2%, to $245 million, consistent with the 2% growth in average interest-bearing insurance policy liabilities.

Realized Gains and Losses. Our life and health insurance companies collect premium income from policyholders for the eventual payment of policyholder benefits, sometimes paid for many years or even decades in the future. Since benefits are expected to be paid in future periods, premium receipts in excess of current expenses are invested to provide for these obligations. For this reason, we hold a significant investment portfolio as a part of our core insurance operations. This portfolio consists primarily of high-quality fixed maturities containing an adequate yield to provide for the cost of carrying these long-term insurance product obligations. As a result, fixed maturities are generally held for long periods to support these obligations. Expected yields on these investments are taken into account when setting insurance premium rates and product profitability expectations.

Despite our intent to hold fixed maturity investments for a long period of time, investments are occasionally sold, exchanged, called, or experience a credit loss event, resulting in a realized gain or loss. Gains or losses are only secondary to our core insurance operations of providing insurance coverage to policyholders. In a bond exchange offer, bondholders may consent to exchange their existing bonds for another class of debt securities. The Company also has investments in certain limited partnerships, held under the fair value option, with fair value changes recognized in Realized gains (losses) in the Condensed Consolidated Statements of Operations.

Realized gains and losses can be significant in relation to the earnings from core insurance operations, and as a result, can have a material positive or negative impact on net income. The significant fluctuations caused by gains and losses can cause period-to-period trends of net income that are not indicative of historical core operating results or predictive of the future trends of core operations. Accordingly, they have no bearing on core insurance operations or segment results as we view operations. For these reasons, and in line with industry practice, we remove the effects of realized gains and losses when evaluating overall insurance operating results.
66
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

The following table summarizes our tax-effected realized gains (losses) by component.

Analysis of Realized Gains (Losses), Net of Tax
(Dollar amounts in thousands, except for per share data)
  Three Months Ended March 31,
  2025 2024
  Amount Per Share Amount Per Share
Fixed maturities:
Sales $ 11  $ —  $ 111  $ — 
Matured or other redemptions(1)
 612  0.01  —  — 
Provision for credit losses 32  —  70  — 
Fair value option—change in fair value 1,873  0.02  (12,168) (0.13)
Mortgages
 342  —  (691) — 
Other investments
 (852) (0.01) 248  — 
Total realized gains (losses)—investments
2,018  0.02  (12,430) (0.13)
Other gains (losses)(2)
 (1,951) (0.02) 3,109  0.03 
Total realized gains (losses)
$ 67  $ —  $ (9,321) $ (0.10)
(1)During the three months ended March 31, 2025 and 2024, the Company recorded $55.7 million and $66.9 million, respectively, of exchanges of fixed maturity securities (noncash transactions) that resulted in a realized gains of $42 thousand and $0 net of tax, respectively.
(2)Other realized gains (losses) are primarily a result of changes in the fair value for assets held in rabbi trust.
67
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

Investment Acquisitions. Globe Life's investment policy calls for investing primarily in investment grade fixed maturities that meet our quality and yield objectives. We generally invest in securities with longer-term maturities because they more closely match the long-term nature of our life and health policy liabilities. We believe this strategy is appropriate since our expected future cash flows are generally stable and predictable and the likelihood that we will need to sell invested assets to raise cash is low.

The following table summarizes selected information for fixed maturity investments. The effective annual yield shown is based on the acquisition price and call features, if any, of the securities. For non-callable bonds, the yield is calculated to maturity date. For callable bonds acquired at a premium, the yield is calculated to the earliest known call date and call price after acquisition ("first call date"). For all other callable bonds, the yield is calculated to maturity date.

Fixed Maturity Acquisitions Selected Information
(Dollar amounts in thousands)
Three Months Ended
March 31,
  2025 2024
Cost of acquisitions:
Investment-grade corporate securities $ 236,723  $ 678,795 
Investment-grade municipal securities 1,000  3,320 
Other securities
 7,122  312 
Total fixed maturity acquisitions(1)
$ 244,845  $ 682,427 
Effective annual yield (one year compounded)(2)
 6.41  % 5.86  %
Average life (in years, to next call) 40.7  30.4 
Average life (in years, to maturity) 43.1  32.3 
Average rating A- A-
(1)Fixed maturity acquisitions included unsettled trades of $12.0 million in 2025 and $0 in 2024.
(2)Tax-equivalent basis, where the yield on tax-exempt securities is adjusted to produce a yield equivalent to the pretax yield on taxable securities.

For investments in callable bonds, the actual life of the investment will depend on whether the issuer calls the investment prior to the maturity date. Given our investments in callable bonds, the actual average life of our investments cannot be known at the time of the investment. Absent sales and "make-whole calls," however, the average life will not be less than the average life to next call and will not exceed the average life to maturity. Data for both of these average life measures is provided in the above chart.

Acquisitions in 2025 and 2024 consisted primarily of corporate and municipal bonds with securities spanning a diversified range of issuers, industry sectors, and geographical regions. In the first three months of 2025, we invested primarily in the industrial, financial, and utility sectors. For the entire portfolio, the taxable equivalent effective yield earned was 5.25%, up approximately 1 basis point from the yield in the first three months of 2024. The increase in taxable equivalent effective yield was primarily due to new purchases at yields exceeding the yield on dispositions and the average portfolio yield. Our investment in fixed maturity securities was lower this quarter as we also invested in other investment opportunities. For the remainder of 2025, the Company will continue to execute on its existing strategy by seeking to invest in assets that satisfy our quality and other objectives, while maximizing the highest risk-adjusted, capital-adjusted return.

68
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

In addition to the fixed maturity acquisitions, Globe Life invested in commercial mortgage loans and in other long-term investments. Other long-term investments primarily consist of investment funds. See Note—4 Investments for further discussion.

The following table summarizes Globe Life's other investment acquisitions of the following assets.

Other Investment Acquisitions
(Dollar amounts in thousands)
Three Months Ended
March 31,
2025 2024
Limited partnerships
 $ 15,831  $ 67,498 
Commercial mortgage loans
 35,621  58,406 
Common stock
 502  11,968 
Convertible notes
 —  1,350 
Total
$ 51,954  $ 139,222 

Since fixed maturities represent such a significant portion of our investment portfolio, 88% of total amortized cost net of allowance for credit losses at March 31, 2025, the remainder of the discussion of portfolio composition will focus on fixed maturities. Selected information concerning the fixed maturity portfolio is as follows:

Fixed Maturity Portfolio Selected Information
At
March 31,
2025		 December 31, 2024 March 31,
2024
Average annual effective yield(1)
 5.26% 5.25% 5.25%
Average life, in years, to:
Next call(2)
 15.3 15.1 14.9
Maturity(2)
 19.4 19.3 18.9
Effective duration to:
Next call(2,3)
 8.8 8.8 8.9
Maturity(2,3)
 10.6 10.6 10.7
(1)Tax-equivalent basis. The yield on tax-exempt securities is adjusted to produce a yield equivalent to the pretax yield on taxable securities.
(2)Globe Life calculates the average life and duration of the fixed maturity portfolio two ways:
(a) based on the next call date which is the next call date for callable bonds and the maturity date for noncallable bonds; and
(b) based on the maturity date of all bonds, whether callable or not.
(3)Effective duration is a measure of the price sensitivity of a fixed-income security to a 1% change in interest rates.

69
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

Credit Risk Sensitivity. The following tables summarize certain information about the major corporate sectors and security types held in our fixed maturity portfolio at March 31, 2025 and December 31, 2024.

Fixed Maturities by Sector
March 31, 2025
(Dollar amounts in thousands)
Below Investment Grade Total Fixed Maturities
% of Total
Fixed Maturities
  Amortized
Cost, net 		Gross
Unrealized
Gains		 Gross
Unrealized
Losses		 Fair
Value		 Amortized
Cost, net 		Gross
Unrealized
Gains		 Gross
Unrealized
Losses		 Fair
Value		 At Amortized Cost, net At Fair Value
Corporates:
Financial
Insurance - life, health, P&C $ 8,009  $ 91  $ —  $ 8,100  $ 2,860,395  $ 66,672  $ (184,455) $ 2,742,612  15  16 
Banks 70,724  439  (3,371) 67,792  996,052  21,525  (51,242) 966,335  6  5 
Other financial 74,973  —  (13,143) 61,830  1,169,714  18,860  (135,319) 1,053,255  6  6 
Total financial 153,706  530  (16,514) 137,722  5,026,161  107,057  (371,016) 4,762,202  27  27 
Industrial
Energy 44,561  —  (4,807) 39,754  1,304,101  42,167  (69,481) 1,276,787  7  7 
Basic materials —  —  —  —  1,142,182  25,342  (85,176) 1,082,348  6  6 
Consumer, non-cyclical 640  —  (2) 638  2,128,380  17,612  (219,475) 1,926,517  11  11 
Other industrials 25,000  —  (4,819) 20,181  1,096,351  19,090  (96,477) 1,018,964  6  6 
Communications —  —  —  —  830,454  15,266  (84,285) 761,435  4  4 
Transportation —  —  —  —  630,157  13,774  (36,726) 607,205  3  4 
Consumer. cyclical 127,790  194  (18,026) 109,958  491,816  3,837  (64,123) 431,530  3  2 
Technology 50,276  —  (631) 49,645  341,407  926  (61,869) 280,464  2  2 
Total industrial 248,267  194  (28,285) 220,176  7,964,848  138,014  (717,612) 7,385,250  42  42 
Utilities 58,998  —  (6,652) 52,346  2,104,309  57,954  (101,935) 2,060,328  11  12 
Total corporates
460,971  724  (51,451) 410,244  15,095,318  303,025  (1,190,563) 14,207,780  80  81 
States, municipalities, and political divisions:
General obligations —  —  —  —  910,054  4,713  (196,496) 718,271  5  4 
Revenues —  —  —  —  2,385,079  22,841  (365,210) 2,042,710  12  12 
Total states, municipalities, and political divisions
—  —  —  —  3,295,133  27,554  (561,706) 2,760,981  17  16 
Other fixed maturities:
Government (U.S. and foreign) —  —  —  —  445,527  81  (41,248) 404,360  2  2 
Collateralized debt obligations 36,609  5,046  —  41,655  36,609  5,046  —  41,655  —  — 
Other asset-backed securities 8,779  23  —  8,802  91,425  69  (1,303) 90,191  1  1 
Total fixed maturities
$ 506,359  $ 5,793  $ (51,451) $ 460,701  $ 18,964,012  $ 335,775  $ (1,794,820) $ 17,504,967  100 100



70
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

Fixed Maturities by Sector
December 31, 2024
(Dollar amounts in thousands)
Below Investment Grade Total Fixed Maturities
% of Total
Fixed Maturities
  Amortized
Cost		 Gross
Unrealized
Gains		 Gross
Unrealized
Losses		 Fair
Value		 Amortized
Cost		 Gross
Unrealized
Gains		 Gross
Unrealized
Losses		 Fair
Value		 At Amortized Cost, net At Fair Value
Corporates:
Financial
Insurance - life, health, P&C $ 38,584  $ 32  $ (7,801) $ 30,815  $ 2,817,161  $ 49,928  $ (206,943) $ 2,660,146  15  15 
Banks 65,718  254  (3,506) 62,466  1,026,367  17,023  (59,795) 983,595  6  6 
Other financial 74,973  —  (14,917) 60,056  1,162,847  15,647  (146,305) 1,032,189  6  6 
Total financial 179,275  286  (26,224) 153,337  5,006,375  82,598  (413,043) 4,675,930  27  27 
Industrial
Energy 44,580  —  (5,410) 39,170  1,318,501  33,825  (77,700) 1,274,626  7  7 
Basic materials —  —  —  —  1,147,932  20,121  (91,699) 1,076,354  6  6 
Consumer, non-cyclical 640  —  (3) 637  2,087,181  11,222  (255,241) 1,843,162  11  11 
Other industrials 25,000  —  (4,796) 20,204  1,089,118  14,847  (108,283) 995,682  6  6 
Communications —  —  —  —  832,355  12,085  (90,817) 753,623  4  4 
Transportation —  —  —  —  572,829  9,800  (38,953) 543,676  3  3 
Consumer. cyclical 128,674  331  (28,378) 100,627  492,653  3,113  (75,592) 420,174  3  3 
Technology 50,278  —  (2,419) 47,859  341,407  597  (67,045) 274,959  2  2 
Total industrial 249,172  331  (41,006) 208,497  7,881,976  105,610  (805,330) 7,182,256  42  42 
Utilities 58,996  22  (6,797) 52,221  2,081,366  39,716  (118,007) 2,003,075  11  12 
Total corporates 487,443  639  (74,027) 414,055  14,969,717  227,924  (1,336,380) 13,861,261  80  81 
States, municipalities, and political divisions:
General obligations —  —  —  —  909,765  3,695  (177,021) 736,439  5  4 
Revenues —  —  —  —  2,391,136  16,967  (357,738) 2,050,365  13  12 
Total states, municipalities, and political divisions
—  —  —  —  3,300,901  20,662  (534,759) 2,786,804  18  16 
Other fixed maturities:
Government (U.S., municipal, and foreign) —  —  —  —  438,636  19  (51,664) 386,991  2  2 
Collateralized debt obligations 36,923  5,943  —  42,866  36,923  5,943  —  42,866  —  — 
Other asset-backed securities 4,754  10  —  4,764  79,237  39  (2,186) 77,090  —  1 
Total fixed maturities $ 529,120  $ 6,592  $ (74,027) $ 461,685  $ 18,825,414  $ 254,587  $ (1,924,989) $ 17,155,012  100 100



71
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

Corporate securities, which consist of bonds and redeemable preferred stocks, were the largest component of the fixed maturity portfolio as of March 31, 2025, representing 80% of amortized cost, net, and 81% of fair value. The remainder of the portfolio is invested primarily in securities issued by the U.S. government and U.S. municipalities. The Company holds insignificant amounts in foreign government bonds, collateralized debt obligations, asset-backed securities, and mortgage-backed securities. Corporate securities are diversified over a variety of industry sectors and issuers. At March 31, 2025, the total fixed maturity portfolio consisted of 1,018 issuers.

Fixed maturities had a fair value of $17.5 billion at March 31, 2025, compared to $17.2 billion at December 31, 2024. The net unrealized loss position in the fixed-maturity portfolio decreased from $1.7 billion at December 31, 2024 to $1.5 billion at March 31, 2025 due to a change in market rates during the period.

For more information about our fixed maturity portfolio by component at March 31, 2025 and December 31, 2024, including a discussion of allowance for credit losses, an analysis of unrealized investment losses, and a schedule of maturities, see Note 4—Investments.

An analysis of the fixed maturity portfolio by composite quality rating at March 31, 2025 and December 31, 2024, is shown in the following tables. The company uses the NAIC designation for credit quality ratings. The NAIC designation is generally determined using the second lowest rating available from nationally recognized statistical rating organizations (“NRSRO”) when three or more ratings are available and the lowest rating when two or fewer rating are available. When NRSRO ratings are unavailable the rating may be assigned by the Securities Valuation Office (“SVO”) of the NAIC.

Fixed Maturities by Rating
At March 31, 2025
(Dollar amounts in thousands)
Amortized Cost, net % of Total Fair
Value		 % of Total Average Composite Quality Rating on Amortized Cost, net
Investment grade:
AAA $ 972,215  5  $ 867,562  5 
AA 3,253,890  17  2,721,303  15 
A 5,636,339  30  5,354,094  31 
BBB+ 3,194,728  17  3,026,913  17 
BBB 4,134,746  22  3,894,070  22 
BBB- 1,265,735  6  1,180,324  7 
Total investment grade
18,457,653  97  17,044,266  97  A-
Below investment grade:
BB 376,248  2  337,197  2 
B 91,303  1  79,650  1 
Below B 38,808  —  43,854  — 
Total below investment grade
506,359  3  460,701  3  B+
$ 18,964,012  100  $ 17,504,967  100 
Weighted average composite quality rating
A-


72
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

Fixed Maturities by Rating
At December 31, 2024
(Dollar amounts in thousands)
Amortized
Cost, net		 % of Total
Fair
Value
 % of Total Average Composite Quality Rating on Amortized Cost
Investment grade:
AAA $ 968,220  5  $ 855,165  5 
AA 3,225,044  17  2,691,908  15 
A 5,508,446  29  5,147,203  30 
BBB+ 3,267,101  17  3,040,313  18 
BBB 4,087,323  22  3,799,696  22 
BBB- 1,240,160  7  1,159,042  7 
Total investment grade
18,296,294  97  16,693,327  97  A-
Below investment grade:
BB 397,823  2  349,028  2 
B 92,176  1  67,593  1 
Below B 39,121  —  45,064  — 
Total below investment grade
529,120  3  461,685  3  BB-
$ 18,825,414  100  $ 17,155,012  100 
Weighted average composite quality rating
A-

The overall quality rating of the portfolio is A-, the same as of year end 2024. Fixed maturities rated BBB are 45% of the total portfolio at March 31, 2025, down from 46% at December 31, 2024. While this ratio is high relative to our peers, it is at its lowest level since 2007 and we have limited exposure to higher-risk assets such as derivatives, equities, and asset-backed securities. Additionally, the Company does not participate in securities lending and has no off-balance sheet investments as of March 31, 2025. Of our fixed maturity purchases, BBB securities generally provide the Company with the best risk-adjusted, capital-adjusted returns largely due to our ability to hold securities to maturity regardless of fluctuations in interest rates or equity markets.

An analysis of changes in our portfolio of below-investment grade fixed maturities at amortized cost, net of allowance for credit losses is as follows:

Below-Investment Grade Fixed Maturities
(Dollar amounts in thousands)
Three Months Ended
March 31,
2025 2024
Balance at beginning of period
$ 529,120  $ 529,511 
Downgrades by rating agencies 5,074  — 
Upgrades by rating agencies (30,555) (4,592)
Dispositions
 (916) (275)
Acquisitions
 4,024  17,737 
Provision for credit losses 36  88 
Amortization and other (424) (447)
Balance at end of period
$ 506,359  $ 542,022 


73
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

Our investment policy calls for investing primarily in fixed maturities that are investment grade and meet our quality and yield objectives. Thus, the balance of below-investment grade issues is primarily the result of ratings downgrades of existing holdings. Below-investment grade bonds at amortized cost, net of allowance for credit losses, were 3% of total fixed maturities at amortized cost as of March 31, 2025. Globe Life invests long term and as such, one of our key criteria in our investment process is to select issuers that are anticipated to weather multiple economic cycles.


OPERATING EXPENSES

Operating expenses are classified into two categories: insurance administrative expenses and expenses of the Parent Company. Insurance administrative expenses generally include expenses incurred after a policy has been issued. As these expenses relate to premium for a given period, management measures the expenses as a percentage of premium income. The Company also views stock-based compensation expense as a Parent Company expense. Expenses associated with the issuance of our insurance policies are reflected as acquisition expenses and included in the determination of underwriting margin.

An analysis of operating expenses is shown below.

Operating Expenses Selected Information
(Dollar amounts in thousands)
  Three Months Ended March 31, Increase
  2025 2024 (Decrease)
Amount % of
Premium		 Amount % of
Premium		 Amount %
Insurance administrative expenses:
Salaries $ 33,688  2.8  $ 31,174  2.7  $ 2,514  8 
Other employee costs 10,301  0.9  10,013  0.9  288  3 
Information technology costs 20,936  1.7  18,307  1.6  2,629  14 
Legal costs 6,249  0.5  5,273  0.4  976  19 
Other administrative costs 16,375  1.4  15,644  1.4  731  5 
Total insurance administrative expenses 87,549  7.3  80,411  7.0  7,138  9 
Parent company expense 3,050  2,826  224 
Stock compensation expense 12,019  9,267  2,752 
Legal proceedings 6,128  —  6,128 
Non-operating expenses —  710  (710)
$ 108,746  $ 93,214  $ 15,532  17 

Total operating expenses for March 31, 2025 increased in comparison with the prior year primarily due to increases in insurance administrative expenses as well as stock compensation and legal proceedings. Insurance administrative expenses increased $7.1 million primarily due to higher information technology costs, legal costs including compliance and security, and employee costs, which include salaries and other costs. Insurance administrative expenses as a percent of premium were 7.3% for the three months ended March 31, 2025 compared to 7.0% for the same period in 2024.

74
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

SHARE REPURCHASES

Globe Life has an ongoing share repurchase program that began in 1986. The share repurchase program is reviewed with the Board of Directors quarterly, and continues indefinitely unless and until the Board of Directors decides to suspend, terminate or modify the program. On November 18, 2024, the Board of Directors authorized the repurchase of up to $1.8 billion under the Company's existing share repurchase program. Management generally determines the amount of repurchases based on the amount of the excess cash flows and other available sources after the payment of dividends to the Parent Company shareholders, general market conditions, and other alternative uses. Since implementing our share repurchase program in 1986, we have used $10.5 billion to repurchase Globe Life Inc. common shares, after determining that the repurchases provide a greater risk-adjusted after-tax return than other investment alternatives.

Excess cash flow at the Parent Company is primarily comprised of dividends received from the insurance subsidiaries less interest expense paid on its debt and other limited operating activities. Additionally, when stock options are exercised, proceeds from these exercises and the resulting tax benefit are used to repurchase additional shares on the open market to minimize dilution as a result of the option exercises.

The following table summarizes share repurchases for the three month periods ended March 31, 2025 and 2024.

Analysis of Share Repurchases
(Amounts in thousands, except per share data) 
  Three Months Ended March 31,
  2025 2024
 Purchases with:
 Shares Amount Average
Price		 Shares Amount Average
Price
Excess cash flow at the Parent Company(1)
 1,451  $ 176,546  $ 121.70  128  $ 15,602  $ 122.13 
Option exercise proceeds 700  86,624  123.76  63  7,927  126.20 
Total 2,151  $ 263,170  $ 122.37  191  $ 23,529  $ 123.47 
(1)Excludes excise tax on the repurchase of treasury stock of $1.4 million and $(60) thousand for the three months ended March 31, 2025 and 2024, respectively.
The amount of share repurchases in the first quarter was higher due to favorable market conditions related to the company's stock price and higher excess cash flow. The amount of excess cash flow was higher than in the prior year primarily due to higher statutory earnings and the inclusion of extraordinary dividends approved in late 2024. Refer to Note 11—Debt for further details. Throughout the remainder of this discussion, share repurchases will only refer to those made from excess cash flow at the Parent Company.

FINANCIAL CONDITION
 
Liquidity. Liquidity provides Globe Life with the ability to meet on demand the cash commitments required to support our business operations and meet our financial obligations. Our liquidity is primarily derived from multiple sources: positive cash flow from operations, a portfolio of marketable securities, a revolving credit facility, commercial paper, and advances from the Federal Home Loan Bank.

Insurance Subsidiary Liquidity. The operations of our insurance subsidiaries have historically generated substantial cash inflows in excess of immediate cash needs. Cash inflows for the insurance subsidiaries primarily include premium and investment income. In addition to investment income, maturities and scheduled repayments in the investment portfolio are cash inflows. Cash outflows from operations include policy benefit payments, commissions, administrative expenses, and taxes. A portion of cash inflows in the current year will provide for the payment of future policy benefits and are invested primarily in long-term fixed maturities as they better match the long-term nature of these obligations. Excess cash available from the insurance subsidiaries’ operations is generally distributed as a dividend to the Parent Company, subject to regulatory restrictions. The dividends are generally paid in amounts equal to the subsidiaries’ prior year statutory net income excluding realized capital gains. While the insurance subsidiaries annually generate more operating cash inflows than cash outflows, the companies also have the entire available-for-sale fixed maturity investment portfolio available to create additional cash flows if required.
75
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

Four of our insurance subsidiaries are members of the FHLB of Dallas. FHLB membership provides the insurance subsidiaries with access to various low-cost collateralized borrowings and funding agreements. While not the only source of liquidity, the FHLB could provide the insurance subsidiaries with an additional source of liquidity, if needed. Refer to Note 11—Debt for further details.

Parent Company Liquidity. An important source of Parent Company liquidity is the dividends from its insurance subsidiaries. These dividends are received throughout the year and are used by the Parent Company to pay dividends on common and preferred stock, interest and principal repayment requirements on Parent Company debt, and operating expenses of the Parent Company.
Three Months Ended
March 31,		 Twelve Months Ended
December 31,
2025 2024 Projected 2025 2024
Liquidity Sources:
Dividends from Subsidiaries $ 23,260  $ 52,046 
$700,000—$750,000
 $ 692,690 
Excess Cash Flows(1)
 $ 196,678  $ 62,118 
$785,000—$835,000
 $ 455,013 
(1)Excess cash flows are reported gross of shareholder dividends. For the three months ended March 31, 2025 and 2024, shareholder dividends were $20 million and $21 million, respectively. For the twelve months ended December 31, 2025, we project approximately $83 million in shareholder dividends, compared to the $85 million paid in 2024.

Dividends from subsidiaries and excess cash flows are projected to be higher in 2025 than in 2024 primarily due to improved earnings from favorable mortality trends and growth in business, as well as positive impacts from lower reserve increases under statutory accounting impacting the 2024 statutory earnings that derive the 2025 dividends. The excess cash flows in 2025 include the extraordinary dividends approved in the latter part of 2024 of $192 million. Additional sources of liquidity for the Parent Company are cash, intercompany receivables, intercompany borrowings, debt markets, term loans, and a revolving credit facility.

Short-Term Borrowings. An additional source of Parent Company liquidity is a credit facility with a group of lenders. The facility was amended on March 29, 2024, resulting in an increased capacity of $250 million. The facility allows for unsecured borrowings and stand-by letters of credit up to $1 billion, which could be increased up to $1.25 billion. While the Parent Company may request the increase, it is not guaranteed. The updated five-year credit agreement will mature on March 29, 2029. Up to $250 million in letters of credit can be issued against the facility. The facility serves as a backup line of credit for a commercial paper program under which commercial paper may be issued at any time, with total commercial paper outstanding not to exceed the facility maximum less any letters of credit issued. Interest charged on the commercial paper program resembles variable rate debt due to its short term nature. As of March 31, 2025, we had available $476 million of additional borrowing capacity under this facility, compared to $561 million a year earlier. As of March 31, 2025, the Parent Company was in full compliance with all covenants related to the aforementioned debt.

As a part of the credit facility, Globe Life has stand-by letters of credits. These letters of credit are issued on behalf of our insurance subsidiaries.

The following tables present certain information about our commercial paper borrowings.

Credit Facility—Commercial Paper
(Dollar amounts in thousands)
At
March 31,
2025		 December 31, 2024 March 31,
2024
Balance of commercial paper at end of period (par value) $ 409,500  $ 419,000  $ 324,000 
Annualized interest rate 5.13  % 5.22  % 5.63  %
Letters of credit outstanding $ 115,000  $ 115,000  $ 115,000 
Remaining amount available under credit line 475,500  466,000  561,000 

76
        GL Q1 2025 FORM 10-Q
Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

Credit Facility—Commercial Paper Activity
(Dollar amounts in thousands)
  Three Months Ended March 31,
  2025 2024
Average balance of commercial paper outstanding during period (par value) $ 478,950  $ 346,088 
Daily-weighted average interest rate (annualized) 5.08  % 5.68  %
Maximum daily amount outstanding during period (par value) $ 605,500  $ 384,000 

The Company reduced commercial paper borrowings by $10 million since year end. The Company was able to issue commercial paper as needed under this facility during the three months ended March 31, 2025 and 2024.

Globe Life expects to have readily available funds for 2025 and the foreseeable future to conduct its operations and to maintain target capital ratios in the insurance subsidiaries through liquid assets currently available, internally-generated cash flow and the credit facility. In the event more liquidity is needed, the Parent Company could generate additional funds through multiple sources including, but not limited to, the issuance of debt, an additional short-term credit facility or term loan, and intercompany borrowing.

Consolidated Liquidity. Consolidated net cash inflows from operations were $432 million in the first three months of 2025, compared with $351 million in the same period of 2024. The increase is attributable to routine fluctuations in the settlement of operating activities. In addition to cash inflows from operations, our insurance companies received proceeds from dispositions of fixed maturities available for sale, mortgage loans, and other long-term investments in the amount of $138 million during the first three months of 2025. As previously noted under the caption Short-Term Borrowings, the Parent Company has in place a revolving credit facility. The insurance companies have no additional outstanding credit facilities.

Cash and short-term investments were $366 million at March 31, 2025, compared with $250 million at December 31, 2024. In addition to these liquid assets, $17.5 billion (fair value at March 31, 2025) of fixed income securities are available for sale in the event of an unexpected need. Approximately $1.4 billion, at fair value, are pledged for outstanding FHLB advances and reinsurance. Further, approximately 98% of our fixed income securities are publicly traded, freely tradable under SEC Rule 144, or qualified for resale under SEC Rule 144A. While our fixed income securities are classified as available for sale, we have the ability and general intent to hold any securities to recovery or maturity. Our strong cash flows from operations, on-going investment maturities, and available liquidity under our credit facility make any need to sell securities for liquidity highly unlikely.

Capital Resources. The Parent Company's capital structure consists of short-term debt (the commercial paper facility and current maturities of long-term debt), long-term debt, and shareholders’ equity. It does not include short-term FHLB borrowings, which are obligations of the insurance subsidiaries and typically repaid over the course of the year.

Long-Term Borrowings. At March 31, 2025 and December 31, 2024, the outstanding long-term debt at book value was $2.3 billion and $2.3 billion, respectively.
77
        GL Q1 2025 FORM 10-Q
Table of Contents
GLOBE LIFE INC.
Management's Discussion & Analysis


Selected Information about Debt Issues
As of March 31, 2025
(Dollar amounts in thousands)
Instrument Issue Date Maturity Date Coupon Rate   Interest Payment Dates Par
Value		 Book
Value		 Fair
Value
Senior notes 09/27/2018 09/15/2028 4.550% semiannual $ 550,000  $ 547,186  $ 548,751 
Senior notes 08/21/2020 08/15/2030 2.150% semiannual 400,000  397,250  346,216 
Senior notes(1)
 05/19/2022 06/15/2032 4.800% semiannual 250,000  246,377  242,348 
Senior notes
 08/23/2024 09/15/2034 5.850% semiannual 450,000  444,915  459,194 
Junior subordinated debentures 11/17/2017 11/17/2057 5.275% semiannual 125,000  123,448  97,340 
Junior subordinated debentures 06/14/2021 06/15/2061 4.250% quarterly 325,000  317,408  208,130 
Term loan(2)
 05/11/2023 08/15/2027 5.798% quarterly 250,000  248,361  248,361 
Total long-term debt
2,350,000  2,324,945  2,150,340 
FHLB borrowings 70,000  70,000  70,000 
Commercial paper 409,500  406,891  406,891 
Total short-term debt
479,500  476,891  476,891 
Total debt
$ 2,829,500  $ 2,801,836  $ 2,627,231 
(1)An additional $150 million par value and book value is held by insurance subsidiaries that eliminates in consolidation.
(2)Interest calculated quarterly using Secured Overnight Financing Rate (SOFR) plus 135 basis points. The term loan was amended on August 15, 2024 extending the maturity date from November 11, 2024 to August 15, 2027 and increasing the principal amount from $170 million to $250 million.

Financing costs consist primarily of interest on our various debt instruments. The table below presents the components of financing costs and reconciles interest expense per the Condensed Consolidated Statements of Operations.

Analysis of Financing Costs
(Dollar amounts in thousands)
Three Months Ended
March 31,		 Increase
(Decrease)
2025 2024 Amount %
Interest on funded debt $ 23,553  $ 16,926  $ 6,627  39 
Interest on term loans 3,889  2,999  890  30 
Interest on short-term debt 7,550  8,683  (1,133) (13)
Other —  13  (13) (100)
Financing costs
$ 34,992  $ 28,621  $ 6,371  22 

During the first three months of 2025, financing costs increased 22% compared to the prior year. The increase in financing costs is primarily due to higher average balances in the current year compared to the prior year due to the issuance of debt in the third quarter of 2024. More information on our debt transactions is disclosed in the Financial Condition section of this report.

Subsidiary Capital: The National Association of Insurance Commissioners (NAIC) has established a risk-based factor approach for determining threshold risk-based capital levels for all insurance companies. This approach was designed to assist the regulatory bodies in identifying companies that may require regulatory attention. A Risk-Based Capital (RBC) ratio is typically determined by dividing adjusted total statutory capital by the amount of RBC determined using the NAIC’s factors. If a company’s RBC ratio approaches two times the RBC amount, the company must file a plan with the NAIC for improving its capital levels (this level is commonly referred to as “Company Action Level” RBC).
78
        GL Q1 2025 FORM 10-Q
Table of Contents
GLOBE LIFE INC.
Management's Discussion & Analysis

Companies typically hold a multiple of the Company Action Level RBC depending on their particular business needs and risk profile.

Our goal is to maintain statutory capital within our insurance subsidiaries at levels necessary to support our current ratings. For 2025, Globe Life has targeted a consolidated Company Action Level RBC ratio of 300% to 320%. The Company has concluded that this capital level is more than adequate and sufficient to support its current ratings, given the nature of its business and its risk profile. For 2024, our consolidated Company Action Level RBC ratio was 316%. The Parent Company is committed to maintaining the targeted consolidated RBC ratio at its insurance subsidiaries and has sufficient liquidity available to provide additional capital if necessary.

Shareholders' Equity: Shareholders’ equity was $5.4 billion at March 31, 2025. This compares with $5.3 billion at December 31, 2024 and $5.0 billion at March 31, 2024. During the three months since December 31, 2024, shareholders’ equity increased as a result of net income of $255 million during the first three months of 2025, but was offset by share repurchases of $177 million and an additional $87 million in share repurchases to offset the dilution from stock option exercises. Additionally, the change in the balance of AOCI increased shareholders' equity $59 million primarily due to increased interest rates and discount rates over the period.

On February 27, 2025, the Parent Company announced that it had declared a quarterly dividend of $0.27 per share. This dividend was paid on May 1, 2025.

We plan to use excess cash available at the Parent Company as efficiently as possible in the future. Excess cash flow, as we define it, results primarily from the dividends received by the Parent Company from its insurance subsidiaries less the interest paid on debt. The cash received by the Parent Company from our insurance subsidiaries is after they have made substantial investments during the year to grow the business. Possible uses of excess cash flow include, but are not limited to, share repurchases, acquisitions, shareholder dividend payments, investments in securities, or repayment of short-term debt. We will determine the best use of excess cash after ensuring that targeted capital levels are maintained in our insurance subsidiaries. If market conditions are favorable, we currently expect that share repurchases will continue to be a primary use of those funds.

Future policy benefits are computed using current discount rates with the impact of changes in discount rates included in accumulated other comprehensive income. Additionally, the liability for future policy benefits is calculated using net premiums rather than gross premiums. Given that gross premiums are considerably higher than net premiums for our business, as seen in Note 6—Policy Liabilities, the measurement of the liability is higher than what it would be had it been computed using gross premiums. This is an important consideration when analyzing shareholders' equity.

We maintain a significant available-for-sale fixed maturity portfolio to support our insurance policy liabilities. Current accounting guidance requires that we revalue our portfolio to fair market value at the end of each accounting period. The period-to-period changes in fair value, net of their associated impact on income tax, are reflected directly in shareholders’ equity. Changes in the fair value of the portfolio can result from changes in market rates.

While a majority of invested assets are revalued, accounting rules do not permit interest-bearing insurance policy liabilities to be valued at fair value in a consistent manner as that of assets, with changes in value applied directly to shareholders’ equity. Due to the size of our policy liabilities in relation to our shareholders’ equity, an inconsistency exists in measurement, which may have a material impact on the reported value of shareholders’ equity. Fluctuations in interest rates cause undue volatility in the period-to-period presentation of our shareholders’ equity, capital structure, and financial ratios. Due to the long-term nature of our fixed maturity investments and liabilities and the strong cash flows consistently generated by our insurance subsidiaries, we have the ability to hold our securities to maturity. As such, we do not expect to incur losses due to fluctuations in market value of fixed maturities caused by market rate changes and temporarily illiquid markets. Accordingly, our management, credit rating agencies, lenders, many industry analysts, and certain other financial statement users prefer to remove the effect of this accounting rule when analyzing our balance sheet, capital structure, and financial ratios.
79
        GL Q1 2025 FORM 10-Q
Table of Contents
Item 3. Quantitative and Qualitative Disclosures About Market Risk
 
There have been no quantitative or qualitative changes with respect to market risk exposure during the three months ended March 31, 2025.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures: Globe Life Inc., under the direction of the Co-Chairmen and Chief Executive Officers and the Executive Vice President and Chief Financial Officer, has established disclosure controls and procedures that are designed to ensure that information required to be disclosed by Globe Life in the reports that it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. The disclosure controls and procedures are also intended to ensure that such information is accumulated and communicated to Globe Life's management, including the Co-Chairmen and Chief Executive Officers and the Executive Vice President and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosures.
 
As of the end of the fiscal quarter completed March 31, 2025, an evaluation was performed under the supervision and with the participation of Globe Life management, including the Co-Chairmen and Chief Executive Officers and the Executive Vice President and Chief Financial Officer, of the disclosure controls and procedures (as those terms are defined in Rule 13a-15(e) under the Securities Exchange Act of 1934). Based upon their evaluation, the Co-Chairmen and Chief Executive Officers and the Executive Vice President and Chief Financial Officer have concluded that disclosure controls and procedures are effective as of the date of this Form 10-Q. In compliance with Section 302 of the Sarbanes Oxley Act of 2002 (18 U.S.C. § 1350), each of these officers executed a Certification included as an exhibit to this Form 10-Q.

Changes in Internal Control over Financial Reporting: During the period ended March 31, 2025, there were no changes to Globe Life Inc.'s internal control over financial reporting or in other factors that could significantly affect the internal control over financial reporting subsequent to the date of their evaluation which have materially affected, or are reasonably likely to materially affect, internal control over financial reporting.
 


80
        GL Q1 2025 FORM 10-Q
Table of Contents
Part II—Other Information

Item 1. Legal Proceedings

Discussion regarding litigation and unclaimed property audits is provided in Note 5—Commitments and Contingencies.


81
        GL Q1 2025 FORM 10-Q
Table of Contents
Item 1A. Risk Factors
 
The Company had no material changes to its risk factors.



Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Purchases of Certain Equity Securities by the Issuer and Others for the First Quarter of 2025
Period
(a) Total Number
of Shares
Purchased
(b) Average
Price Paid
Per Share
 (c) Total Number of
Shares Purchased as 
Part of Publicly Announced
Plans or Programs
(d) Maximum Number
of Shares (or
Approximate Dollar
Amount) that May
Yet Be Purchased
Under the Plans or
Programs
January 1-31, 2025 354,000  $ 112.47  354,000  — 
February 1-28, 2025 1,082,776  122.97  1,082,776  — 
March 1-31, 2025 713,774  126.38  713,774  — 


Item 5. Other Information

(c) Trading arrangements

During the three months ended March 31, 2025, none of our directors or officers adopted or terminated a Rule 10b5-1 trading arrangement or a Non-Rule 10b5-1 trading arrangement, as each term is defined under Item 408(a) of Regulation S-K.
82
        GL Q1 2025 FORM 10-Q
Table of Contents
Item 6. Exhibits
 
Exhibit No. Description
31.1
31.2
31.3
32.1
101.INS XBRL Instance Document- the instance document does not appear in the Interactive Data file because the XBRL tags are embedded within the Inline XBRL document.
101.SCH Inline XBRL Taxonomy Extension Schema Document.
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document.
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document.
104 Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101).


83
        GL Q1 2025 FORM 10-Q
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 
GLOBE LIFE INC.
Date: May 7, 2025 /s/ J. Matthew Darden
J. Matthew Darden
Co-Chairman and Chief Executive Officer
Date: May 7, 2025 /s/ Frank M. Svoboda
Frank M. Svoboda
Co-Chairman and Chief Executive Officer
Date: May 7, 2025 /s/ Thomas P. Kalmbach
Thomas P. Kalmbach
Executive Vice President and Chief Financial Officer

84
        GL Q1 2025 FORM 10-Q
EX-31.1 2 a10-qex311dardenq1fy2025.htm EX-31.1 Document

Exhibit 31.1
CERTIFICATIONS
I, J. Matthew Darden, certify that:
 
1.I have reviewed this quarterly report on Form 10-Q of Globe Life Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 7, 2025 /s/ J. Matthew Darden
J. Matthew Darden
Co-Chairman and Chief Executive Officer


EX-31.2 3 a10-qex312svobodaq1fy2025.htm EX-31.2 Document

Exhibit 31.2
CERTIFICATIONS
I, Frank M. Svoboda, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Globe Life Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)    Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)    Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:  May 7, 2025
 /s/ Frank M. Svoboda
Frank M. Svoboda
Co-Chairman and Chief Executive Officer


EX-31.3 4 a10-qex313kalmbachq1fy2025.htm EX-31.3 Document

Exhibit 31.3
CERTIFICATIONS
I, Thomas P. Kalmbach, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Globe Life Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 7, 2025 /s/ Thomas P. Kalmbach
Thomas P. Kalmbach
Executive Vice President and Chief Financial Officer

EX-32.1 5 a10-qexhibit321allq1fy2025.htm EX-32.1 Document

Exhibit 32.1
CERTIFICATION OF PERIODIC REPORT
We, J. Matthew Darden, Co-Chairman and Chief Executive Officer, Frank M. Svoboda, Co-Chairman and Chief Executive Officer, and Thomas P. Kalmbach, Executive Vice President and Chief Financial Officer, of Globe Life Inc., certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that, to the best of our knowledge:
 
(1)the Quarterly Report on Form 10-Q of the Company for the period ended March 31, 2025 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated:  May 7, 2025

/s/ J. Matthew Darden
J. Matthew Darden
Co-Chairman and Chief Executive Officer
/s/ Frank M. Svoboda
Frank M. Svoboda
Co-Chairman and Chief Executive Officer
/s/ Thomas P. Kalmbach
Thomas P. Kalmbach
Executive Vice President and
Chief Financial Officer